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Abstract 
The future of human embryonic stem cell  (hESC) research with regards to their applicability 
in a therapeutic setting, relies on the development and standardisation of consistent and 
robust methods to demonstrate their defining characteristics; their pluripotent ability to form 
all three germ layers and their capacity for self-renewal. Although much research has been 
carried out to investigate new methods of culturing hESCs, many of these studies have not 
robustly concluded the impact of prolonged culture on genetic and genomic stability nor have 
they examined in any comparative detail the impact of the culture conditions such as 
differences in feeders used or the media composition in which the stem cells are cultured in. 
The aim of this thesis therefore was to investigate and evaluate methods for improving the 
uniform and robust culture and characterisation of hESCs over prolonged periods in culture.  
Four hESC lines ( RH5, HUES9, SHEF1 and NCL5) were chosen on the basis that they had 
not previously been well characterised and therefore could potentially benefit the wider stem 
cell community by increasing diversity, rather than continue to use the already small subset 
of well publicised lines. The RH5, HUES9, SHEF1 and NCL5 cells were subjected to long 
term passaging using recombinant enzyme TrypLE™ Express, on human feeders, mouse 
feeders and feeder free matrix Matrigel in combination with defined media mTeSR1, for 
uniform scale up. Changes in characteristic stem cell surface markers were compared using 
two techniques; flow cytometry and quantitative in situ fluorescence microscopy. Genomic 
stability was assessed by real time PCR. Chromosomal integrity was monitored using array 
genomic hybridisation (aCGH).   
Array genomic hybridisation analysis of cells cultured for 20 passages by enzymatic 
passaging revealed changes in copy number variations in all the stem cell lines. Aberrations 
on chromosomes 12, 17 and 20, appeared most commonly as a result of long term culture. 
Although no significant differences were seen between hESCs cultured on mouse and 
human feeders, cultures on Matrigel showed fewer detected chromosomal aberrations. 
Expression of cell surface stemness markers SSEA3, SSEA4, TRA1-60 and TRA1-81 were 
maintained by hESC cultured on all matrices and confirmed by the use of flow cytometry and 
high throughput quantitative immunofluorescence imaging using the TissueFaxs™ cell 
analysis microscopy system.  In depth imaging revealed subtle but important differences in 
the way in which hESCs attach and proliferate on different matrices. Genetic profiling of 
each of the stem cell lines using Taqman Low density array cards to assess the expression 
of 96 genes by Real Time PCR, demonstrated the continued expression of stemness genes 
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at late passage, and low level expression of differentiation genes, inherent to particular stem 
cell lines.  
Although both mouse and human feeders and Matrigel support the undifferentiated growth of 
hESCs, subtle differences from the hESCs were seen as a result of their use, most 
obviously, changes in morphology and how they proliferate.  This was further explored in the 
stem cell line NCL5, as it demonstrated a readiness to adapt to new matrices, better 
chromosomal stability and higher expression of cell surface markers compared with the 
other hESC lines. Using in vitro differentiation assays to all three germ layers, NCL5 cultured 
to late passage (p+20) on human feeder iMRC5, mouse feeder iMEF and feeder free matrix 
Matrigel, demonstrated the ability to differentiate to ectoderm, endoderm and mesoderm 
progenitors after induction using three 7 day flat based directed differentiation protocols. 
Altered differentiation patterns were detected by Real Time PCR and TissueFaxs™ imaging 
and quantitative analysis, as a consequence of the prolonged culture on the specific 
matrices used. Such key findings allude to the strong influences of microenvironment and 
will help to improve the standardisation of in vitro differentiation assays. From these studies, 
chromosomal changes had no impact on NCL5 stem cell lines‘ ability to form progenitors, 
however small genetic instabilities may still play a role in terminal differentiation of germ 
lineage specific cell types.  
The findings of the programme of work described has led to the  successful culture methods 
and characterisation testing validated in this project being incorporated into routine culture 
and banking of research grade hESCs at the UK Stem Cell Bank. These protocols will now 
be made more widely available and should assist stem cell researchers in adopting the most 
suitable and optimum conditions for culturing stem cells in the undifferentiated and stable 
state.  With the huge surge in stem cell research over the past decade, the development of 
robust characterisation and culture methods will undoubtedly have significant impact on the 
exploitation of these cells for regenerative medicine and to assist with this a future aim of the 
stem cell bank will be to standardise methodologies for clinical grade banking. 
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Chapter 1 
General Introduction 
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1. Introduction 
Historically, traditional treatments for human disease had been focussed on the 
repair of damaged tissue and organs or the pharmacological management of 
disease and injury through the use of drugs. Fundamental advances in biology 
impacting on treatments have been rare. However, three in particular have resulted 
in radical progression during the last 50 years. 
The human genome project has forwarded the understanding of disease and opened 
up new areas of biomedical research, resulting in gene therapies. Molecular 
pathology has propelled the concept of personalised medicine, unveiling many 
possibilities, including the use of genetic screening for diseases such as chronic 
leukaemias and breast cancer in order to treat specific mutations within individuals 
(Holleman et al., 2004; Apostolou et al., 2013). Nonetheless, these remain extremely 
costly thus limiting their use for routine treatment of injury and diseases.  
Secondly, the concept of regenerative medicine has been introduced. This term was 
initially used as an umbrella to cover organ transplant and replacements such as 
joints (Tayton., 2012) and artificial tracheal replacement (Baiguera et al., 2010). 
These utilise biomedical scaffolds on which replacement tissues are built. The 
increase in sophistication of technology in the surgical setting has resulted in many 
such procedures becoming routine.  
The term regenerative medicine has also been expanded to include the use of stem 
cells in various settings such as bone marrow transplantation for the treatment of 
leukaemias. Stem cells have a unique pluripotential and can give rise to all the cell 
types in the body. It was in the 1900s that scientists became fascinated with the 
potential use for stem cells when it was first recorded that progenitor cells gave rise 
to immature blood cells (Lord & Dexter., 1995). Further studies resulted in their use 
in bone marrow cell transplants in the late 1950s (Lorenz et al.,1952; Jacobson et 
al.,1950) as stem cells present in the bone marrow are able to produce all the 
different blood cell types from a single stem cell. Adult stem cells are present in 
various parts of the body, notably the bone marrow and conjunctiva and can be 
harvested, grown and used to repair injury and disease for personalised individual 
therapies without the concern of host rejection. This is an advantage over organ 
transplantation. However, it is the discovery of embryonic stem cells by Thomson et 
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al. (2008) which has ushered in a new era of regenerative medicine possibilities in 
the form of ‗cell therapies‘ and is the third major advance in biology to fundamentally 
effect the treatment of injury and disease. 
1.1 What are Stem Cells? 
Stem cells are unspecialised cells of the embryo, foetus or adult and are defined by 
two main characteristics: they are capable of becoming any cell type in the body and 
they have the ability of self-renewal through cell division to continue producing 
progeny of unspecialised cells (Morrison & Kimble, 2006). Each new ‗daughter‘ cell 
may remain the same as its progenitor or become a more specialised cell type 
(differentiate). The majority of adult stem cells in the human body are lineage 
restricted. Stem cells become restricted by a process defined as differentiation. Cell 
differentiation is the process by which a cell  becomes fully mature, non-dividing with 
a specialised gene expression profile needed to carry out a specific tissue function 
(Reubinoff et al., 2000). It is this special characteristic that gives stem cells the 
unique potential to replace any cell type in the body.  
1.2 Stem cell differentiation potential 
On the basis of their developmental or differentiation potential ES cells can be further 
subdivided into the following types: totipotent, pluripotent, multipotent and unipotent. 
Totipotent stem cells are those which have the ability to form any cell type in the 
body. These stem cells have the ability to form the entire organism for example, the 
embryo and the trophoblast of the placenta. Multipotent cells have a more limited 
range of potential. Multipotent cells can form multiple lineages of differentiated cell 
lineages for an entire tissue or tissues and tend to be specific to their location for 
example, haematopoietic cells.  Cells with unipotential capacity (e.g. spematogenic 
stem cells) only have the potential to form cells of a single lineage (Smith., 2006). 
Pluripotent cells have the ability to form any cell type of all three of the germ layers, 
mesoderm, endoderm and ectoderm (Figure 1) and also include germ cells. It is this 
unique capacity to differentiate into numerous, varied cell lineages that makes 
human embryonic stem cells an exceptional tool to treat a host of illnesses and 
neurodegenerative disorders as well as an ideal model to understanding the intricate 
biology and various disease pathways in humans.  
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(Image obtained by free link to 
http://en.wikipedia.org/wiki/File:Stem_cells_diagram.png#file) 
 
1.3 Types and sources of stem cells 
1.3.1 Adult stem cells are found throughout the body. They have been identified 
and characterised in the skin, blood, gut, and bones. Their main role is maintenance 
through replacement and repair of the organ/tissue type from which they originate. 
Adult stem cells maintain their ability to divide throughout life, from early 
development through to late adulthood and they also give rise to specific cell types. 
For example, promyeloblasts in blood have the ability to form basophils and 
eosinophils (Schroeder, 2008). Tissue specific stem cells maintain a careful balance 
of proliferation, differentiation and cell death at a steady-state.  
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1.3.2 Foetal and neonatal stem cells have huge therapeutic potential but were 
originally very difficult to obtain due to ethical issues concerning the use of foetal 
material. Foetal stem cells were used for the treatment of neural diseases in the late 
1990s (Kordower et al.,1995; Shamblott et al., 1998; Deacon et al., 1999) including 
Parkinson‘s disease. It is during foetal development at approximately 5-6 weeks 
gestation, when primitive organs begin to form. This is thought to be a stem cell rich 
stage in development and has much potential for scientists to study developmental 
pathways that are crucial to organogenesis as well as other therapeutic potentials. 
Following on from the research of various groups (Andrews et al., 1991) a source of 
stem cells was found in the gonadal ridge of the aborted fetus. These cells are 
known as embryonic germ cells (EG) as they go on to develop germ cells. They have 
similar properties to embryonic stem cells (Shamblott et al., 1998) and have aided 
scientists with many important studies into the function of germ cells and 
embryology. 
Much foetal stem cell research has been conducted in mice (Martin, 1980; Liu et al., 
1997) and these types of studies may be the key to unlocking the secrets to 
promoting the regeneration of stem cells reserves, in order to repopulate damaged 
adult tissue. Foetal tissue had also been used in research into regenerating areas of 
neuronal cell growth within the brain to aid healing of damaged cells due to 
Parkinson‘s Disease and other mid brain trauma. Nonetheless, the use of foetal cells 
and tissue is an ethically sensitive area of research and has many barriers to 
overcome before being classed as acceptable tools for research. 
More recently cord blood has proved to be an easily obtainable source of 
concentrated neonatal stem cells. Its use in a clinical setting has been well translated 
and many companies have been set up to bank cord blood stem cells due to their 
potential use (Bertram & Shearer., 2007; Thornley et al., 2009).  
1.3.4 Embryonic Germ cells (EG) are cells found in the specific part of the embryo 
known as the gonadal ridge that normally develops into mature gametes. These cells 
share properties similar to those of ESCs (Geijsen et al., 2004; Hua et al., 2009). 
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1.3.5 Embryonic carcinoma cells (EC) are pluripotent stem cells derived from 
teratocarcinomas. These are malignant germ cell tumors that include a mixture of 
various differentiated cells (Andrews, 2002). Before the derivation of embryonic stem 
cells both EG and EC cells were used as in vitro models of mammalian 
differentiation (Solter, 2006). However, their value is limited as EC cell lines are well 
known to carry severe chromosomal abnormalities and have a relatively limited 
differentiation potential.  Therefore, these cell lines are better served as reference 
lines to the ES cell lines (Josephson et al., 2007).  
1.3.6 Embryonic stem cells (ESC) are derived from the blastocysts stage of an 
embryo. In humans, the majority of embryos are obtained from fertility clinics from 
patients undergoing IVF treatment. Specialist consent is given by the donors who 
allow the use of their embryos for research. These embryos would otherwise be 
discarded (Mitalipova et al., 2003). 
1.4 Deriving embryonic stem cells 
The first embryonic stem cell derivation came from mouse models, almost 30 years 
ago in 1981 when scientists Kaufman and Evans and Martin detailed the derivation 
culture process from mouse embryos (Evans, 1981). Previously, research on 
embryonic development and differentiation of cells was based around embryonic 
germ cells and embryonic carcinoma cells. Based on previous studies of early 
morula formation (Evans, 1972) and using delayed implantation, mimicked in 
laboratory mice through the administration of hormones, Kaufman and Evans 
extracted the blastocysts of pregnant mice. The blastocysts were recovered and 
carefully cultured. After a few days it was possible to dissociate the blastocysts into 
individual cells and transfer them to mitotically inactivated fibroblast feeder layers. 
The difference between Kaufman and Evans and Martins‘ work was that Martin 
chose to grow the cells using conditioned media from EC cells, whereas Evans and 
Martin used mitotically inactivated mouse feeders. From both culturing conditions 
mouse embryonic stem cells were successfully derived and mass-cultured in an 
undifferentiated state.  
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Following on from this work almost ten years later, Thomsons‘ group made the 
remarkable breakthrough of propagating human embryonic stem cells (Thomson et 
al., 1998) following the derivation of primate embryonic stem cells (Thomson et al., 
1996). The progression of Thomsons‘ work fuelled a number of labs to begin deriving 
human embryonic stem cell (hESC) lines in order to explore the many possibilities 
that these cells may hold for disease treatment.  
The inner cell mass (ICM) of the human blastocyst is isolated from the 
trophectoderm layer via immunosurgery at day five to six post fertilisation, and plated 
onto a mitotically inactivated fibroblast layer. After approximately two weeks in 
culture the ICM-derived cells are carefully dissociated by manual dissection and re-
plated, as outlined by Figure 2 (Bongso et al., 1994). Characteristic undifferentiated 
hESC morphology can be distinguished by a high nuclear: cytoplasmic ratio and 
many prominent nucleoli (Sathananthan et al., 2002).  
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Figure 1.2. The derivation process of human embryonic stem cells, as carried 
out by Thomsons‘ research group. (Obtained from website on 10th august 2010) 
obtained from: 
http://stemcells.nih.gov/StaticResources/info/scireport/images/figurec1.jpg 
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1.5 Induced pluripotent stem cells 
Stem cell research achieved another breakthrough in 2006, when Yamanaka et al 
successfully reprogrammed adult mouse fibroblasts to ES-like cells called induced 
pluripotent stem cells (IPSCs) using 4 pluripotency associated genes: OCT4, Sox2, 
Klf4 and c-Myc (Takahashi and Yamanaka, 2006). This resulted in the 
reprogramming of cells which have the characteristics of pluripotent ‗ES-like‘ cells 
and thus capable of differentiating into multiple lineages. Although reprogramming of 
cells is well practiced and documented (Li., 2002; Maherali et al., 2008; Kim et al., 
2009) the process of reprogramming to give rise to stem cells had not been achieved 
or previously attempted as scientists assumed that the adult stem cell pathway was 
finite and could not possibly be reversible. 
Induced pluripotent stem cells have an advantage over hESCs as they can be 
derived from the same person requiring differentiated cells/tissue, thus eliminating 
potential rejection (Zhao et al,. 2009; Knoepfler., 2009). The creation of IPSCs is a 
significant advancement towards personalised medicine and removes the ethical and 
political issues surrounding the use of embryos.  However, to realise the full potential 
of IPSCs, their detailed molecular characterisation is necessary to decide how 
comparable they are to human embryonic stem cells (Chin et al., 2009; Bock et al., 
2010; Chen et al., 2011), as little is known about their cellular reprogramming and 
stability and many scientists are concerned that the epigenetic memory of IPSC is 
retained by the cells from which they were reprogrammed (Kim et al., 2010). More 
recently the derivation of IPSCs using non integrating methods such as the 
StemGent™ mRNA kit, hold much greater promise for the progression of IPSCs into 
therapeutic applications (Warren et al., 2010; Yakubov et al., 2010) as they remove 
the use of viruses which present safety and biocontamination issues.  
1.6 Undifferentiated stem cell characteristics 
To be able to exploit the potential of hESCs their characteristics need to be fully 
understood. The characterisation of a stem cell is assessed through a number of 
different techniques. The first and most obvious is morphology. Distinct tight clusters 
of cell colonies with prominent bright nuclei and a high nuclear to cytoplasmic ratio, 
as shown in Figure 1.3,  gives a clear indication of undifferentiated stem cells under 
a microscope (Sathananthan., 2001). The method of passaging and substrate used 
to support hESC growth can have an effect on their growth rate. The process of 
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dissociation and potential expansion of colonies is known as subculturing or 
passaging. Although they are mostly reported to proliferate as distinct round 
colonies, hESCs can be maintained as monolayers, particularly when passaged by 
enzymatic methods.  hESCs can also be cultured on immortalised human feeders, 
but this can change their morphology. Such changes can make determining their 
state of pluripotency difficult if they do not exhibit typical morphological features. 
Therefore the expression of key ‗stemness genes and cell surface markers, which 
are the genes involved in maintaining pluripotency and promoting self-renewal 
becomes crucial when attempting to predict stem cell fate (Draper et al., 2002). 
These genes can be detected using Real Time Polymerase chain reaction (RT-PCR) 
and phenotypically using fluorescence conjugated antibodies to cell surface proteins 
by ‘in situ’ staining and flow cytometry. 
 
 
Figure 1.3. Typical morphology of hESCs cultured on inactivated mouse 
embryonic fibroblasts MEFs.  hESCs typically proliferate in tight discreet colonies 
supported by MEFs, inactivated using Mitomycin C. 
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The pluripotency of hESCs is associated with the expression of key transcription 
factors such as Oct4 (POU5F1), from the family of POU genes, an important 
regulator of self-renewal in ESCs (Nichols et al., 1998). Its expression is important 
when maintaining cultures of stem cells in the undifferentiated state over extended 
passages. The suppression of Oct4 leads to loss of pluripotency and differentiation 
(Atlasi et al., 2008). Other transcription factors of importance include Nanog 
(Chambers et al., 2007) and SOX2, which are both essential for determining self-
renewal in hESCs. Similarly, MYC, located on chromosome 8, plays a key role as 
one of the main four factors used in reprogramming of fibroblasts to IPS cells 
(Takahashi and Yamanaka, 2006). In addition to transcription factors, other 
molecules such as fibroblast growth factor 2 (FGF2) may also be involved in 
maintaining pluripotency (Vallier et al., 2005).  
Apart from the above, glycolipid cell surface antigens such as SSEA3 and SSEA4 
(Kannagi, 1983), and TRA160 and TRA181 (Draper et al., 2002; Schopperle & 
DeWolf, 2007) are also important when assessing undifferentiated hESCs and are 
easily detected by flow cytometry and immunostaining.  
To assess the pluripotent potential of hESCs in vivo, teratoma forming assays are 
still currently employed as the gold standard as they demonstrate the ability to form 
all three germ layers. hESCs are injected into immunocompromised mouse models  
and then left to form teratomas, which are assessed for the presence of all three 
germ layers by histological methods (Muller et al., 2010). This method has however 
been criticised for being too variable between laboratories and extremely difficult to 
standardise (Muller et al., 2011; Buta et al., 2013). Thus, attempts have been made 
to introduce new methodologies that meets the needs of researchers, especially 
where scientists want to refrain from using animal models (Muller et al., 2011; Buta 
et al,. 2013). These include using in vitro differentiation assays to demonstrate the 
presence of germ lineage specific genes using PCR (Bock et al, 2010). 
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Figure 1.4. Diagram outlining the relationship between pluripotency and 
tumorgenicity. Taken from (Knoepfler., 2009). 
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1.7 Ethics surrounding the use of stem cells 
The UK and much of Europe have long debated the ethical and political issues 
surrounding derivation and research using human embryonic stem cells. This is due 
to founding religious beliefs in the use of unwanted embryos and fertility treatment. 
Although guidelines surrounding the use of hESCs have been developed 
(Sugarman, 2008), much scrutiny has been put forward by modern society, in that 
people should be given a choice of which technologies they choose to improve their 
lives. The majority of the medical and scientific communities support the use of stem 
cells due to their immense potential. 
1.8 Regulation and governance of stem cell use 
Following the derivation of many stem cell lines worldwide the UK government put in 
place certain measures to ensure the regulation of hESCs used for research 
purposes certified the collection of consent from donor embryos. In 2004 the Medical 
Research Council (MRC) agreed that all stem cell lines derived in the UK must be 
deposited and stored in the UK Stem Cell Bank (UKSCB) (White paper reference, 
House of Lords, 2004). It is the role of the UKSCB to provide quality controlled 
stocks of these cells to researchers worldwide. To obtain cells, formal applications 
have to be made and the bank, along with guidance from the Steering Committee, 
who determine the eligibility of the project and whether it would benefit the stem cell 
community, before deciding whether the application is successful.  The UKSCB also 
acts as a hub for hESC information (Stacey and Hunt, 2006) and provides support 
through various collaborations including the International stem cell initiative (ISCI). 
The latter comprises of participating stem cell laboratories worldwide, whose overall 
aim is to provide consistent consensus relating to best methods of practice in relation 
to the culture of hESCs (Stacey et al., 2009). The National institute for health (NIH) 
has reviewed the derivation of hESCs regarding donor consent and has so far issued 
22 lines from the UK as having sufficient supporting evidence and consent before 
derivation (http://grants.nih.gov/stem_cells/registry/current.htm). The derivation, 
storage and manufacture of hESCs are governed by the Human Tissue Authority 
(HTA) who issue various licences based on the type stem cell work being conducted. 
They ensure that premises are suitable for such activities by auditing. The UKSCB 
currently holds a HTA licence for the storage and distribution of research grade 
hESCs. 
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1.9 The potential of stem cells in translational medicine 
In order to fully support the potential that hESCs hold for regenerative medicine, 
standard laboratory methods for stem cell culture and maintenance is critical. This 
includes suitable clinics obtaining embryos with consent for the derivation of stem 
cell lines, alongside advice from regulatory authorities to govern the use and storage 
of hESCs with the potential for research and later, clinical applications (Coecke et 
al., 2005; ISCBI 2009). Also, the transplantation of differentiated stem cells provides 
challenges that need to be overcome as stem cells move towards clinical application. 
As hESCs differentiate they express markers on their cell surfaces which are 
recognised by the bodys‘ immune system, which could lead to the rejection of 
implanted differentiated cells without the use of strong immunosuppressive drugs. 
Although many scientists see IPSCs as a solution to this problem as reprogrammed 
cells can be taken directly from a patient and HLA matched (Nakatsuji et al., 2008), 
research is still being conducted to demonstrate that IPSCs are equivalent and have 
the same capabilities as hESCs. In addition, the epigenetic memory of the IPSCs‘ 
original cell type that they were programmed from is a cause for concern, as this 
could have implications for their differentiation potential. Furthermore, the way in 
which these cells are derived is also important as it has been documented that viral 
vectors can leave a ‗molecular footprint‘ in reprogrammed cells. This could have an 
effect on the potential application of these cells used for therapy (Lakshmipathy et 
al., 2010). 
The need to develop robust culturing methods using well defined components is of 
paramount importance. Some clinical applications require 10x109 cells in order to 
begin scale up. Uniform, qualified and well tested banks of hESCs need to be 
produced under GMP which can be easily reproduced and cultured rapidly without 
compromising the end use/product.  
For stem cells to be accepted for clinical therapy trials, scientists must be able to 
demonstrate that the cells are non-tumorigenic (Gropp., 2012). Research has shown  
links between pluripotency and tumorgenicity (Dressel., 2011) and methods for 
overcoming the challenges of stem cell tumorgenicity have been explored 
(Schuldiner et al., 2003). The tumorigenic nature of hESCs has been repeatedly 
discussed (Dalebar et al., 2007; Baker et al.,2007; Ben-David and Benvenisty., 
2011) and culture methods have been identified as a means for selection, as it has 
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been well documented that stem cells acquire a greater number of genetic 
alterations through prolonged culture (Draper et al., 2004; Amps et al., 2012). 
Attempts to yield and accurately identify purer populations of hESCs which are 
homogenous appear to be the aim of such studies, however more work needs to be 
done on predicting the nature of smaller, undifferentiated hESC populations. 
Furthermore, the profound effects of reprogramming for IPSC production have yet to 
be determined (Knoepfler., 2009) as the elementary concepts that govern stem cell 
biology are shared with tumorigenesis, for instance, the roles that Myc and KLF4 
play in regulating pluripotency and differentiation pathways. Figure 1.4 outlines the 
relationship between pluripotency and tumorgenicity. 
Techniques used to characterise human embryonic stem cells are abundant and well 
documented. However, there is little consensus as to which methods are most 
appropriate in terms of robustness and sensitivity and also, none of these methods 
have been assured for the use of clinical Stem cell banking applications. Much work 
is needed to validate and standardise these techniques as the field rapidly 
progresses towards clinical applications. In particular, it is important that cell culture 
methods are simple, robust and reproducible. Characterisation testing must 
demonstrate that the cells still exhibit the key characteristics of undifferentiated 
hESCs. Addressing these concerns has been within the core remit of the UK Stem 
Cell Bank.   
1.10 Characterisation and quality control of banked stem cells at the 
UKSCB 
The UKSCB aims to produce banks of undifferentiated stem cells through 
standardised methods for thawing, subculturing, scale- up, cryopreservation and well 
defined quality control testing release criteria, to ensure the stem cells being 
provided to other research and industry-based organisations are of the highest 
standard. Banking facilities such as the UKSCB ensure that this is the case, thus 
saving the end users a considerable amount of time involved with the laborious, time 
consuming and sometimes costly process of producing their own cells from source.  
In fulfilling its role, the UKSCB ensure each hESC bank meets predefined 
acceptance conditions for release criteria QC tests to ensure that the stem cells 
provided are safe and free of contamination from microorganisms or other cell lines. 
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Each cell bank is tested for viability, mycoplasma contamination, sterility, mandatory 
viral markers and identity by DNA profiling as a minimum. This is also in line with 
good cell practice guidelines (Coecke et al., 2009) and cell banking codes of practice 
(ISCBI, 2006). As a rule therefore, newly deposited hESC lines are maintained under 
quarantine conditions until the first post-thaw mycoplasma and sterility tests are 
completed to demonstrate that the lines are free of contamination. Following 
expansion to give a pre master and master cell bank, stem cell lines are held in an 
‗In-process‘ status, in a liquid nitrogen vessel, until the sterility, mandatory viral 
markers and DNA profile indicate that it is safe for the cells to be moved to the 
distribution vessel following review of necessary paperwork by quality assurance 
personnel. On completion and successful review of its cell line master file, which 
contains all the necessary production paperwork and data on quality and sterility 
testing, a certificate of analysis is issued, and the distribution cell bank stem cell line 
is made available for release. Such procedures ensure that the banks of cells 
produced are of high quality, and do not run the risk of compromising the 
reproducibility of cutting edge research. It has been estimated that 30% of cell lines 
reported in published work have been misidentified, cross contaminated with another 
cell line or contaminated with Mycoplasma (Capes-David et al., 2010; Uphoff et al., 
1992).  
Sterility testing is performed as soon as the cells are in culture and then 
subsequently every three to four weeks and before and after a bank is frozen down 
and thawed out again, to confirm that the cells are free of microbial contamination. 
This also demonstrates that the cells have been handled carefully with a good 
aseptic technique. Microbiological broths are used to screen for the presence of 
bacteria and moulds. Once inoculated, the broths are incubated and the appearance 
recorded after several days. 
Mycoplasma testing is carried out as soon as the cells are in culture, and before 
each of the banks are frozen down. This ensures that the cell lines banked for 
distribution are free of contamination. Mycoplasmas are free living organisms that 
can detrimentally affect cell cultures and can spread quickly through a shared 
laboratory facility. Mycoplasma can also be extremely difficult to remove once 
cultures are contaminated, therefore consistent and sensitive testing methods is the 
best way of assuring that cultures remain mycoplasma free. Testing consists of both 
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PCR test against well-known strains of mycoplasma species and the mycoplasma 
culture test using selective agar plates, which are inoculated with cell culture sample 
and cultured for 6 weeks before being read. 
Cell line identity testing by DNA profiling is used to ensure that the hESC banks have 
the same DNA profile as the original starting material. This demonstrates that no 
cross contamination or misidentification has occurred during the transfer, thawing or 
during the banking process. This test has historically been carried out externally by 
specialised laboratories such as The Doctors Laboratory (TDL) using Short tandem 
repeat analysis which uses a standard set of forensic markers. Viral PCR may also 
be performed to demonstrate that the cells banked are free from viruses that may 
cause harm in humans or have the potential to alter the genome of the host. The 
UKSCB employs pass/fail criteria; therefore stem cell lines which fail these tests will 
either be discarded, or quarantined for further investigation.  
 
 
Figure 1.5. Diagram outlining the process of banking hESCs at the UKSCB.   
Samples are deposited as vials/straws and quarantined until suitable testing 
confirms that the line is free of contamination. The banking process consists of the 
production of three banks; Pre-Master Cell Bank (PMCB), Master Cell Bank (MCB), 
and Distribution Cell Bank (DCB). Between each bank stem cells are expanded, then 
frozen down by standard freezing methods. Cells are tested at each banked level to 
show that they suitable for release however only the DCB is available for 
external/worldwide distribution. 
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Apart from providing banked hESCs, The UKSCB supports the wider stem cell 
community by giving advice on standardising methods for culture, characterisation 
and safety testing of hESCs and through participation in a number of collaborations 
and research programmes. For example the use of hESCs for toxicology screening 
(ESNATs European project) requires their ability to differentiate towards neuronal 
lineage (Pistollato et al., 2012). Previous well established collaborations such as the 
international Stem Cell Initiative (ISCI), immensely improved the characterisation of 
hESCs in 2007. As part of a 21 worldwide collaborative study, the UKSCB 
characterised 60 hESC lines using gene expression by Real Time PCR, cell surface 
antigen expression of pluripotency markers by flow cytometry, DNA profiling, 
tumorgenicity studies, imprinting and X chromosome inactivation to address 
epigenetic status and microbiology to examine viral and bacterial presence within 
feeder and hESC culture (Adewumi et al., 2007). This body of work was aimed at 
standardising methodologies used by scientists to characterise hESCs, as there is 
much variation in the type and techniques used to test stem cell lines for expression 
of pluripotency markers, chromosomal stability and ability to differentiate. The 
UKSCB also participated in  ISCI 2, who published a study comparing eight culture 
systems and from this concluded that only two media, STEMPRO and MTeSR1 
maintained consistent undifferentiated growth (Akopian et al., 2010).  
The studies in this thesis are focused on developing and optimising culture 
conditions to standardise the culture and maintenance of hESCs for banking and for 
world-wide distributions. Although some of the techniques discussed below and in 
the project have already been established, most have not been optimised for stem 
cell culture in a way that supports culture of the different cell lines available. 
Moreover most protocols are have only been used for a limited number of stem cell 
lines and have not taken into account emerging lines and heterogeneity in these 
lines. Thus, to be able to standardise culture conditions the Bank embarked on 
developing and optimising various protocols required for culture including 
investigating the use of enzymes for improving the speed and scale up of passaging 
hESCs. 
In addition, techniques not previously used in stem cell research have been adopted 
to improve the characterisation of hESC lines and include the use of newer 
molecular based techniques such as array comparative genomic hybridisation for 
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genetic stability studies and TissueFaxs™ image analysis to quantitatively 
demonstrate the expression of cell surface markers. Such techniques have the 
added advantage of improving the sensitivity of testing, once optimised for use with 
stem cells.  
1.11 The development of stem cell culture systems and methodologies 
Embryonic stem cells are renowned for being difficult to culture long term and are 
extremely sensitive to environmental change including accumulation of excess 
toxins, C02 and 02 levels, changes to media composition and dissociation methods. 
All these factors, if wrongly altered, have the potential to permanently induce 
unwanted differentiation. This has resulted in research into new culturing methods to 
better regulate these processes.  
Stem cells are routinely cultured at 37°C, 5% C02, on inactivated murine embryonic 
fibroblasts (MEF) also known as mouse feeder layers. Studies have demonstrated 
that feeders enhance attachment by allowing stem cells to anchor themselves, and 
are important for growth, due to the secretion of multiple growth factors including 
FGFs, activin, Wnts, TGFb and antagonists of BMP signalling (Unger et al., 2008; 
Yoon et al., 2010; Hongisto et al., 2011; Lee et al., 2012). Co-culture systems using 
feeder layers have been used extensively for isolating and growing other types of 
cell lines i.e. stroma cells for the culture of haematopoietic stem cells (Funk et al., 
1995; Bramono et al., 2010).  
Inactivated MEFs were originally used in the derivation of mouse embryonic stem 
cells (Evans & Kaufman, 1981), and for the derivation of the first hESC lines 
(Reubinoff et al., 2000; Zhang et al., 2006). Nonetheless, using MEFS, as with 
bovine serum, introduces animal derivatives into the culture system and can lead to 
possible contamination by mouse retroviruses. For instance, hESCs cultured on 
MEFs have been found to express immunogenic non-human sialic acid (Martin et al., 
2005; Wang et al., 2011). Unfortunately such a  finding compromises the ability for 
stem cells to act as therapeutic tools (Amit et al., 2004), as it may provoke an 
immune response and lessen the benefits of autologous transplant therapies (Wang 
et al., 2011;Padler-Karavani, 2011). It also raises the need for the derivation of 
clinical grade hESCs, free of animal product contamination. 
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In addition to using feeders, another progression in stem cell culture has been the 
development of suitable media which will maintain hESCs in the undifferentiated 
state and/or keep the cultures free of contaminating factors that could limit their 
potential exploitation. Originally stem cells were cultured in bovine serum albumin 
supplemented with glutamine, amino acids and growth factors. This still however 
requires the use of animal components which carry the risk of potential 
contamination. The use of human serum (Stojkovic et al., 2005), and subsequently 
serum-free media has been a considerable step forward towards establishing 
conditions that would limit contamination and aid towards the production of clinical 
grade hESCs (Inzunza et al., 2005; Skottman and Hovatta, 2006).  
The function of mouse feeder cells has been documented and translated to the use 
of human feeder cells. The use of human feeders is well documented and many 
different sources of human feeders have been shown to support undifferentiated 
hESC growth. Human feeders derived from foetal muscle (Richards et al., 2002), 
foetal skin (Richards et al., 2003), adult fallopian tube epithelial cells, foreskin 
fibroblasts (Hovatta et al., 2003), adult marrow cells (Cheng et al., 2003) and adult 
endometrial cells (Lee et al., 2005) have all demonstrated the supportiveness of 
hESC growth and are easy to obtain and from a variety of human tissues and cell 
sources. Many laboratories have proved that their suitability to support stem cells is 
as proficient as mouse feeders (Eiselleova et al., 2008). They have also been shown 
to support IPSCs (Unger et al., 2009). The use of MEFs however, continues to be 
the gold standard method for culture. 
1.11.1 Feeder free culture of hESCs 
Derivation of stem cells on extra-cellular matrix (ECM) from human feeders is a well-
documented method (Amit et al, 2004; Klimanskaya et al, 2005; Stojkovic et al., 
2005; Escobedo-Lucea et al., 2012) and has been adopted from the use of ECM 
derived from mouse feeders. The use of ECM in cultures is not novel but has 
continually shown to be supportive. The usefulness of feeder free matrices such as 
Matrigel and Laminin have been documented (Xu et al., 2001) (Rodin et al., 2010). 
Although the use of Matrigel was not novel (Amit et al., 2003) it has been extremely 
successful and led to many other laboratories developing and testing new feeder 
free methods to support stem cell growth in order to move away from feeders. 
Matrigel (BD) matrix is a soluble basement membrane extract from Engelbreth-Holm-
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Swarm mouse tumour that forms a basement membrane; a continuous sheet of 
specialised extra cellular matrix. It has been successfully used in a number of 
laboratories, has shown to maintain undifferentiated cells for prolonged culture 
periods and has demonstrated its use as a suitable matrix for the derivation of 
hESCs (Ludwig et al., 2006). 
The work of Ludwig et al (2007) was one of the first studies to list the components 
used in defined media, mTeSR1. This led to the development of well-defined media 
and matrices which contain the essential growth factors and nutrients to sustain 
undifferentiated hESC proliferation. However, there are varying opinions of how well 
these matrixes can support stem cells for extended culture and whether their 
robustness is sufficient to support a variety of different hESC lines in different hands.  
Much recent research has been emphasised on investigating new support matrices 
for the growth of hESCs and many laboratories have reported the successful 
derivation of hESCs cell lines with conditioned media and on feeder free, synthetic 
matrices (Yoon et al., 2009; Klim et al., 2010; Hannoun et al., 2010). Furthermore, 
the use of synthetic matrices has been shown to aid differentiation studies (Tate et 
al., 2009). However these biomaterials and synthetic matrices have proved too 
expensive for most laboratories, and have slowed its development. 
Despite all the progression of culture methods within the field, scientists still use 
mouse feeders as the gold standard for maintaining undifferentiated cultures of 
hESCs. This is most likely due to the method being well established and widely 
accepted in the majority of laboratories. Still, the use of feeders is not a simple 
process and requires time and effort to prepare, inactivate and test banks of feeders 
to ensure they are supportive. It can also be difficult to adjust stem cell lines onto 
new feeder batches as there can be much variation due to the type of mouse strain 
used, whether consistency is maintained when preparing banks, plating density etc. 
Opportunities to focus the needs of new research and revisit the use of human 
feeders, ECM and synthetic matrices such as Matrigel always arise. The need for 
xeno free grade hESCs for clinical applications has also encouraged the 
development of xeno free media and related culturing products, for the production of 
such cells (Ellerström et al., 2006; Unger et al., 2008; Hua et al., 2009). The 
progression of xeno free, defined media and matrices serve as valuable tools for 
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standardising the culture of hESCs to benefit both research and clinical application of 
these cells (Villa-Diaz et al., 2010). 
 As the requirement for xeno-free media increases, increased effort must be made to 
standardise alternative support matrices to successfully culture hESCs, without 
altering their gene expression (Stephenson et al., 2010). This is especially important 
to the UKSCB, as the move towards banking clinical grade stem cell lines 
approaches, it is important to find ways of substituting animal products for xeno free 
products but with a need to ensure that their function and quality is not 
compromised. Studies Such as the ISCI 2 (Akopian et al., 2010) are important for 
demonstrating the use of new culture systems, as a standardised example to 
encourage change within the stem cell community. 
1.11.2 Passaging methods  
The first established hESC lines were passaged using manual cutting procedures 
under a dissection microscope (Thomson et al., 1998; Reubinoff et al., 2001). This is 
the process of dissecting confluent colonies of hESCs and transferring them onto 
new feeders, to expand and give rise to new colonies, continuing their culture in 
vitro. Although these methods clearly demonstrated how hESCs could be maintained 
in an undifferentiated state for long culture periods, they are not suitable for the scale 
up and banking of large numbers of hESC lines as they are laborious, time 
consuming and extremely operator variable. 
Literature has shown that researchers are keen to adapt enzymatic passaging 
methods in order to speed up culturing times and scale up cell culture production 
(Oh et al., 2005; Couture., 2010), as manual dissection is time-consuming and 
labour-intensive. hESCs must be cultured by methods which give rise to uniform, 
undifferentiated colonies in large quantities, to be beneficial for pre-clinical and 
clinical studies. In particular the research conducted by Ellerström et al (2007) 
demonstrated the ease with which hESCs could be expanded by single cell 
dissociation, and that their clonal survival was enhanced through culture on human 
foreskin fibroblasts in contrast to MEFs. It has however been argued that this type of 
passaging can induce differentiation and it can be difficult to recover cells to form 
colonies once made into single cells. Furthermore, the long term use of enzymes has 
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been shown to incur chromosomal instability (Brimble et al., 2004; Buzzard et al., 
2004). 
1.11.3 Expansion and Scale up 
The expansion and scale up of hESC cultures in the form of gel beads (Phillips et al., 
2008) and bioreactors on a small scale has been successful (Dang et al., 2004; 
Kehoe, 2010). Researchers have also investigated the suitability of scaling up stem 
cell cultures in suspension (Steiner et al., 2010). Also, the use of scaffolds for scale 
up has been successfully documented (Dellatore et al., 2008). Robotic automated 
systems have been successful in large scale up of hESCs but are expensive to 
obtain. However novel and interesting these methods are, they have not yet been 
applied in laboratories needing to maintain robust ‗research scale‘ volumes of 
hESCs, therefore most scientists still employ the use of more simplified solutions, for 
the scale up of stem cell cultures, such as using enzymes. 
Many commercial enzymes are available for the dissociation of cells and up until 
recently the most widely used enzyme for cell culture was Trypsin. This enzyme 
proved to be harsh and when used with embryonic stem cells induced karyotypic 
instability (Draper et al., 2004; Amit et al., 2003). Other commercial enzymes were 
developed including Collagenase 2 and 4, TrypLE select, Dispase, and more 
recently, Versene. TrypLE™ Express is a recombinant trypsin-like enzyme that is 
faster, more gentle on cells and boasts better clonal cell survival (Gray et al., 2009). 
Previously used enzymatic treatments including porcine Trypsin and Dispase have 
been known to damage cell membranes, decrease clonal survival and reduced 
attachment ability (Ellerstrom et al., 2007). The importance of using a recombinant 
Trypsin preparation has been stressed as more of hESC culture moves away from 
animal derived products (Ellerstrom et al., 2006). In order for newer enzymes such 
as TrypLE™ Express to be used routinely as part of the banking procedure it must 
be validated and confirm that there are no karyotypical changes associated with its 
long term use. It also needs to demonstrate that it doesn‘t change other fundamental 
characteristics of the hESCs. Although there is no well-established criteria for how 
many passages a single stem cell line should be cultured through before it is 
deemed ‗unacceptable‘ for use, it is advised that hESCs go through minimal 
manipulation and passaging during the cell culture and banking process, as advised 
by the International Stem Cell Banking Initiative (ISCBI, 2009). Further advice has 
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been provided by documents such as Guidance on good cell culture practice 
(Coecke et al., 2005). The wide range of enzymes available have made it difficult to 
standardise the use of one or two within a robust culture system, as laboratories 
culturing hESCs tend to adhere to in-house methods which are well practiced, rather 
than test out new methods which is time consuming.  
Important issues still remain to be addressed if hESCs are to be used to their full 
therapeutic potential. These include optimising protocols for efficient and 
reproducible scale-up and scale out, thereby producing purified populations of both 
undifferentiated and differentiated stem cells as well as developing robust 
differentiation protocols. Opportunities to focus the needs of new research and revisit 
the use of human feeders, ECM and synthetic matrices such as Matrigel always 
arise. As the requirement for xeno-free media increases, increased effort must be 
made to standardise alternative support matrices to successfully culture hESCs, 
without altering their gene expression (Stephenson et al., 2010). This is especially 
important to the UKSCB. 
1.12 Characterisation testing of hESCs 
Techniques for the characterisation of banked hESC lines are recommended by the 
International stem cell banking initiative ISCBI (2009). Currently there are over 700 
hESC lines used in published studies (International Stem Cell Registry, ISCR). 
Consensus on techniques for characterising hESCs is becoming more important as 
the applications of hESCs move closer to the clinic. Although not part of release 
criteria testing, the UKSCB does characterise banked lines of hESCs by employing 
methods such as karyology, gene expression profiling by real time PCR, 
immunofluorescence by flow cytometry and in situ staining. The results are included 
in the cell line master files as information only, to potential customers requesting the 
lines. Information on banked hESC line characteristics is important to researchers as 
they give key information on the stability and genetic state of hESC lines when they 
are banked, which can have a significant impact on their research.  
1.12.1 Karyology 
Long term passaging, culture conditions and epigenetic changes can all contribute to 
karyotypic changes of hESCs, which can lead to the selection of certain populations 
of stem cells that have enhanced self-renewal over other populations.  Particular 
populations within long term cultures gain copies of extra chromosomes, for example 
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chromosome 17 and 20q. These populations of stem cells continue to proliferate with 
an increased growth advantage over other populations (Draper et al., 2003), and are 
therefore selected and passaged on. Detection of these populations is crucial if we 
are to examine their stability in culture. The karyology of hESCs is tested by 
metaphase spread analysis and conventional chromosomal analysis in the form of G 
banding, to look for chromosomal deletions or additions, mosaicisms and balanced 
translocations at low resolutions. Karyology provides important information as cell 
lines with significant chromosomal aberrations may affect the reproducibility and 
reliability of experimental results and can reduce the potential for clinical application 
(Josephson et al, 2007). Although G banding has been the preferred method of 
choice by most researchers wanting to assess the chromosomal stability of their 
hESC lines, novel molecular methods have been developed, which are far more 
sensitive and can detect copy number variations (CNVs) in whole populations of cell 
cultures. Comparative genomic hybridisation has been shown to be useful in 
detecting a number of different known aberrations in hESCs (Lefort et al., 2008; 
Spits et al., 2008).   Clinical applications of aCGH outlined by Shinawi and Cheung 
(2008) describe how routine karyotype analysis is not sensitive enough to detect 
subtle chromosomal rearrangements of less than 4MB. However aCGH has been a 
sensitive and useful tool in the detailed detection of chromosomal aneuploidies and 
structural aberrations which are an underlying cause of congenital anomalies, 
dysmorphism, autism, miscarriages and several other genetic syndromes (Shaffer et 
al., 2007; Bejjani & Shaffer, 2006).  
1.12.2 Flow cytometry 
Another technique used to characterise hESCs is flow cytometry analysis. Flow 
cytometric techniques are used to quantify and separate sub populations of cells 
within complex mixed cell samples. The technique works by using the basic 
properties of each cell type; its ability to absorb fluorescence and scatter light, based 
on reaction with specific cell surface markers. This information is translated into 
forward scatter, side scatter, which is captured and transmitted to a screen where it 
can be analysed. Human embryonic stem cells characteristically express a well-
known panel of cell surface markers for pluripotency. The most frequently used are 
stage specific embryonic antigens SSEA-1, SSEA-3, SSEA-4 (Draper et al., 2002). 
Another group of commonly used cell surface antigens include high molecular mass 
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glycoproteins TRA1-60, TRA1-81 (Schopperle and DeWolf., 2007). These antigens 
are shared with mouse ESCs, but the expression of SSEA-1 and SSEA-4 is 
reversed. In situ immunofluorescent staining provides a qualitative method of 
assessing undifferentiated hESC growth, by staining for the cell surface markers 
outlined above, and for intracellular transcription markers OCT4 and Nanog. 
1.12.3 Gene expression 
The regulation of gene expression for pluripotency and some early differentiation 
markers are important for establishing gene profiles, which can help to predict their 
pluripotent capacity as well as demonstrating expression of key stemness genes 
(Abeyta et al., 2004; Liu et al., 2006). Gene expression can be measured using 
traditional Reverse transcriptase PCR or quantitative PCR (qPCR). Although many 
laboratories use PCR for the detection of stemness genes, the type of PCR used 
tends to be qualitative and therefore only demonstrates the presence or absence of 
a small selection of genes. More recently real time PCR has demonstrated to be a 
more accurate and sensitive method, particularly when relative quantification is 
performed, with reference to endogenous controls samples and using stable 
housekeeping genes (Derveaux et al., 2010; Veasey et al., 2011). The application of 
real time PCR has led to the development of Taqman low density arrays, which work 
as customisable 348-well microfluidic cards. This enables hundreds of real time PCR 
reactions to occur simultaneously and can accommodate 1-8 samples to be run in 
parallel. LDA card technology utilises novel gene signature arrays designed 
especially to detect 16 housekeeping genes specific to hESCs, using endogenous 
control selection. Ensuring hESCs maintain a relatively stable genetic profile is of 
importance particularly at late passage, as this property demonstrates their 
applicability in a therapeutic environment. The studies in this thesis will also aim to 
investigate this particular question using TLDA cards, to monitor whether there is a 
difference in genetic stability over long term passaging and possibly reveal which 
genes (stemness or germ lineage specific) are most affected.  
1.12.4 Differentiation studies 
In order to fully assess the pluripotency of hESCs they must be able to differentiate. 
Although the majority of lines will do so spontaneously in culture, their therapeutic 
potential can only be reached by the application of robust, efficient and controlled 
differentiation protocols. There are many different methods to directly differentiate 
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hESCs and most have the aim to mimic signalling pathways in vivo. However their 
efficiency to produce pure populations of differentiated cells are extremely variable.  
Figure 1.6 demonstrates the process of gastrulation and subsequent formation of all 
three germ layers. 
Neuroectoderm differentiation 
The successful differentiation of hESCs to neural lineage is an important step 
towards the use of hESCs for treatment of neurological diseases (Reubinoff et al., 
2001). The commitment of cells to one of the three germ layers marks the second 
major step towards embryonic development. As multipotent cells begin to organise 
themselves, some cells undergo nurulation. This is the development of the neural 
plate for the formation of nervous system, which sequentially leads to the formation 
of the neural tube. Neural differentiation commences with the formation of the 
notochord from mesodermal cells can be identified by gene expression of the 
regulatory protein brachyury. Neural progenitors can be characterised by the 
expression of PAX6, frequently seen in neuroectoderm differentiation, FOXG1 and 
OXT2.   
Mesoendoderm 
Endoderm and mesoderm differentiation is induced by nodal signalling by TGf-B 
molecules. Higher nodal levels specify endoderm and lower levels specify 
mesoderm. Although no source of nodal protein is known, Activin A from the tgf-b 
family binds to the same receptors, triggering intracellular events which, in the 
presence of low serum and high Wnt3a or BMP4 (bone morphogenic protein 4) 
(D‘amour et al., 2006), which is known to play a pivotal role in formation of primitive 
streak, endoderm and mesoderm, lead to the induction of endoderm formation.  
Endoderm differentiation can be seen after 5 days and demonstrated by the 
expression of definitive endoderm marker SOX17 and FOXA2 (McLean et al., 2007) 
and alpha fetoprotein (AFP), known for early stage specification to hepatic lineage. 
Early mesoderm/mesoendoderm can be detected by the presence of GSC gene 
encoding the homeobox protein goosecoid, Brachyury and PTF1a, a gene encoding 
for pancreas specific transcription factor.  
Differentiation to mesoderm and, in particular, cardiomyocytes is one of the most 
dramatic and difficult transformations. Although many laboratories report 
spontaneous differentiation and formation of visible beating cardiomyocytes, robust 
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protocols that report high yield are far and few between (max 20-30%). Recently 
research has focused on the directed differentiation of hESCs to hematopoietic-
mesoderm lineage specification  (Cerdan et al., 2012). 
Recent publications have enabled faster and far more reliable differentiation 
methods, due to a varied choice of starting material in the form of embryoid bodies 
(Iskovitz-Eldor et al., 2000) or adherent cultures using conditioned media (D‘Amour 
et al., 2006), small molecules and growth factors coupled with specific matrices 
including Poly-D lysine for Neural differentiation (Reubinoff et al., 2001), co-culture of 
hESCs with visceral endoderm like cells for cardiomyocyte differentiation (Mummery 
et al., 2003) and Matrigel (Ludwig et al., 2006) designed to enhance lineage specific 
cell production in purer populations in under a month. However each protocol 
recommends optimisation of their method when using different stem cell lines, which 
is costly, time consuming and ultimately such variability in protocols will limit stem 
cell fields‘ progression with regards to demonstrating the production of progenitors or 
terminally differentiated cell types. Also, the methods used to confirm differentiation 
have not been standardised, with many labs self-selecting one or two genes and cell 
surface markers to confirm differentiation towards a particular germ layer. 
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Figure 1.6.  Diagram showing process of gastrulation and subsequent 
formation of the three germ layers. Image obtained 
fromhttp://www.bio.miami.edu/dana/106/106F05_4.html. 
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1.13 Stem cells: Research to clinical use 
In order to support the potential that hESCs hold for regenerative medicine, standard 
laboratory methods for cell culture passaging and cryopreservation have to be 
developed and need to be reproducible and robust. The need to develop robust 
culturing methods using well defined components is of paramount importance. 
Clinical applications require 10x109 cells in order to begin scale up. Uniform, 
qualified and well tested banks of hESCs need to be produced under GMP which 
can be easily reproduced and cultured rapidly without compromising the end 
use/product. hESCs have the potential to revolutionize medicine and healthcare. 
Research has begun into the applications of iPSCs for the production of mature 
HSCs to help with the growing number of blood transplants (Migliaccio et al., 2012; 
Wagner et al., 2013). However such applications will require significantly large 
numbers of robustly specialised and functional HSCs to fully fulfil this goal. 
Techniques used to characterise human embryonic stem cells are abundant and well 
documented however, none of these methods have been assured for the use of 
clinical Stem cell banking applications. Much work is needed to validate and 
standardise these techniques as the field rapidly progresses towards clinical 
applications. Such techniques will be of importance to demonstrating the progression 
of hESCs as they are differentiated into lineage specific cells for transplantation into 
diseased and damaged organs such as cardiomyocytes (Zwi-Dantsis et al., 2013) 
and for the replacement of skin grafts derived from patient specific iPSCs using 
bioscaffolds (Bi & Jin, 2013). 
Many researchers have demonstrated their ability to maintain the undifferentiated 
growth of hESCs, but with huge variations in culture methods. It is important that 
these methods are standardised as well as simple, robust and reproducible. 
Characterisation testing must demonstrate that these hESCs still exhibit the key 
characteristics of undifferentiated human embryonic stem cells.  Furthermore the 
same stem cell lines are continually characterised, which although demonstrates 
their ease of culture, can be seen as biased as these lines are clearly easy to grow 
and manipulate. It does not add to the diversity of hESCs available for use which 
may precede the benefits of hESCs currently trending use. The approaches and 
developments described should help the UKSCB to achieve its objectives and meet 
its commitments to the wider stem cell community.  
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1.14 Aim of thesis 
The aim of this thesis is to conduct a comparative study of different mouse and 
human feeders and feeder-free Matrigel (together with mTeSR1) in supporting long 
term culture of hESCs in the undifferentiated state, and to further explore the 
chromosomal stability of cultures under these conditions. Studies on the different 
matrices will be coupled with the use of TrypLE™ Express to assess its suitability of 
the latter as a clump passaging method that would be better tolerated by cells and 
thus enable uniform scale up of hESC cultures. Matrices will also be compared to 
demonstrate their ability to support the differentiation of hESCs to progenitor cells by 
in vitro methodologies, as a measure of their pluripotency following long term 
passage.  Furthermore, the use of TissueFaxs™ for image analysis of cell surface 
markers and aCGH for assessing chromosomal stability of stem cells in routine 
culture will also be validated. This is considered important since these methods have 
not been qualified for use in the host laboratory and currently the field of stem cell 
research requires robust and sensitive methodologies for routine characterisation, 
particularly for the prolonged culture of cells. Chromosomal stability, gene 
expression, detection of cell surface pluripotency markers will be determined using 
aCGH, real-time PCR, immunofluorescence (IF) using flow cytometry and in situ 
staining, respectively.  
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Chapter 2 
Materials and Methods 
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Materials  
The tables below show details of the materials used for the culture of cell lines 
including list of feeder line and stem cell lines used in this project. The hESC lines 
HUES9 (Harvard, USA), RH5 (University of Edinburgh), SHEF1 (Pfizer, originally 
from Sheffield University) and NCL5 (University of Newcastle) were all obtained 
through deposit agreements within the UK Stem cell Bank. 
Table 2.1 Details of feeder lines and fibroblasts used to grow 
hESCs 
Name Organism Origin  
MEF MF1 mouse Embryo Fibroblast 
3T3-J3 Swiss Albino 
mouse 
Embryo Mouse cell line 
HDFn human Neonatal fibroblast 
MRC-5 human Fetal lung Cell line 
11235 human Fetal skin fibroblast 
HUVECJR2 human Umbilical cord vein 
epithelial cells 
Cell line and ECM 
MRC-5JR human Fetal lung ECM 
Table 2.2.Details of Stem cell lines used in this project 
Stem cell line Cell type Depositor Country 
HUES-9 p24 Human embryonic Harvard USA 
HUES-3 p22 Human embryonic Harvard USA 
SHEF-1 p27 Human embryonic Pfizer UK 
RH5 p35 Human embryonic University of 
Edinburgh 
UK 
NCL-5 p27 Human embryonic Newcastle upon 
Tyne 
UK 
NCL-2 p22 Human embryonic Newcastle upon 
Tyne 
UK 
H9 p26 Human embryonic WiCell USA 
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Table 2.3. Details of media used in this project 
 
Knockout 
hESC 
media 
Components Volume Final 
concentration 
Cat number Supplier 
Knockout serum 
replacement 
100ml 20%  Invitrogen 
Knockout DMEM 388ml 77% 10829-018 Invitrogen 
Non-essential amino 
acids (NEAA) 100x 
5ml 1% 11140-035 Invitrogen 
Glutamax 100x 5ml 1% 35050-038 Invitrogen 
bFGF 1ml 0.1%  Invitrogen 
Betamercaptoethanol 
(BME) 
1ml 0.1% 313350-010 Invitrogen 
Total volume  500ml 
MEF 
media 
DMEM  445ml 89% D5456 Sigma 
Foetal Calf Serum 50ml 10%  Biosera 
Glutamax 5ml 1% 35050-038 Invitrogen 
Total volume  500ml 
mTeSR1 
Media 
Stem cell 
technologies Basal 
media 
400ml 80% 05850/05896 Stem Cell 
Technologies 
5x supplement 100ml 20% 05850 Stem Cell 
Technologies 
Total volume  500ml 
 DMEM/F12 500mL  36254 Stem Cell 
Technologies 
Matrix Matrigel Made up to 
342 µl per 14 
vials 
 354277 BD Biosciences 
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Table 2.4. Enzymes used for subculture 
Name of 
enzyme 
Supplier Cat 
number 
Derivative System used with 
TrypLE™ 
Express 
(25mM) 
Invitrogen 12604-
013 
recombinant Stem cell subculture 
Trypsin 
(0.25mM) 
Invitrogen  Porcine Original feeder bank 
preparation 
Dispase in 
F12 
BD Biosciences 07923  Matrigel/mTeSR1 
 
Table 2.5. Reagents used for inactivation of feeder cells 
Reagent Supplier Cat 
number 
Used for Concentration/ 
dilution 
Mitomycin C Sigma-
Aldrich  
50-07-7 Inactivation of 
feeders 
2mg/ml 
DMSO Fisher 
Bioreagents 
67-68-5 Component of 
freezing media 
10% of final 
solution 
FCS Biosera 5170G Component of 
freezing media 
90% of final 
solution 
Cryovials    N/A 
T175 filtered flasks Falcon  Culturing 
feeders  
N/A 
Mr frostie 
HandiFreeze 
supplemented with 
Isopropanol 
Fisher 
Scientific 
 Slow freezing of 
cells 
100% Isopropanol 
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Table 2.6. Reagents and supplies used for PCR 
Reagent Supplier Cat 
number 
Used for Concentration/dil
ution 
1.5ml sterile 
v bottom 
tubes with 
screw cap 
lids 
Starsted  Storing DNA/RNA 
pellets at -80°C 
N/A 
PCR tubes Life 
Technologies 
 Performing PCR 
reactions 
N/A 
RNAse free 
H20 
Invitrogen  Dilution of RNA/DNA 
and Mastermix 
component 
N/A 
Ethanol Fisher 
Scientific 
 RNA extraction 70% solution 
made up with 
distilled H20 
TBE NIBSC, SSS Made in 
house 
Buffer for running gel  
Agarose   Gel electrophoresis  
Syber Safe 
DNA stain 
  DNA stain  
BME/RT 
buffer 
solution 
UKSCB, SK n/a Used to store RNA 
pellets at -80°C 
10ul BME into 
1ml RT buffer 
solution. 
cDNA kit Applied 
Biosystems 
 Components used to 
make cDNA 
As instructed 
see method 
Gene 
expression 
Mastermix 
for RT PCR 
Applied 
Biosystems 
 Used for PCR 
reaction 
2x concentration 
 
 
  
58 
 
 
Table 2.7. Reagents and supplies used for immunofluorescence 
staining and flow cytometry  
Reagent Supplier Used for Concentration/ 
dilution 
Distilled H20 NIBSC, 
SSS 
Plate washing  
Washbuffer 
solution 
NIBSC, 
SSS 
Plate 
washing/diluting 
antibodies 
0.1% PBS, 
sodium azide 
and 0.1%BSA 
PBS NIBSC, 
SSS 
Plate washing  
96 well flat 
bottomed plate 
Falcon Processing stem 
cells for flow 
cytometry 
N/A 
96 well v bottomed 
plate 
Falcon Preparation of 
stem cells for flow 
cytometry 
N/A 
Flat bottomed 24 
well plate 
Falcon Culturing stem 
cells for in situ 
fluorescence 
staining 
N/A 
Paraformaldehyde 
(PFA) 
Fisher fixative 16% (10ml vial) 
diluted to 4% 
final solution in 
PBS 
Triton X Invitrogen Permeabilisation of 
stem cells 
1/100 dilution in 
PBS 
Acetone/ methanol 
solution 
Fisher 
Scientific 
Permeabilisation of 
stem cells 
1:1 final 
concentration 
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Table 2.8a. Materials used for aCGH preparation of samples and slides. 
Reagent Lot number Supplier 
H20 559788 Perkin Elmer 
0.5M EDTA 0711004 Ambion 
0.5M NaCl 0710004 Ambion 
Primers 554056 Perkin Elmer 
Klenow 549120 Perkin Elmer 
Cye 5 dye 549395 Perkin Elmer 
Cye 3 dye 549396 Perkin Elmer 
70% ethanol 531893 Sigma 
Isopropanol 559787 Sigma 
 
Table 2.8b. Washbuffer solutions for washing slides 
Reagent Prewash  
(100 ml) 
Washbuffer 1 
(250 ml) 
Washbuffer 2 
(250 ml) 
Washbuffer 3 
(350 ml) 
SSC (20x) 10 17.5 1.25 1.75 
SDS (10x) 1 3.5 2.5  
dH20 89 329 246 348 
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2.1 Culture method overview 
Traditionally, hESCs are cultured directly onto a layer of inactivated MEF and 
passaged by manual dissection under a microscope. An alternative mouse feeder 
line 3T3 was also used in these studies. The mouse cell line 3T3 was established by 
Todaro and Green in 1963 from disaggregated Swiss mouse embryos. It has already 
been shown to support growth of stem cell lines as well as being used in clinical 
applications for skin transplantation (Dadheech et al., 2013; Petek et al., 2010; Supp 
et al., 2000).  
Other culture methods have been explored, including the use of inactivated human 
fibroblasts, human cell lines, MRC-5 derived from foetal lung tissue and used in 
vaccine production and HDFn, human dermal fibroblasts, which have also shown to 
support undifferentiated hESC growth. Furthermore the use of enzymes to passage 
hESCs as a faster method for scale up has been explored. 
The methods used in these studies include the preparation and culture of hESCs by 
enzyme using TrypLE™ Express  to dissociate hESCs into single cells or small 
clumps on human and mouse feeders TrypLE™ Express  (25mM) is a xeno-free, 
gentler version of Trypsin, and is thought not to lead to genetic changes of cells 
during extended culture use. Also, the use of Matrigel (BD Biosciences) and 
mTeSR1 (Stem Cell Technologies) with Dispase (Stem Cell Technologies); a 
commercially available enzyme were tested. The use of extra cellular matrix (ECM) 
derived from human cell lines to support the undifferentiated growth of hESCs was 
also investigated and its preparation from human feeders is described below. 
2.2.1 Preparation of primary mouse feeder cells and mouse fibroblast 
cell lines 
Mouse embryonic fibroblasts (MEFs) were obtained from pregnant MF1 mice 
(Harlan) at 13.5 days using a standard preparation technique employed by UKSCB 
scientific staff. The Murine embryonic fibroblast line 3T3-J3 was originally obtained 
from CellTran, Sheffield (UKSCB, Acc. No. R-05-004). See Table 2.1. 
Using a Class II safety cabinet (Labconco purifier), one vial of frozen MEF p0 was 
thawed, centrifuged for 5 minutes at 1200rpm (Sorvall Legend RT) and resuspended 
into a T75cm flask in MEF media consisting of DMEM (Invitrogen D6546), 1% 
Glutamax (Gibco, ref:35050-38) and 10% FCS. Cells were incubated at 37oC, 95% 
O2 5% CO2 (Heraeus, HeraCell 240) until culture was at 70-80% confluency. 
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Flasks were then passaged/expanded enzymatically at 1:6 ratio. Media was 
removed from flasks, cells were gently washed with PBS, replaced with 10 mLs of 
TrypLE™ Express  (Gibco, ref: 12604-013) and incubated at 37°C for 3-5 minutes 
until a few cells were starting to detach and appear bright under a phase contrast 
microscope. TrypLE™ Express was gently removed and cells resuspended in fresh 
media. Flasks were tapped to dislodge cells which were gently pipetted and 
transferred into clean T175 flasks containing fresh MEF media (30-50 mLs). Cells 
were passaged every 4 to 5 days in T175 flasks until enough cultures were obtained 
to make a large enough bank (70-100 vials). 
2.2.2 Preparation of primary human feeder cells and human fibroblast 
cell lines 
Human dermal fibroblast cells (neonatal) HDFn (cat. no. C-004-5C) and human fetal 
lung fibroblast line MRC-5 were obtained from Cascade Biologics® and NIBSC (Acc. 
No. 660902). The cells were thawed and subcultured as above. 
2.2.3 Inactivation of fibroblasts using Mitomycin C and Cryopreservation 
Fibroblast cell cultures were inactivated using Mitomycin C treatment for 2-4 hours to 
arrest their growth and provide a support matrix for the hESCs to attach and grow. 
Mitomcyin C is a compound isolated from Streptomyces Caespitosis and is an 
alkylating agent that targets guanine nucleosides and produces oxygen free radicals 
that are preferentially toxic to hypoxic cells. It works by inhibiting DNA synthesis and 
nuclear division. 
Mitomycin C at a concentration of 2 mg/ml was dissolved using 20-50 ml MEF media 
(DMEM, 10% FCS and 1% Glutamax), then filtered using a 0.2um filter and a 20ml 
syringe. The filtered solution was then diluted in 200ml of MEF media, which was 
equally distributed between the T175 flasks contained 70-80% confluent feeders and 
incubated for 2-4 hours at 37oC, 5% CO2. Following  incubation, the media 
containing mitomycin C solution was poured off each T175 flask and the feeder 
cultures within the flasks were washed three times using phosphate buffered saline 
(PBS, NIBSC). Each flask was then treated with 10ml of TrypLE™ Express (25 Mm, 
Invitrogen) and incubated for 5 minutes to allow the cells to dissociate. The TrypLE™ 
Express was then removed carefully by pipetting and 10 ml MEF media was added 
to each flask. The cells were dislodged by tapping sharply on each side of the flask. 
The flasks were swirled and the cell solution pipetted carefully into 50ml conical 
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tubes (BD biosciences). The cells were then centrifuged (Sorvall Legend) at 300g for 
5 minutes. The supernatant was discarded and the cell pellet re-suspended in 10 ml 
MEF media and pipetting up and down several times. A cell count was performed 
using Trypan Blue (Invitrogen, 0.4% solution, T8154) and a disposable 
haemocytometer (C-Chip). The cells were centrifuged again and the pellet, re-
suspended in FCS containing 10% DMSO at final concentration of  1x106 cells/ ml 
These cell were then pipetted into labelled cryovials (1ml per vial). Each vial was 
frozen slowly at -1° C per minute using a Mr Frostie HandiFreeze at -80°C freezer, 
overnight. The vials were then transferred to liquid nitrogen (-196°C) for long term 
storage. 
2.2.4 Examination of feeders for confluency 
A vial of each feeder line was thawed out quickly and resuspended into 1 ml of MEF 
media, then diluted into 10 ml of MEF media in a 15 ml conical tube (BD, Falcon) 
and centrifuged for 5 minutes at 300g to remove the cryopreservant. The 
supernatant was carefully removed and the cell pellet was resuspended in fresh 
MEF media. 2 ml of media was added to each well of a 6 well plate (BD, Falcon), 
previously coated with 0.1 % gelatin for a minimum of 1 hour at room temperature 
(Porcine, NIBSC). The plate was gently swirled to ensure even distribution of feeder 
cells across each well. 
After 24 hour incubation at 37 °C each feeder plate was examined and photos taken 
using a phase contrast microscope at x4 objective (Olympus CKX41), to ensure the 
feeder layer density was confluent enough for the growth of all the stem cell lines (at 
least 80 % of the well surface covered with feeders). 
2.2.5 Preparation of feeders from Fibroblasts 
Vials of inactivated feeder cells were thawed by fast thawing at 37 °C. Cells were 
pipetted out of their cryovials and placed in 7 mls of pre-warmed MEF media. Each 
vial was then washed with 1-2 ml MEF media and then centrifuged at 300g for 5 
mins to remove the cryopreservation media. The supernatant was carefully removed 
by pipetting, and the feeder cells re-suspended into 2 mls of fresh MEF media and 
transferred to pre gelatin coated FB6. Plates were gently swirled to evenly distribute 
cells, and placed in an incubator to settle for 24 hours before observation. After 24 
hours, the confluency was assessed and if suitable for seeding with hESCs, MEF 
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media was replaced by KO-HES (see Table 2.3 for composition) media consisting of 
Knockout serum replacement, Nonessential amino acids (NEAA), Beta-
mecaptoethanol (BME), DMEM and Foetal Calf Serum (FCS), and incubated for a 
minimum of 1 hour to equilibrate the media and condition the MEFs, prior to the 
addition of HESCs. 
2.3. Thawing of hESCs 
Each stem cell line was thawed from cryovials by fast thawing at 37C. Cells were 
gently mixed and pipetted from their cryovials into 7 mls pre-warmed KO-HES 
media. Each vial was then washed using 1-2 ml KO-HES media and then centrifuged 
at 200g for 5 mins to remove the cryopreservant. The supernatant was carefully 
removed by pipetting, and the stem cells re-suspended into 2 mls of fresh KO-HES 
media and transferred into 1-2 wells/FB6 of prepared inactivated feeder layers. Stem 
cells were left to settle for 3-4 days before observation and partial media change.  
2.3.1 Routine culture of hESCs 
Culture media was changed every other day (2mls per well). Once the stem cell line 
had successful thawed and re-established, the colonies were manually passaged by 
cutting, using disposable mini Pasteur pipette under a dissection microscope 
(Olympus) and transferred onto fresh inactivated feeders once a week for 1-2 
passages. 
All four hESC lines were adapted to enzymatic passaging using TrypLE™ Express 
(GIBCO), and were subcultured every 5-7 days. Morphology was assessed when 
media was changed and when passaging. Images were taken to document adaption 
onto different feeders using TrypLE™ Express. As each stem cell line was received 
at a different passage number by the depositors of derivation laboratories, stem cell 
cultures were collected at time points p+5 for early passage, and p+20 for late 
passage.  
  
64 
 
2.3.2 Manual passaging of hESCs 
Fresh Hes media was used to replace old media using an aspirating pipette or 10 ml 
pipette, at least 1 hour before passaging. At the point where the stem cell colonies 
were deemed ‗confluent‘ and a sufficient number of colonies were confluent, the cells 
were placed under a dissection microscope (Vision Lynx, 029986, ISIS Ergohead) 
for manual passaging. A sterile ‗hook‘ or thin Pasteur pipette tip was used to ‗cut‘ 
around the edges and across the stem cell colony (Figure 2.1). The colony pieces 
were then gently lifted at the edges and gently pipetted so they could float up into the 
media. A 20 µl pipette tip was used to quickly collect the colony pieces, which were 
transferred to a plate of fresh feeders which had been incubated with Hes media for 
a minimum of 1 hour. The colony pieces were carefully pipetted onto a well of the 6 
well plate, then evenly distributed across the well. The whole process was repeated 
again for a number of colonies until sufficient amount of material had been dissected 
and transferred to new feeders. 
1.0 mm
     
Figure 2.1. Diagram showing manual passaging of hESCs using mini Pasteur 
pipette. 
2.3.3 Enzymatic passaging 
After about a week of growth confluent stem cell colonies were passaged. Media 
from the 6 well plate of stem cells was removed and replaced with 1 ml per well of 
TrypLE™ Express, and left for 3-4 minutes at room temperature. The TrypLE™ 
Express was then carefully removed and 2 ml of HES media added to the well. The 
cells were gently dissociated to small clumps using a 1 ml pipette tip and transferred 
to a fresh 6 well plate containing inactivated mouse (i3T3 and iMEF) or human 
feeders (iMRC5 and iHDFn). The plate was gently swirled to evenly distribute the 
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stem cells, then carefully placed at 37°C, 5% CO2 until the media required replacing 
(on average every 2 days). Stem cells were passaged for 20 passages (p+20). 
2.3.4 Cryopreservation of human embryonic stem cell lines 
2 to 3 vials of each stem cell line cultured on each feeder line or on Matrigel, were 
frozen down at early (p+5) and later passage (p+15 to p+17) in order to provide a 
small stock to repeat culture experiments at a later date. 1 or 2 confluent wells (70-
80%) of each stem cell line were TrypLE™ Express  treated for 3-4 minutes to allow 
dissociation to small clumps, then 1ml freezing media consisting of 10% DMSO 
(Fisher Scientific) and 90% foetal calf serum (FCS) added. The hESCs were pipetted 
to resuspend cultures, then immediately transferred to cryovials, placed in a Mr 
Frostie Handifreeze (submerged in isopropanol) and slow-frozen at -80C. After 24 
hours, cryovials were transferred into liquid nitrogen vessels for long term storage. 
2.3.5 Culture of hESCs using human fibroblasts 11235. 
Human fetal skin tissue was used to prepare banks of human feeders 11235, which 
were mitotically inactivated using Mitomycin c, at various passages and then plated 
onto 6 well plates. Stem cell lines NCL2, SHEF1, H9 and NCL5 were then cultured 
on i11235 for 5 passages and their morphology observed.  
2.4.0 Feeder free culture of hESCs 
2.4.1 Culture of hESCs by Extracellular matrix (ECM) derived from human cell 
lines 
Human feeder cell line MRC-5, at various passages (p9 and p11), were cultured 
using commercial medium supplemented with 2 % and 10 % FBS respectively, in 6-
well plates and 25 cm2 flasks to 100 % confluency.  To remove the cells, the cell 
layer was rinsed with PBS, then incubated in H2O, agitated vigorously and further 
rinsed with H2O. Plates/flasks were stored immediately at -70° C or air-dried in an 
MSC and stored at room temperature. Additional preparation conditions tested 
included incubation in 2M NaCl prior to, or 70 % ethanol after the final rinse with 
H2O. 
hESCs lines SHEF1, NCL2, HUES3, H9, RH5, NCL5, TRANS1, MEL1 and an IPS 
line were all cultured on ECM preparations, by transferring hESCs cultured on 
mouse feeders using manual passaging, and assessed for expression of 
pluripotency markers, morphology, karyology, embryoid body formation and  
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expression of differentiation markers. 
2.4.2 Culture of hESCs using Matrigel (BD). 
Human embryonic stem cell lines HUES9, SHEF1, NCL5 and RH5 were cultured on 
Matrigel coated plates using mTeSR1 (Stem Cell sciences). Matrigel was prepared 
following manufacturer‘s instructions. 300 µl aliquots of Matrigel was carefully mixed 
into 24 mls of DMEM/F12 media, then equally distributed amongst 4 flat bottomed 6 
well plates and left to coat for 1 hour at room temperature (minimum). Plates that 
were not used immediately were wrapped in parafilm and stored at 4°C for up to 2 
weeks. After 1 hour the Matrigel coating was removed and wells were washed in 1-2 
mls of DMEM/F12. mTeSR1 media was made up by adding the x5 supplement and 
mTeSR1 basal media together and mixing well. 2 ml of mTeSR1 media was 
transferred into each well of FB6, and plates were then ready to use immediately. 
Stem cells were transferred from feeder cultures onto Matrigel/mTeSR1 and allowed 
1-2 passages to adjust to the matrix/media before being counted as (n+1) from their 
original passage, for the study. Media changes were performed on cultures every 2 
days and passaged every 5 to 7 days. Stem cells were cultured for 20 passages. 
Morphology was assessed at each passage. Cell pellets for gene expression and 
flow cytometry were obtained from early p+5 and late passage p+20. Microbiological 
monitoring and mycoplasma testing was also routinely carried out on cultures as 
described below. 
2.5.0 Release criteria testing 
2.5.1 Sterility and mycoplasma testing 
The stem cell cultures were all routinely tested to ensure sterility was maintained 
using a European pharmacopeia method. 0.5-1 ml of cell suspension to inoculate 
agar broths Tryptone soya broth (TSB) and Fluid thioglycollae medium (FTM) at 
37°C and Sabourauds liquid medium (SAB) at 25°C. TSB is used to detect a broad 
range of microorganisms, including Bacilli, Staph, Strep, E. coli, Pseudomonas, 
Clostridia and non-sporing anaerobes. FTM is used to detect a range of 
microorganisms, including Bacilli, Staph, Pseudomonas & Clostridia. SAB detects 
fungal species. Testing was completed by NIBSC Microbiology department and 
assessment carried out at 14 days to check for turbidity/contaminants before the 
results were given back to UKSCB staff. 
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2.5.2 Mycoplasma screening by direct PCR 
Samples were also tested to ensure that the cultures were negative for mycoplasma 
contamination. This test was completed in-house by PCR. Reference numbers were 
assigned  to the negative control sample (H20), followed by consecutive numbers to 
each test sample and the positive control, which consisted of a sample of 
mycoplasma-contaminated cell line or a standard mycoplasma organism e.g. 
Acholeplasma laidlawii, which must produce a positive result i.e. a clear band visible 
on an agarose gel. A number of PCR tubes were labelled with sample reference 
numbers and the PCR master mix prepared as outlined in the table below. Then 39 
μl of master mix was added to each tube/well and the samples were centrifuged at 
200g for 3 minutes. 1 μl of supernatant was added to the appropriate tube/well and 
the contents mixed well. The tubes were then placed in the Bio-Rad DNA Engine 
Peltier Thermal cycler and the programme set to run as follows: 
 95 oC for 5 min. 
 94 oC for 30 sec. 
 57 oC for 30 sec         40 cycles 
 72 oC for 1 min. 
 72 oC for 10 min. 
A 2% gel was made up by dissolving 3g of ultra-pure agarose in 150 ml of 1x TBE 
made from a 10x TBE stock. The agarose was dissolved by heating in a microwave 
on full power for 2 minutes. This was allowed to cool slightly before adding 15 µl of 
SYBR Safe DNA gel stain and mixing well. The mixture was then poured into the gel 
preparation tank.  A size 30 well comb was placed into the gel mix and the gel 
allowed to set for approximately 30 minutes. After the gel had set the comb was 
carefully removed and the gel placed in the electrophoresis tank. 1x TBE was poured 
into the tank to cover the gel. 4 µl of 100bp DNA ladder was pipetted into the first 
well and 18 µl of each test sample and positive controls into the appropriate wells. 
The gel was then run at 100V for approximately 60 to 80 minutes, after which it was 
photographed using the UV illuminator and camera. 
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Table 2.9.  Details of PCR Mastermix 
PCR MASTER MIX For 1 reaction Master Mix 
(e.g. for 10 reactions) 
HotStarTaq Plus Master Mix, 2x 20 μl 200 μl 
MGSO primer (10 µM) 1 μl 10 μl 
GPO-3 primer (10 µM) 1 μl 10 μl 
CoralLoad Concentrate, 10x 4 µl 40 µl 
DNase-free water  13 μl 130 μl 
Total 39 µl 390 µl 
 
2.5.3 Collection of stem cell pellets for DNA profiles. 
DNA profiling, also known as DNA fingerprinting, is method of distinguishing one cell 
type from another by PCR. Although 99.9% of human DNA is the same in everyone, 
0.1% is variable and easily detected using PCR. The most widely used PCR based 
method is STR. It is a comparable test which matches the base pairs of a sample of 
DNA and can be used to distinguish one sample from another. The technique works 
by using short tandem repeats regions of sequences which are repeated side by 
side, usually between 2-6 base pairs. It very similar in closely related humans, but 
different enough that it can be used to distinguish between individuals of no relation.  
Confluent colonies of stem cells cultured on feeders as per the culture methods 
above. were scraped  using a Falcon cell scraper and pipetted into a 1ml Eppendorf 
tube, centrifuged for 1 minute to pellet the cells (Eppendorf centrifuge 5415D) and 
the supernatant removed. The cell pellet was stored at -80 0C until sufficient 
numbers had been collected to be sent off for external DNA profiling at TDL (Doctors 
Laboratory, London). This process was carried out at P+5 and P+20 and compared 
to ensure there was no cross-contamination amongst the 16 cultures being studied.  
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2.6. Characterisation of hESCs 
2.6.1 Classical cytogenetics: karyotyping by g banding 
Human embryonic stem cells are routinely karyotyped to evaluate chromosomal 
abnormalities. Cytogenetics is currently the easiest method for detecting 
chromosomal abnormalities. Basic conventional cytogenetic method involves 
chromosome harvest, slide preparation, banding of chromosomes, analysis of 
Banding patterns and interpretation of the results.  Chromosome harvest consists of 
arresting the cell cycle at metaphase, hypotonic treatment of the cells and their 
fixation, after which the chromosomes are spread onto glass slides, dried and 
stained before banding. Bands are defined as part of a chromosome that is clearly 
distinguishable from its adjacent segments by appearing darker or lighter (Loring et 
al,2006).  
G banding is a commonly used method of banding patterns using Giemsa stain for 
the analysis of metaphase spreads. Each band has a specific number assigned to 
indicate its location on the human chromosome. The nomenclature of band 
assignment and chromosome aberrations is endorsed by the International system of 
human cytogenetic Nomenclature ISCN 2005. 
For quality control of banked hESCs the UKSCB routinely prepares samples for 
chromosome spreads, which are screened on glass slides which are Giemsa stained 
to observe a minimum of 20 metaphase spreads. The samples are then stored in 
fixative, and sent out to an external company, The doctors Laboratory (TDL), for G 
banding. 
2.6.2 Preparation of samples for metaphase spreads 
Samples for metaphase spread analysis were prepared using stem cell cultures 
between 3 to 5 days old.  60-70% confluent wells of a 6 well plate (Falcon) were 
incubated using 10ug/ml colcemid (GIBCO KaryoMax) for 1 hour, then enzymatically 
treated using TrypLE™ Express  (Gibco) to dislodge cells The cell suspension was 
then transferred to a 15ml Falcon tube and spun down for 5 minutes at 200g. 
The supernatant was removed and the remaining cell pellet was swollen using a 
hypotonic solution of equal volumes (1:1) PBS and H20 for 15 minutes at 37°C. The 
cell solution was centrifuged again, the supernatant removed, and the cells fixed 
slowly using acetone/methanol (3:1) by adding drops of fixative while continuously 
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vortexing the solution. The fixed cell solution was then centrifuged, resuspended and 
fixed again using acetone/methanol (3:1 ratio). The sample was subsequently stored 
at 4°C in 4 ml fixative or at -20°C for up to 6 months (if unable to send for Gbanding 
assessment immediately) until ready for staining. 
2.6.3 Examination of metaphase spreads 
The fixed cell solution was further diluted in 1-2 ml of fixative if the suspension was 
too cloudy, then spread onto a methanol dipped-glass slide (VWR, superfrost plus, 
cat: 631-0108) by angling the slide at 45° and using a 2 ml pasteur pipette to place a 
few drops of solution onto the slide from a height of 2 or 3 metres. The slide was 
allowed to air dry completely before undergoing staining using Giemsa stain 1:20 
(Invitrogen, Karyomax) with PBS. 
2.6.4 Giemsa staining 
The prepared slides with samples were  dipped into coplin jars of 0.25% Trypsin 
(Invitrogen) for 2 seconds, then straight into saline for 10 seconds, saline again for 
30 seconds, then into Giemsa stain (1:20) diluted in Gurrs buffer for 10 minutes 
(Invitrogen). The excess Giemsa was washed off in PBS and the slides were allowed 
to dry on a hot plate before being examined under a Phase contrast microscope at 
x20 objective. 
Between 15/20 metaphase spreads were examined before the fixed sample was 
deemed qualitatively good enough to be sent to TDL for external G-banding analysis. 
2.7. Array Comparative genomic hybridisation (aCGH) 
Molecular karyotyping by array comparative genomic hybridisation was set up in-
house. Array comparative genomic hybridisation (aCGH) is a cutting edge tool used 
for detection of deletions and duplications in chromosomes with a detection range of 
1MB-500KB. This method involves differential labelling and hybridisation of sample 
DNA and (normal) reference DNA to an array of genetic probes covering the whole 
genome.  The detection of unbalanced gains or losses is revealed by the comparison 
of sample DNA to reference DNA. This method enables sub-microscopic 
chromosomal aberrations to be detected as well as enabling the analysis of the 
genome at a higher resolution than that achieved by conventional G-banding. 
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Each of the four stem cell lines was cultured on four feeder lines (16 samples in 
total) up to P+20 on 0.1% gelatine-coated flat bottomed 6 well plates. Cell pellets 
were collected at p+5 and p+20. 
DNA from all four stem cell lines on each different feeder layer was obtained by 
scraping cells from 6 well plates into 1ml eppendorf tubes using a Falcon cell 
scraper. The cells were centrifuged in a microcentrifuge, the supernatant removed 
and then stored at -80°C.  DNA extraction was carried out using Qiagen DNeasy 
blood and tissue kit (cat number 69504) as per instructions. DNA was then quantified 
using the NanodropTM. Normal male and female reference DNA was obtained from 
Promega. 
2.7.1  NanoDrop™ DNA Quantification 
DNA quantification was carried out using a NanoDrop (Labtech, ND-1000 
spectrophotometer and software ND-1000 v3.3.0) so as to enable the correct 
quantity of DNA to be used for aCGH. The NanoDrop is a spectrophotometer that 
does not require the use of cuvettes, and is capable of measuring large 
concentrations, and so eliminating the need for dilutions that may cause 
inaccuracies. The prepared DNA sample (1µl) was loaded onto the fibre optic 
measurement surface directly, and the arm lowered. The sample meets the upper 
fibre optic tip and a liquid column results. The path length of the resultant column of 
sample is controlled. Absorbance measurements were made automatically. Between 
each sample the surfaces were wiped with a tissue, and after each measurement, a 
blank (water) was loaded to ensure correct readings were being obtained and there 
was no carryover of sample. NanoDrop results were obtained as a measurement of 
ng/µl. 
2.7.2 Array preparation 
The Perkin Elmer (PE) Constitutional Chip 4.0 kit was used as per instructions. The 
kit includes the arrays, labelling reagents, and hybridisation buffers. NaCl, EDTA, 
Isopropanol and reference DNA. Reference and sample DNA were labelled with 
labelling dye and incubated at 70oC for 10 minutes, then snap-cooled on ice-slurry. 
The reference and sample DNA was then mixed together and allowed to hybridise 
for 20 minutes before the precipitation step in 70% alcohol. The reaction was 
stopped using EDTA (0.5Mm). The samples were then carefully pipetted onto a 
cover slip which was very carefully placed onto a new clean array. 
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2.7.3 Hybridisation of arrays 
The arrays were placed in hybridisation chambers, on top of moistened wypalls and 
into plastic boxes. The arrays were then incubated at 56°C for 16 hours (minimum) in 
a hybridisation oven. This step was always carried out overnight. The following day 
the arrays were carefully disassembled from hybridisation chambers and carefully 
washed in copping jars using a series of 3 buffers (SDS buffer details). Finally 
excess buffer was removed using an alcohol wash in 70% w/w isopropanol and the 
slides spun-dry (Labnet slide spinner) and stored in a desiccators until ready to be 
scanned. 
The arrays were scanned using a ScanArray Gx Scanner (Perking Elmer) and 
analysed using Scanarray Express. Spectral views of the chromosomes were viewed 
using SpectralWare Molecular Karyotype Analysis v2.3.3.  Analysis was completed 
using the OneClick aCGH software (version 4.3.3). Figure 2.2 demonstrates an 
overview of aCGH method. 
  
73 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Method overview of aCGH obtained from Perkin Elmer 
Constitutional Chip 4.0 User manual. 
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2.8.0 Flow cytometry using the GuavaTM for the expression of 
pluripotency markers 
 Cells were cultured on their respective feeders using culture method outlined above. 
Cells were enzymatically treated using TrypLE™ Express for 3-4 minutes and gently 
pipetted using 2 mls Hes media, transferred to 15 ml Falcon tubes and centrifuged 
for 5 minutes at 200 g. The supernatant was removed and the cell pellet 
resuspended in 500 µl PBSa and fixed in 4% PFA for 15 minutes. 5 ml PBSa was 
added to the cell culture suspension and the tube was centrifuged for a further 5 
minutes at 200 g.  The cell solution was then stored at 4°C in 10ml WashBuffer 
(PBSA+0.1% BSA and 0.1% Sodium azide) until ready for staining (maximum 6 
months). 
 Stem cell suspension was pelleted and cells counted using the NucleoCounter 
(Chemotec). The cell suspension was then resuspended in Washbuffer and 20 ul 
pipetted onto 96 well plates at a dilution of 4x106/ml. Cells were incubated with 
designated antibodies and their respective isotype controls for each cell surface 
marker at optimised dilutions for at least 30 minutes at room temperature and 
covered with foil to avoid exposure to light. Pluripotency cell surface antibodies Oct 4 
SSEA1, SSEA3, TRA160 and TRA181 and their respective isotype controls (Table 
2.10) were all grown and filtered in-house (UKSCB, NIBSC) using hybridomas. 
Hybridoma technology is the production of monoclonal antibodies using hybrid cells 
that are specifically selected for their ability to grow in cell culture with an absence of 
antibody chain synthesis. The antibodies produced by the hybridoma are of single 
specificity (monoclonal). 
The plates were then washed twice in Washbuffer and centrifuged at 600 g for 5 
minutes. The cells were finally resuspended in wash buffer and the stained cells 
transferred to a flat bottomed 96 well plate. The final volume was adjusted to 300µl 
using wash buffer and the plate was loaded onto the GuavaTM Flow cytometer 
(Millipore, Guava Easycyte W/SSC) for the cells to be processed. Control carcinoma 
cell line n2102EP (CSCB, Andrews et al, 2002) was used and routinely set up and 
stained on the same plate. The analysis was completed on the Guava using 
CytoSoft 3.6.1 ExpressPlus programme and the results exported to a Word Excel 
spreadsheet to produce bar charts and line graphs in order to visually compare 
expression of cell surface markers between the 16 samples. 
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Table 2.10. Details of primary antibodies and isotype controls used 
for Flow cytometry and in-situ fluorescence staining. 
Antibody Subtype supplier Cat 
number 
Lot number Dilution 
IgM Mouse 
IgM 
Caltag MGM00 1000A  1/100 
Tra-1-60 Mouse 
IgM 
Hybridoma Made in 
house 
Made in 
house 
1/5 
Tra-1-81 Mouse 
IgM 
Hybridoma Made in 
house 
Made in 
house 
1/5 
SSEA1 Mouse 
IgM 
Hybridoma Made in 
house 
Made in 
house 
1/5 
IgG3 Mouse 
IgG3 
Abcam AB18392 305108 33ug/ml (1/50) 
SSEA4 Mouse 
IgG3 
Abcam Ab16287 339164 33ug/ml (1/50) 
Rat IgM Rat IgM Caltag RGM004 0503 1/50 
SSEA3 Rat IgM Hybridomas Made in 
house 
Made in 
house 
1/5 
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Table 2.11. Details of secondary antibodies used for flow cytometry 
and in-situ fluorescence staining  
Antibody supplier Cat 
number 
Lot 
number 
dilution 
Mouse Igm + 
IgG FITC 
Caltag LM30801 30801 1/100 
Goat anti-
mouse (PE) 
IgM 
Caltag M31504 488000A 1/100 
 Alexafluor  
647 (CY5) 
Goat anti rat 
IgM 
Invitrogen A21248 764793 1/200 
Alexafluor 488  
(FITC) Goat 
antimouse IgG 
Invitrogen A11017 796017 1/200 
4′,6-diamidino-
2-phenylindole, 
dihydrochloride 
(DAPI) nucleic 
acid stain 
Invitrogen D1306  1/1000 
 
 
 
 
2.9.0 TissueFaxsTM   quantitative Imaging system 
Stem cells cultured  in 6 well plates on each of the four feeder types were transferred  
into flat bottomed 24 well plates (BD Biosystems) using TrypLE™ Express  and 
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cultured as above until 70% confluent and containing <5% differentiated cells. The 
cells were fixed in-situ using 4 % PFA for 20 minutes, then washed three times in 
PBSa. 3-4 mls of wash Buffer was carefully pipetted into each well and each plate 
was sealed using parafilm and stored at 4°C until ready for staining and imaging. 
Plates were stained using SSEA-3, TRA1-60, TRA1-81 and their respective isotype 
controls (Hybridomas, UKSCB, NIBSC) at 1:5 dilution for 1 hour at room temperature 
or 4°C overnight. Primary antibodies were washed off using WashBuffer and the 
secondary antibody (1:100 dilution) pipetted into each well and incubated for a 
minimum of 1 hour at room temperature. The secondary antibody was washed three 
times using Washbuffer before staining each well with DAPI (1:100, Invitrogen) for 5 
minutes at room temperature. Once washed off and resuspended using Washbuffer, 
the plate was set-up for imaging using the TissueFaxs™ imaging system (x20 
magnification).  Analysis of successfully stained wells was carried out using the 
TissueQuest analysis software (version 3.02) to give accurate quantitation of the 
expressed cell surface markers in each stem cell sample.   
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78 
 
Figure 2.3. Plate layout for in-situ staining.  The wells in column A were used as 
an isotype control.  Column B was used as a negative control with only secondary 
antibody staining.  All plates fixed for this project were stained in the following order 
to allow for easy and comparable analysis and combinations of antibody expression: 
Wells C2, C3 D4, F2, F3:SSEA4 
Wells C1, F2-F4, E4, D4, C4:SSEA3 
Wells C4, D4, F1, E2, E3:TRA1-81 
Wells D2, D3, E1, E4: TRA1-60  
 
2.10. Taqman Low Density Array (TLDA) cards for relative expression of 
pluripotency genes 
Stem cells were cultured using the same culture methods stated above. Cell pellets 
were collected at passaging intervals p+5, p+20. Confluent cell cultures containing 
>5% differentiated stem cell colonies were carefully scraped using Falcon cell 
scrapers and pipetted into 1ml eppendorf screw cap tubes. The cell pellets were 
spun down in an Eppendorf microfuge, supernatant removed and stored at -80°C 
until ready for RNA extraction using Qiagen Rneasy spin column as per leaflet 
instructions. An extra step was added to this method using Qiagen QiaShredder, to 
increase RNA purity. 
2.10.1 RNA Extraction 
Total RNA isolation was carried out using a Qiagen Rneasy mini kit according to the 
protocol provided (Qiagen, Cat. No 74104). This method combines the selective 
binding properties of a silica based membrane with spin technology. Samples for 
RNA extraction were obtained by harvesting the cells using trypsin/EDTA passaging. 
After centrifugation for 2 minutes at 200 g (Eppendorf table top centrifuge 5415D) the 
cell pellet was re-suspended in 350 µl of RLT buffer (a highly denaturing guanidine-
thicyanate containing buffer, which inactivates RNases to ensure purification of intact 
RNA) and stored at -80°C. To each sample, 350 µl of 70% ethanol was added, which 
created appropriate binding conditions to the silica membrane. The sample was then 
transferred to an Rneasy column in a 2ml collection tube, and centrifuged for 15s at 
8000g and the flow-through discarded. To each tube, 700 µl of buffer RW1 was 
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added, and the tubes centrifuged for 15s at 8000g, with the flow-through once again 
being discarded. 500 µl of buffer RPE (made up with 4 volumes of 100% ethanol 
added to the stock bottle) was added to each tube, and centrifuge for 15s at 8000g, 
again discarding the flow-through. This step was repeated. The columns were then 
transferred to new 2 ml tubes, and centrifuged for 2 minutes at full speed. The 
Rneasy columns were placed into clean 1.5 ml tubes, and 50 µl of PCR grade 
RNase-free water added to each column to elute the RNA. The columns were 
centrifuged for 1 minute at 8000g. The optional step of re-using the flow-through in 
order to elute more RNA, with 50 µl of RNase-free water was also carried out, using 
a fresh volume of water, and the tubes centrifuged for 1 minute at 8000g, giving a 
total volume of 100 µl containing RNA. 
The prepared RNA was measured using NanoDrop™ to access 260/280 ratio 
integrity, using the method outlined above. The RNA was then examined further 
using Agilent Nano Chip (Agilent Technologies) to decide whether the extracted RNA  
was of good enough quality to use for LDA cards. This was performed according to 
Agilent technology instructions. 
2.10.2 Preparation of samples for Agilent Assay 
RNA integrity was assessed by RIN number (RNA integrity number). RNA with a RIN 
measurement of 8-10, calculated as a result of 28s:18s ribosomal RNA ratio, was 
processed further to make cDNA. 1-10, with 1 being poor and 10 been excellent. RIN 
10: Intact RNA, RIN 5: Partially degraded RNA, RIN 3: Strongly degraded RNA. 
First the Agilent RNA 6000 Nano kit was taken from 4C and left at room 
temperature for 30mins. The RNA samples of interest and one aliquot of RNA ladder 
(already aliquoted into 1 µl per sample) were denatured at 70°C for 2 mins using a 
heating block, then snap cooled on ice. 550 µl of RNA 600 nano gel matrix was spun 
down in a spin column provided in the Agilent kit at 1500g for 10 mins. The filtered 
gel was aliquoted (65µl) into 0.5ml RNase-free microfuge tubes (Agilent RNA free 
tubes). Filtered gels can be stored at 4C for up to four weeks. The RNA 6000 Nano 
dye concentrate was vortexed for 10 seconds, then spun down and 1µl of dye added 
to the 65µl aliquot of filtered gel. The solution was vortexed and centrifuged at 
13000g for 10 minutes. The prepared gel was used within one day.  
 Using a new Agilent Chip 9.0 µl of gel-dye mix was pipetted in the well-marked (G). 
The chip was then carefully placed into the chip priming station and the plunger 
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placed at position 1ml. The chip priming station was then closed and the plunger 
pressed so it was held in place by the clip. Using a timer the plunger was left in this 
position for exactly 30 seconds, before being released. After 5 seconds, the plunger 
was slowly and carefully returned to the 1ml position by hand. 9.0 µl of gel-dye mix 
was carefully pipetted in the 2 wells marked (G). 5 µl of RNA 6000 Nano marker in all 
12 sample wells and in the well-marked ladder, avoiding pipetting bubbles and 
touching the bottom of the chip so as not to pierce the chip. Pipette 1µl of prepared 
ladder in the well-marked ladder. 1µl of sample was pipetted in each of the 12 
samples well. RNA 6000 Nano Marker was pipetted into each unused well (All wells 
must be full). The chip was carefully placed horizontally in the adapter of the IKA 
vortexer and vortexed for 1 minute at 2400rpm. The Chip was then run on the Agilent 
2100 Bioanalyser within 5 minutes on the Eukaryotic total RNA assay selection. 
Figure 2.7 below shows an electrogram of a hESC RNA sample. Two peaks are 
shown from which the RIN ratio is calculated (28s:18s). 
 
 
 
                 
Figure 2.4. Electrogram showing example of RNA integrity from a 
stem cell sample. 
 
2.10.3 cDNA preparation 
 cDNA was prepared from suitable RNA on ice using Applied Biosystems High 
capacity cDNA Reverse Transcription kit with random primers for use with the 
TaqMan LDA cards. The RNA samples were mixed with PCR master mix (see 
concentrations/dilutions in table) and loaded into a pre-set thermocycler and 
amplified using the following cycle. The cDNA was then stored at -20C until ready to 
be loaded onto a TLDA card. 
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Table 2.12. Preparation for 2XRT master mix (20 µl per reaction) 
Component Volume/Reaction (µ/L) 
10XRT Buffer 2.0 
25XdNTP Mix (100mM) 0.8 
10xRT Random Primers 2.0 
MultiScribe Reverse Transcriptase 1.0 
RNase Inhibitor 1.0 
Nuclease-free H20 3.2 
Total per reaction 10.0 
 
Table 2.13. Reverse Transcription program for Thermocycler 
(Applied Biosystems 7900HT). 
 Step 1 Step 2  Step 3 Step 4 
Temperature 
(C) 
25 37 85 4 
Time 10min 120min 5min  ∞ 
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2.10.4 Preparation of TLDA cards 
 cDNA samples were prepared by adding RT PCR Mastermix (Applied Biosystems) 
and loaded into a TaqMan array card which has been pre-filled with TaqMan gene 
expression assays prepared by Applied Biosystems for the UKSCB. These cards 
contain 96 genes specific to embryonic stem cell markers including 6 endogenous 
controls and 16 house-keeping genes. Once carefully loaded with 100 µl sample-
specific PCR reaction the cards were centrifuged at 300 g for 2x1 minute. 
The cards were then sealed to remove the fill reservoirs using an AB card sealer. 
The fill reservoirs were then subsequently cut off carefully using scissors and the  
prepared card loaded onto a 7900HT fast real time PCR analyser (Applied 
Biosystems) for relative quantification using comparative Ct. Once the cycles were 
complete the data was transferred into RQ manager software (version 2.1) for 
analysis. Further analysis was carried out using ExpressionSuite software version 
1.1 (Life Technologies). 
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Chapter 3.  Assessment of human 
embryonic Stem Cell morphology 
on different matrices and release 
criteria testing. 
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3.1 Introduction 
In keeping with the stringent quality testing that the UKSCB needs to adhere to, it 
was necessary to ensure that the stem cell lines used for these studies were 
subjected to quality control testing. This is particularly important since the protocols 
developed will be incorporated into improving the culturing procedures for a more 
standardised banking process. Rigorous ‗release‘ criteria is employed by the UKSCB 
to test banked stem cell lines, consisting of viability, sterility, mycoplasma testing, 
viral PCR and DNA profiling along with detailed records of the banking procedure. 
Such testing ensures that the banks of cells produced are of high quality, and do not 
run the risk of compromising the reproducibility of cutting edge research. It is this 
type of quality assurance testing that ensures scientists accessing banked hESC 
lines that they are reliably cultured, free from contamination and furthermore, it 
distinctly separates the UKSCB apart other research organisations and providers of 
research grade hESC lines. 
Thus in this thesis, a panel of screening protocols have been adopted for testing the 
quality of the cells used in all the studies and include screening for bacterial, fungal, 
yeast and mycoplasma contamination. More importantly, since the characteristics, 
morphology and differentiated status of hESCs can be regulated by the matrix on 
which they are cultured as well as the method of passaging and media used, 
experiments were carried out to preliminary evaluate the suitability of an ECM source 
MRC5, derived from human feeder lines. These were compared with fibroblasts 
derived from foetal skin, neonatal skin and mouse fibroblast line 3T3 with the current 
standard culture matrix, MEFs, to determine whether hESCs can adapt to and 
maintain their undifferentiated state on these matrices.  
The use of better defined media and matrices for the undifferentiated culture of 
hESCs is becomingly increasingly routine, especially as researchers move away 
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from using feeders. Often, such media is used in combination with defined media 
components and a non-feeder matrix such as Matrigel, a basement membrane 
matrix derived from Engelbreth Holm-Swarm (EHS) mouse sarcoma cells. Matrigel,  
in combination with defined media such as mTeSR1 has been shown to support the 
growth of a variety of stem cell lines (Ludwig et al., 2005), for many different 
applications. Moreover, it is batch tested, which again, adds another level of quality 
assurance to its benefits, compared with using mouse feeders which have huge 
variation due to the use of different mouse strains, preparation methods and 
variation due to the number of viable cells and method of inactivation (Stacey et al., 
2006). In this thesis, additional comparative studies were therefore carried out 
examining the morphological effects of stem cell growth ECM derived from human 
lung fibroblast line MRC5, Laminin and Matrigel and mTeSR1 media. 
The investigations in this first results chapter were essential before any further 
studies are carried out, to ensure that the quality of the cells used and the basic 
conditions that determine their undifferentiated status are defined.  
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3.2 Methods 
3.2.1 Preparation of mouse, human feeders and Matrigel/mTeSR1 and for 
culture assessment using hESCs 
Preparation of mitotically inactivated feeder banks from two mouse cell lines, 3T3 
and MEF, and two human cell lines MRC5 and HDFn, and the subsequent culture 
adaption of hESCs onto different feeder types were as described in the general 
methods section (chapter 2.1). Matrigel and mTeSR1 media was prepared according 
to manufacturer‘s protocols, as described in Methods chapter section 2.4.2. The 
stem cell lines HUES9, NCL5, SHEF1 and RH5 were all cultured on feeder free 
matrix Matrigel using mTeSR1 media, for extended passage, up to p+20. Stem cells 
were assessed for morphology throughout the culture process. Throughout the 
culture process the cells were closely observed and images taken to document their 
adaption from mouse to human feeder layers and Matrigel, and for two of the hESC 
lines, their adaption from mechanical dissection passaging (cutting) to enzymatic 
passaging using TrypLE™ Express.  
3.2.2 Assessment of undifferentiated hESC growth using human feeders 
derived from foetal skin 
Foetal skin tissue obtained from ethical sources was prepared by standard methods 
to give foetal fibroblast line 11235. The cell line was cultured using MEF media 
(DMEM, 10% FCS and 1% Glutamax) and inactivated according to standard 
methods described in methods chapter 2.3.5. Stem cell lines H9, H7, NCL5, and 
NCL2 were cultured on i11235 using KO HES media for 5 passages, and 
subcultured every 5-7 days using traditional cutting method for the first 1-2 
passages, then adapted to passaging using TrypLE™ Express for the remaining 
passages. The cells were assessed for typical undifferentiated hESC morphology. 
3.2.3 Preparation of extracellular matrix (ECM) from human feeders for culture 
assessment using hESCs 
The human cell line MRC5 was cultured for up to 5 passages using standard MEF 
media as described in chapter 2.2.1, and ECM prepared from MRC5 as described in 
section 2.4.1.The stem cell lines NCL5 (P31), HUES9 (P23), and H9 (P27) were 
culture on ECM using KO he‘s media and passaged using TrypLE™ Express as 
described in methods chapter 2.3.3.  
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3.2.4 DNA profile, sterility and mycoplasma PCR testing 
Samples for DNA profile and viral PCR testing were prepared from stem cells 
cultured on i3T3s, iMEFs, iHDFns, iMRC5s and Matrigel at early and late passages 
(P+5, P+20) to ensure that cross contamination of cell lines had not occurred 
through the extended culture process, and that the cultures were free of viral 
contamination. Collection of samples for DNA profiling for PCR analyses were 
carried out as described in chapter 2. Mycoplasma broths were also inoculated with 
cell suspension, for potential detection by culture method, as described in the 
general methods chapter (section 2.5.3).   
Samples (spent media) for sterility testing were taken throughout the culture process, 
in particular, at thawing and freezing down stages, and subjected to the various tests 
as described in sections 2.5.1 of the general methods chapter. 
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3.3 Results 
 
3.3.1 Effects of human and mouse feeders on growth and morphology of 
hESCs 
Figures 3.1 to 3.8 shows the morphology observed from RH5, HUES9, NCL5 and 
SHEF1 cultured on human and mouse feeders, at late passage (p+20). Post thaw, 
following two weeks of culture using iMEFs, all cell lines appeared to be healthy, with 
typical morphology. Both RH5 and HUES9 quickly adjusted and appeared to 
proliferate well on human feeders, and required passaging twice a week with 
TrypLE™ Express.  Passage ratios were adjusted from 1 in 6 wells, to 1 in 12 wells 
to allow for all the different stem cell lines/conditions to be passaged at the same 
time once a week. At early passage (P+5) HUES9 grew in between the human 
feeders and pushed the feeders either side of their colonies as they became larger 
and more confluent. At later passage the morphology of these cells changed as a 
result of culture on human feeders. Figures 3.1 A and 3.2 B showed much larger 
colonies with angular borders. Slightly more differentiation was also seen from 
cultures grown on iHDFn human feeders than iMRC5 overall.  When compared to 
cultures on human feeders, HUES9 colonies on mouse feeders (Figures 3.2 C and 
D) became much smaller in size, with more differentiation around the edges of the 
colonies.  
Stem cell line RH5 showed some signs of differentiation and cell death at early 
passage as the cells adapted to different feeders, as demonstrated by Figure 3.3 (A, 
B, black arrows). Distinct morphology changes were observed with early passage 
(p+5) cultures of the RH5 cells on human feeders which appeared to grow not in a 
typical round shape as they did on mouse feeders, but in elongated, more angular 
colonies, which followed the patterns produced by the plated inactivated human 
feeders. At late passage RH5 stem cells grew on top of mouse fibroblast line i3T3 as 
shown in Figure 3.4 (image B), and on iMEF, in distinct colonies (Figure 3.4 image 
A). RH5 also proliferated with distinct morphology on human fibroblast iHDFn, as 
they grew in between the feeders, as shown by Figure 3.4 (image C) and in swirls 
(image D). RH5 appeared to adapt better to iMRC5 and iHDFn human feeders, in 
comparison to iMEF and i3T3 mouse feeders, as there were a lower number of 
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attached colonies and more differentiation (denoted by arrows) observed on mouse 
feeders (Figure A, B) compared with colonies on both human feeders. 
Considerable differentiation and cell death was observed when SHEF1 were initially 
enzymatically passaged on iHDFn human feeders. As a result this stem cell line was 
manually passaged for 1-2 passages on human feeders before switching to 
enzymatic passaging. This approach enabled this cell line to grow undifferentiated 
on iMEFs but not on human feeders or on the mouse fibroblast line i3T3, with more 
spontaneous differentiation occurring between passages, despite adjustments made 
to passage ratios, from 1 to 6 wells to 1 to 3 wells. SHEF1 maintained typically small 
distinct colonies of hESCs, with clear defined edges, with the exception of iHDFn 
cultures and iMRC5, which were elongated (Figure 3.5 image C) and more angular 
(Figure 3.5 image D, E). Figure 3.5 (D and E) also demonstrates how the stem cells 
cultured on iMRC5 human feeders proliferated, as they pushed the feeders to the 
sides, as shown by the thickened edges of the stem cell colonies (denoted by 
arrows). The culture of SHEF1 cells using TrypLE™ Express resulted in more 
confluent cells, as their colonies became large and began to merge and grow as a 
monolayer. This pattern of growth was seen in Figure 3.6 by all feeder types at later 
passage (p+11). 
Stem cell line NCL5 required more time to adapt to culture on human feeders (1-3 
passages) and in particular, on iHDFn, as more spontaneous differentiation was 
observed. Following 5 passages, NCL5 demonstrated better adaption and was 
consistently growing with mostly undifferentiated colonies on all four feeder types. 
Colonies on both human feeders appeared angular and elongated and grew in 
between the feeder layers. As observed by SHEF1 cell line, NCL5 pushed the 
feeders aside of the colonies as the cells proliferated (Figure 3.7, denoted by 
arrows). As shown by Figure 3.8 (C, D) much larger, more elongated colonies with 
irregular borders were observed compared with those observed on mouse feeders, 
which were round, tight and distinct colonies (image A, B). Slightly more 
differentiation was observed from cultured on i3T3 and iHDFn (Figure 3.8 image B, 
C). The morphologies observed at late passage were mostly consistent with images 
at early passage (p+5) on human and mouse feeders, suggesting that the culture 
procedure using TrypLE™ Express did not alter the morphology of the cells in 
culture. 
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Figure 3.1.  Morphology showing HUES9 stem cells cultured on human feeder 
iMRC5 (A), iHDFn (B), i3T3 (C), and on iMEF mouse feeders (D, E) at early 
passage (p+5). Cells were dissociated from monolayers using TrypLE™ 
Express and seeded onto the respective feeders at a seeding density of 
2x105cells/ml. The photographs were taken with a light microscope at x4 
magnification. Scale bar: 100 µm. 
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Figure 3.2.   Morphology showing HUES9 stem cells cultured on human feeder 
iMRC5 (A), iHDFn (B), i3T3 (C), and on iMEF mouse feeders (D) at late passage 
(p+20). Cells were dissociated using TrypLE™ Express and seeded onto the 
respective feeders at a seeding density of 2x105cells/ml. The photographs 
were taken with a light microscope at x4 magnification. Scale bar: 100 µm. 
 
 
   
 
 
92 
 
 
 
 
 
 
 
 
Figure 3.3. Morphology showing RH5 cultured on iMEF (A), i3T3 (B), iHDFn (C) 
and iMRC5 (D) at early passage (p+5). Cells were dissociated using TrypLE™ 
Express and seeded onto the respective feeders at a seeding density of 
2x105cells/ml. The photographs were taken with a light microscope at x4 
magnification. Scale bar: 100 µm. Arrows indicate areas of cell differentiation 
and cell death. 
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 Figure 3.4. Morphology showing RH5 cultured on iMEF (A), i3T3 (B) and iHDFn 
(C), iMRC5 (D) at late passage (p+20). Cells were dissociated using TrypLE™ 
Express and seeded onto the respective feeders at a seeding density of 
2x105cells/ml. The photographs were taken with a light microscope at x4 
magnification. Scale bar: 100 µm. 
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Figure 3.5. Morphology showing Stem cell line SHEF1 cultured on iMEF (A) 
i3T3 (B), iHDFn (C), iMRC5 (D,E) at early passage (p+5). Cells were dissociated 
using TrypLE™ Express and seeded onto the respective feeders at a seeding 
density of 2x105cells/ml. The photographs were taken with a light microscope 
at x4 magnification. Scale bar: 100 µm. Arrows indicate areas where 
inactivated feeder cells have been pushed to the sides of the stem cell 
colonies to allow for further proliferation.  
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Figure 3.6. Morphology showing stem cell line SHEF1 cultured on iMEF (A), 
i3T3 (B), iHDFn (C), iMRC5 (D) at late passage (p+11). Cells were dissociated 
using TrypLE™ Express and seeded onto the respective feeders at a seeding 
density of 2x105cells/ml. The photographs were taken with a light microscope 
at x4 magnification. Scale bar: 100 µm. 
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Figure 3.7. Morphology showing NCL5 cultured on iMEF (A), i3T3 (B), iHDFn 
(C), iMRC5 (D) at early passage (p+5). Cells were dissociated using TrypLE™ 
Express and seeded onto the respective feeders at a seeding density of 
2x105cells/ml. The photographs were taken with a light microscope at x4 
magnification. Scale bar: 100 µm. Arrows indicate areas where inactivated 
feeder cells have been pushed to the sides of the stem cell colonies to allow 
for further proliferation.  
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Figure 3.8. Morphology showing stem cell line NCL5 cultured on iMEF (A), i3T3 
(B), iHDFn (C) and iMRC5 (D) at late passage (p+20). Cells were dissociated 
using TrypLE™ Express and seeded onto the respective feeders at a seeding 
density of 2x105cells/ml. The photographs were taken with a light microscope 
at x4 magnification. Scale bar: 100 µm. 
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3.3.2 Morphology of stem cells cultured on human foetal fibroblast line i11235 
The hESC lines H9, NCL2, NCL5 appeared to readily adapt to culture on in-house 
derived fibroblast line i11235 with little differentiation observed. Although cells at p+1 
did exhibit some irregular colony borders (as shown by Figure 3.9 A-C), morphology 
was consistent with cultures on MEFs, particularly at p+5 (Figure 3.13 D-E.). 
Very small areas of differentiation were seen from all hESC lines, consistent with 
their culture on mouse and human feeders. Later passage stem cells lines (p+5) 
exhibited very little morphological difference from earlier passages and were easily 
adapted to enzyme passaging using TrypLE™ Express. 
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 Figure 3.9. Morphology of stem cell lines NCL5, NCL2, and H9 cultured on 
human foetal fibroblast line i11235. Images A-C at p+1 and D-E at p+5. Stem 
cells were dissociated using TrypLE Express™ and seeded onto the 
respective human feeders at a seeding density of 2x105cells/ml. The 
photographs were taken with a light microscope at x4 magnification. Scale 
bar: 100 µm. 
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3.3.3 Morphology of hESCs cultured on feeder-free matrix Matrigel with 
mTeSR1™ media 
Although each stem cell line appeared to adapt to Matrigel/mTeSR1™ there were 
significant changes in morphology, particularly for the two stem cell lines which were 
traditionally enzyme passaged, RH5 and HUES9. Both lines appeared to grow in 
large colonies and eventually as sheets at 80% confluency, whereas NCL5 and 
SHEF1 appeared to be growing in smaller defined colonies. This may be due to the 
absence of feeders, as cell colonies grew in flatter, larger colonies, as they required 
contact with the Matrigel surface for support. The colonies also appeared thinner, 
which also may have been due to the absence of feeders. When left for more than 8 
days without subculturing, spontaneous differentiation was visible in all the stem cell 
lines cultured on Matrigel. This was similar to observations seen from hESCs 
cultured on feeders. NCL5 appeared to adapt quickly and grew well on Matrigel for 
20 passages with little differentiation. NCL5s also maintained discreet tight compact 
morphology as seen from feeder based cultures (Figure 3.10 A). Large flat colonies 
were also observed when confluent, which would merge together to form large 
sheets if left unpassaged. NCL5 proliferated much faster and maintained healthy 
colonies with very little differentiation. They also required passaging after 4 to 5 days 
instead of 5-7 days, at early passage. More differentiation was seen from HUES9 
colonies which required passaging every 3 to 4 days and proliferated in large sheets. 
RH5 also proliferated in large colonies, with smaller colonies only observed 1 day 
after they had been passaged. . 
The SHEF1 cells could not be cultured further than passage n+12. This was thought 
to be due to insufficient cell number from the original project bank thawed or poor 
quality of banked cells. Clear morphological differences were seen when NCL5, 
SHEF1, HUES9 and RH5 were cultured on feeder free matrix Matrigel. NCL5 and 
SHEF1 (3.10 A and B) proliferated as tight, round distinct colonies whereas HUES9 
formed very small colonies (Figures 3.10C and 3.11C), which merged into large flat 
sheets as they became more confluent. RH5 also grew into large colonies; however 
they were more elongated than the other stem cell colonies (Figure 3.10 D). 
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Figure 3.10. Morphology  of stem cell lines NCL5 (A), SHEF1 (B), HUES9 (C) 
and RH5 (D) on Matrigel at early passage (p+5). Cells were dissociated using 
TrypLE Express ™ and seeded onto Matrigel coated plates at a seeding 
density of 2x105cells/ml. The photographs were taken with a light microscope 
at x4 magnification. Scale bar: 100 µm. 
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Figure 3.11. Morphology of stem cell lines NCL5 (A), SHEF1 (B), HUES9 (C) and 
RH5 (D) on Matrigel at late passage (p+20). Cells were dissociated using 
TrypLE™ Express and seeded onto Matrigel coated plates at a seeding density 
of 2x105cells/ml. The photographs were taken with a light microscope at x4 
magnification. Scale bar: 100 µm. 
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3.3.4 Morphology of hESCs cultured on ECM of human feeders 
Cells transferred for culture on ECM did display some changes in morphology. 
Initially, cells proliferated slowly and colonies remained small in size  with irregular 
borders, as demonstrated by all three hESC line HUES3, H9 and NCL5 (Figure 3.12 
image A-C). A considerable amount of cell death occurred from all three hESC lines, 
and NCL5 also exhibited some differentiation around the edges of the colonies. As 
cells adapted, they became larger in colony size. Care was taken not to over 
trypsinise the cells when passaging with TrypLE™ Express. After 5 passages, cells 
had clearly adapted to the ECM and proliferated well forming large colonies with 
more typical rounded, hESC morphology from all three hESC lines (Figure 3.12 D-F). 
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Figure 3.12. Morphology of stem cell lines HUES3, H9 and NCL5 cultured on 
ECM from human feeder line MRC5. Images A-C at p+1 and D-E at p+5. Cells at 
passage p+5 were dissociated using TrypLE™ Express and seeded onto the 
respective human feeders at seeding density of 2x105cells/ml. The 
photographs were taken with a light microscope at x4 magnification. Scale 
bar: 100 µm. 
     
 
105 
 
 
 
3.3.5 DNA profile, Viral, mycoplasma and sterility testing 
Results obtained from the DNA profiling studies were manually checked against the 
previous DNA profiles from the same samples to confirm that there has not been any 
cross contamination with other stem cell lines during the extended culture process. 
As can be seen in Table 3.10, the summary data shows no cross contamination as 
all cell lines were found to match their original DNA profiles provided by the 
depositors and did not display additional alleles. 
Results for mandatory viral markers are given in Table 3.2. The method of reporting 
is denoted by ‗detected‘ or ‗not detected‘ and the data obtained show clearly that all 
cell lines analysed were free of viral contamination. Similarly, no microbial or 
mycoplasma contamination was found through the extended culture process in any 
of the stem cell or feeder lines used in this project, as demonstrated by the sterility 
test reports summarised in Table 3.2. The results demonstrate that good aseptic 
techniques were effectively used throughout the culture process. 
Unfortunately, stem cell line SHEF1 failed to grow beyond P+12 on either human 
feeders or mouse feeders. This was apparent by slowed growth, small colony 
formation and differentiation upon further attempted passage. 
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Table 3.1. Summary of DNA profile results of stem cell lines SHEF1, 
HUES9, RH5 and NCL5 cultured on mouse feeders iMEF at early 
and late passage.  
DNA profiling was carried out by TDL, using an AMP/STR identifier kit (Applied 
Biosystems), analysing 15 polymorphic autosomal DNA markers. The cell line 
gender has been identified as male. No contamination with other cell lines was 
detected, as SHEF1 had the same DNA profile as that obtained from the Distribution 
cell bank (DCB). 
Cell line DNA Profile at early 
passage 
DNA profile at late passage 
HUE9 on iMEF Match with DCB  Match with early passage 
HUES9 on i3T3 Match with DCB Match with early passage  
HUES9 on iMRC5 Match with DCB Match with early passage  
HUES9 on iHDFn Match with DCB  Match with early passage  
RH5 on iMEF Match with DCB Match with early passage 
RH5 on i3T3 Match with DCB Match with early passage 
RH5 on iMRC5 Match with DCB Match with early passage 
RH5 on iHDFn Match with DCB Match with early passage 
NCL5 on iMEF Match with DCB  Match with early passage  
NCL5 on i3T3 Match with DCB Match with early passage  
NCL5 on iMRC5              Match with DCB  Match with early passage  
NCL5 on iHDFn Match with DCB  Match with early passage  
SHEF1 on iMEF Match with DCB Match with early passage 
SHEF1 on i3T3 Match with DCB Match with early passage 
SHEF1 on iMRC5 Match with DCB Match with early passage 
SHEF1 on iHDFn Match with DCB Match with early passage 
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Table 3.2. Summary of sterility, viral and mycoplasma test results for Stem cell 
lines HUES9, RH5, NCL5 and SHEF1 cultured on mouse, human feeders and 
Matrigel/MTeSR1 at early and late passage. 
Cell line Sterility test results at 
early passage 
Viral and Mycoplasma test 
results at early passage 
Sterility test results at 
late passage 
Viral and Mycoplasma test 
results at late passage 
HUE9 on iMEF Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
HUES9 on i3T3 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
HUES9 on iMRC5 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
HUES9 on iHDFn Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
HUES9 on Matrigel Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
RH5 on iMEF Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
RH5 on i3T3 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
RH5 on iMRC5 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
RH5 on iHDFn Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
RH5 on Matrigel Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
NCL5 on iMEF Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
NCL5 on i3T3 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
NCL5 on iMRC5 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
NCL5 on iHDFn Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
NCL5 on Matrigel Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
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Overall results from three broths TSB, FTM and SAB are reported back from 
Microbiology after day 14. Results are denoted by a measurement of turbidity. 
Mycoplasma PCR testing was carried out in-house by NIBSC Cell Supply. These 
results confirm that no microbial or mycoplasma contamination was detected from 
any of the cell lines cultured on four feeder types iMEF, i3T3, iMRC5 and iHDFn.  
 
  
SHEF1 on iMEF Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
SHEF1 on i3T3 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
SHEF1 on iMRC5 Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
SHEF1 on iHDFn Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
SHEF1 on Matrigel Contamination not detected Contamination not detected Contamination not 
detected 
Contamination not detected 
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3.4 Discussion 
The UKSCB produces and distributes hESC banks for worldwide use under a HTA 
licence. Thus it is of paramount importance that best practice methods are adhered 
to. This is partly achieved by following guidelines outlining the minimum standards 
required for cell and tissue culture known as Good Cell Culture Practice, GCCP 
(Stacey et al., 2006). Testing includes assessing maintenance of essential 
characteristics as well as traceability, reporting, quality assurance, training and 
education and safety. The stem cell lines cultured for this project were subjected to 
release criteria testing as part of best practice methods (Coecke et al., 2009) and in 
accordance to UKSCB banking procedures for research grade stem cell lines. Such 
testing adds value to a cell line, as it assures the end user that a considerable 
amount of care has been taken when culturing these cell lines. Quality assurance 
testing is not frequently carried out in academic labs, where a number of cell lines 
can be cultured at one time, and incubators and safety cabinets are shared. This 
type of testing is mandatory for cell lines that are to be provided for worldwide 
distribution.  
Contamination is the largest cause to loss of cell cultures and to start with, all the cell 
lines used were first checked for contamination, focusing not only on bacterial, fungal 
and mycoplasma but also on identifying cross-contamination with other cell lines. 
Testing by broth inoculation confirmed that all the cell lines cultured for these studies 
were free of contamination from bacteria and fungi throughout the culturing process. 
This provided assurance that the different cell lines cultured on different feeders and 
feeder free matrices had been cultured with good aseptic technique. The testing was 
also sufficient to ensure that low levels of microbial contamination could be detected, 
as the tests are carried out by a Microbiologist as part of a service agreement for the 
release of the stem cell lines for worldwide distribution. This type of testing is easy to 
set up, implement perform and is relatively low cost. Many research labs do not 
routinely carry out microbial testing and instead rely on antibiotics which can mask 
low level infections.  
Mycoplasmas are also a frequent problem for scientists culturing cells and can be 
detrimental as, once introduced in a laboratory, they spread quickly and can 
sometimes be difficult to detect at low levels. They are also extremely difficult to 
remove from contaminated cultures without adversely affecting the cell line. 
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Contamination with mycoplasma can go unnoticed for many months if routine testing 
is not carried out. The only sure method is adequate and regular culture testing by at 
least two methods. The results obtained from both tests confirmed that stocks 
obtained and subsequent cultures were mycoplasma free. This finding together with 
the lack of detectable bacterial or fungal infections and maintenance of cell line 
identity fulfil important criteria for scale-up and banking of cells.   
All stem cell lines with the exception of SHEF1 were deemed viable under each of 
the culture conditions. SHEF1 differentiated extensively after p+12 on both human 
feeders and mouse feeders and on Matrigel.  Further investigation by repeat thaw 
and culture found this to be due to poor banking of the original project line, and was 
confirmed by the subsequent thawing of 3 more vials, which had poor viability on 
thawing and then failed to grow after 3 or 4 passages. Furthermore, a vial of SHEF1 
from the distribution cell bank was thawed and found to be viable, confirming the 
poor viability of the project cell bank.  Therefore the SHEF1 line was excluded from 
further analysis and instead the thesis focused on the hESC lines RH5, HUES9 and 
NCL5, which all maintained healthy cultures on mouse and human feeders to late 
passage.  
The results concluded that the established hESC cultures were contamination free 
and could be maintained in culture in a viable state up to high passages. hESCs 
cultured on human feeders did proliferate well, which has also been confirmed by 
previous findings (Richards et al., 2002; Hovatta et al., 2006). Distinct morphology 
changes of hESCs HUES9, NCL5 and RH5 were seen on human feeders as 
colonies became elongated and elliptical in shape. This was consistent with previous 
reports (Amit et al., 2003), however, no apparent morphological advantage for 
culturing hESCs on human feeders compared to mouse feeders such as increased 
attachment or proliferation was observed. There were no negative observations, 
such as differentiation or loss of attachment, seen on stem cell growth following the 
initial 1-2 passages when adaption occurred. Further characterisation testing will be 
carried out to confirm these findings. Observations did reveal that the hESCs 
required contact with the feeder cells to proliferate, either by attachment on top of the 
mouse feeders, or by attachment in between the human feeders. Further 
investigation will establish whether human feeders induce genotypic or genomic 
changes, or negatively affect protein marker expression associated with 
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undifferentiated hESC culture. Differences in morphology may be due to the way in 
which each different feeder type supports the growth of different stem cell lines in 
relation to adhesion, attachment and release of cytokines and growth factors. In this 
regard, the observations from these studies are consistent with published work, as 
comparable levels in BMP-4, TGFß1 and FGF-2 were found in varied amounts from 
MEF mouse embryonic fibroblasts and HFF human foreskin fibroblasts (Eiselleova et 
al., 2008). Also mouse feeder cells secreted larger quantities of Activin A than 
human feeder cells (Eiselleova et al., 2008). 
All hESC lines cultured on ECM displayed undifferentiated morphological hESC 
characteristics. Further characterisation testing is required to confirm that these cells 
were indeed undifferentiated. The use of ECM from human feeders to support the 
undifferentiated growth of hESCs has been previously described (Escobedo-Lucia et 
al., 2010). However, with any cell based culture system, there are heterogeneous 
differences between batches of prepared ECM. Thus, although preliminary 
observations from these studies have demonstrated that ECM does support the 
differentiation of hESCs this would need to be further validated with characterisation 
testing and until this can be produced on a larger scale with better standardised 
methodologies, the use of in house ECM was not be continued in this project. For 
the same reason, the use of i11235 foetal derived fibroblasts will not be continued, 
however the ease of producing such feeders will allow for the potential creation of 
clinical grade banks, should appropriate consent for use be allowed. This is also 
within the remit of UKSCB research work and has been previously discussed 
(Stacey et al., 2006).  
The move to culturing hESCs on defined matrices is important for the progression of 
stem cells for clinical applications. The results from these experiments demonstrate 
that there were varying degrees of success when culturing hESCs on 
Matrigel/mTeSR1, however the ease of adapting hESCs to this culturing system 
using TrypLE™ Express was apparent. In the first instance, some differentiation was 
detected in some of the stem cell lines, and they were slower to proliferate when 
compared with cultures on mouse feeders. However, after a few passages the stem 
cell lines began to adapt and proliferate steadily, with much less differentiation. As 
Matrigel/mTeSR1 is a commercial preparation and can be purchased as hESC 
qualified preparation, further culture and characterisation of undifferentiated hESCs 
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will be conducted, and will provide a robust comparison against the use of both 
mouse and human feeder systems. It is however worth noting that there are reports 
of varying success of culturing different stem cell lines on Matrigel/MTeSR1.  For 
instance there are issues with adapting cell lines onto Matrigel when they have 
previously been cultured on feeders. Often the cells fail to establish and this has 
been confirmed at the UKSCB with a number of different stem cell lines. Even when 
attempting to thaw stem cells directly onto Matrigel there is often significant cell 
death when compared with thawing onto feeders. Explanations for this may be due 
to considerable differences in the components within mTeSR1 and Matrigel, such as 
higher levels of FGF, compared to KO-HES media and MEFs (in house 
observations). 
Local research groups have reported problems with differentiating stem cells once 
they have been cultured in MTeSR1/Matrigel for long periods of time (in house 
communication with NIBSC Biotherapeutics and CBI departments). Other groups 
report the successful differentiation to specific germ lineages using Matrigel (Ludwig 
et al., 2007; Ma et al., 2008; Lawton et al., 2013). To overcome some of these 
issues, certain protocols have developed a stepwise process of adapting stem cells 
to feeder layer free culture by first using Laminin coated plates combined with media 
such as MEF conditioned media (Hongisto et al., 2011). Nonetheless, these methods 
can take time and involves the hESC line having to adapt twice, adding to 
instabilities and time/increase in passage, for the line to adapt. Newer stem cell 
manuals explore much faster routes to adaptation, which do not include additional 
steps and instead instruct the thawing of hESCs straight onto Matrigel (Loring and 
Peterson., 2012; Stem Cell Technologies Handbook 2012) but have yet to be tested 
with different hESC lines. In these studies, adaption appeared to occur within a few 
passages. What was notable was that selection of healthy cultures to transfer onto 
new matrices/media tended to result in successful adaption, compared with those 
cells which had visible differentiating colonies. Although hESC lines with a larger 
proportion of differentiated cultures (20- 30%) were manually removed by scraping, 
positive attempts were made to ensure that entire wells of culture were enzymatically 
passaged on, to ensure minimal biased and selection occurred from passage to 
passage. The practice of removing differentiated areas of hESCs before passaging 
is commonly adopted in many laboratories and has been recommended by Stem 
113 
 
Cell Technologies, where large areas of differentiation occur (personal 
communication with Stem Cell Technologies). 
The successful adaption of cultures on feeder free matrices was achieved simply by 
passaging at lower ratios using TrypLE™ Express. This allowed greater cell survival 
on new matrices, and proved to be consistently successful. Greater clonal survival 
as a result of TrypLE express usage over Trypsin had been previously demonstrated 
by Ellerstrom et al (2006) in the derivation of Xeno free hESC line.  It also removed 
the step wise process which has been recommended which in turn, streamlined the 
transition onto different feeder types and Matrigel.  hESCs cultured on human 
feeders were first manually passaged for the first 1-2 passages. As soon as they had 
settled they were passaged using TrypLE™ Express, to assess the suitability of the 
enzyme to efficiently expand cells for banking. Previously the standard method for 
culturing hESCs in-house had been by manual cutting methods. Although different 
cutting tools have been tested in-house including the StemPro Ezy passage tool™ 
(Invitrogen) and Biopsy pipettes by Hunter Scientific, little consistency was gained 
due to operator variability. Also, different enzymes have been tested in house, 
including Collagenase IV and Dispase. Although these enzymes did provide greater 
scale up of cell culture, differences in banked vials of cells were observed due to 
differences in the time that cells were enzymatically treated, which resulted in greater 
cell death as a result of colony dissociation to single cell  (usually due to over 
trypsinisation of cells, in-house observations). The use of glass beads with 
Collagenase has also been a recommended method (Andrews and Moore, CSCB, 
2008 Handbook). However this method increases time taken to passage cells and 
introduces variability and potential contamination, as the beads need to be kept 
sterile. 
 The use of TrypLE™ Express significantly standardised the method and reduced 
the time taken to passage stem cells (3-5 minutes per well of a 6 well plate) in 
comparison to manual dissection which can be time-consuming (up to 30 minutes 
per plate) and extremely variable, depending on the scientists‘ experience and tool 
used for dissection. Manual dissection also requires a lot of precision and patience 
as bad dissection can lead to poor clump size, which can result in differentiated 
colonies. Furthermore, when compared with other enzymes, TrypLE™ Express is 
not as harsh on cultures as Trypsin, even at low concentrations of 0.25% (In house 
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observations, Invitrogen, product information sheet). In addition it does not require 
neutralisation with media, which speeds up passaging time and reduces cell death In 
addition to the above advantages, passaging of stem cells with TrypLE™ Express  
did not compromise viability and allowed for the cells to be passaged as clumps 
rather than single cells which is desirable (Gray et al., 2009). Thus, the use of 
TrypLE™ Express provides an easy, rapid and robust method for scaling up stem 
cell cultures. TrypLE™ Express could also be used in combination with manual 
dissection for difficult or sparse cultures, as differentiated areas can be removed by 
manual dissection and the remaining undifferentiated areas could then be passaged 
by enzyme. More recently TrypLE™ Express has been used to culture Neural stem 
cells (et al., 201) and hESC cells for in vitro differentiation experiments (Chetty et al., 
2013). 
Although research has already demonstrated the successful use of enzymes to 
passage and scale up hESCs  (Ellerstrom et al., 2007; Oh et al., 2005), as well as 
the use of human feeders to support the undifferentiated growth of hESCs 
(Eiselleova et al., 2008; Lee et al., 2004; Inzunza et al., 2005) it was of particular 
importance to the UKSCB to carry out this work, in order to assess, and hopefully 
progress its own methods used in-house, for banking stem cells.   
The widespread use of well-defined media such as mTeSR1™ had led to the 
development of other better defined media and culture components such as 
mTeSR2™, E8™, which contains eight essential components (Invitrogen). However 
reports have yet to confirm the widespread success of much more novel matrices 
and xeno free media on different hESC lines. This is important to establish because 
these culture systems can be very costly as they are produced in much smaller 
batches compared to standard cell culture media.  
Despite the emergence of feeder-free systems, culturing stem cells on feeders 
remains the chosen method for many researchers. This may be because it is not 
always within a groups‘ best interest to attempt to use new methods if it has no 
overall benefit to the endpoint of their research projects, for instance, differentiation 
of stem cells to mature cardiomyocytes for functional testing. Such projects are often 
time limited so scientists tend to use methods that work and are routinely used in 
house rather than testing new systems.   
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3.5 Conclusion 
From the results shown in this chapter, the stem cell lines used for this project were 
deemed consistent with their previous DNA profiles therefore no cross-contamination 
had occurred during the stem cell culture process and confirmed to be not 
contaminated with Mycoplasma, viruses or bacteria/fungi by sterility broth 
inoculation. 
The findings from these experiments demonstrate the suitability of human feeders 
and Matrigel/mTeSR1 to support the growth of hESCs. Differences in morphology 
were observed as a result of culture on different feeders and Matrigel. Further 
characterisation testing by gene expression and protein/cell surface marker studies 
are required to confirm whether these cells were truly undifferentiated. 
These studies have led to the inclusion of Matrigel as an alternative to mouse 
feeders in the banking of research grade hESCs for worldwide distribution however it 
has not yet been deemed appropriate to replace MEFs with Matrigel. This is an 
important and positive step towards the standardisation of banking procedures and 
an example of the UKSCBs‘ aim to work with the wider stem cell community by 
supplying banks of well tested hESCs on feeder free conditions. As a result of this 
culture experiment, the use of TrypLE™ Express has also been adopted into routine 
passaging at the UKSCB. Further characterisation studies will help to determine 
whether human feeders and Matrigel/mTeSR1 maintain hESC growth as well as 
mouse feeders. 
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Chapter 4: Characterisation of human 
embryonic stem cells using 
immunofluorescence (IF). 
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4.1 Introduction 
Immunofluorescence (IF) is a widely accepted technique, used for the identification 
of nuclear and cell surface antigens in many different cell types, and is a continually 
developing field. It is a useful way to identify specific cell populations, particularly in 
heterogeneous cell cultures by detection of antigens, conjugated to fluorescent 
antibodies. The improvement of antibodies and fluorophores has enabled dual and 
triple staining with greater specificity alongside sophisticated microscopes. 
Immunofluorescence (IF)  is frequently used to characterise human embryonic stem 
cells (Damjanov et al., 1984; Draper et al., 2002; Henderson et al., 2002). 
Undifferentiated, pluripotent human embryonic stem cells can be characterised by 
their unique expression of cell surface markers. The most frequently used were 
established by the International Stem Cell Initiative (ISCI), which involved 12 
participating labs worldwide, with the UKSCB acting as a ‗hub‘ (initiative, 2007). Sixty 
stem cell lines were characterized using the following stem cell markers for flow 
cytometry including the glycolipid stage specific embryonic antigens, SSEA3, SSEA4 
(Kannagi, 1983; Henderson et al., 2002) keratin sulphate associated proteins TRA1-
60, TRA1-81 (Draper et al., 2002; Schopperle and DeWolf, 2007) and nuclear 
markers octamer binding transcription factor 4, Oct-4   (Nichols et al., 1998; Matin et 
al., 2004) and homeobox transcription factor Nanog (Chambers et al., 2003). Over or 
under expression of either one of these transcription factors results in differentiation 
(Chamber et al., 2007; Korkola et al., 2006). These transcription factors interact 
directly with DNA targets and additional genes which are also highly expressed in 
pluripotent cell populations. Alkaline Phosphatase (AP) a hydrolase enzyme 
responsible for removing phosphate groups from many types of molecules is found 
in most tissues/organs in the body. It is expressed at elevated levels in hESCs and 
therefore used as a test of undifferentiated cells.  Glycan cell surface antibody 
SSEA1 is used as an early indicator of differentiation. These markers are also 
shared by mouse embryonic stem cells, but the expression of SSEA1 and SSEA4 
are reversed (as demonstrated by Table 4.1). 
Flow cytometry employs the technique of measuring cellular properties as they move 
through a steady fluid stream past stationary detectors and works by using the basic 
properties of each cell type; its ability to absorb fluorescence and scatter light, based 
on how they react with specific cell surface and nuclear markers. This information is 
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translated into forward scatter and side scatter, which is captured and transmitted to 
a screen where it can be analysed. Flow cytometry is based on the detection of 
fluorescence; therefore fluorescent chemicals found in the particle or attached to the 
particle may be excited into emitting light at a higher wavelength than the light- 
source. 
Currently, most IF staining of stem cells in situ is carried out on fixed cultures on 
cover slips or on 8/16 well glass chamber slides (Turksen et al., 2010). In the past, 
such techniques were used as they do not require large numbers cells and are more 
cost effective due to smaller amounts of antibody. However, it was found that these 
fixed cultures were very fragile and had a tendency to disassociate during staining 
and/or washing steps. Therefore a new in-house method for IF staining, using fixed 
cultures on 6 or 24 well plates was developed. It was found that this gives greater 
representation of how stem cells grow in situ and allows for more statistically 
relevant data. 
Stem cells are assessed qualitatively using IF and quantitatively using flow cytometry 
(Draper et al., 2002; Carpenter et al., 2003; Menendez et al., 2006; Ungrin et al., 
2007). However, significant information about the morphology and co-location of 
cells within a heterogeneous population is not captured. Such information can give 
significant insight into the way in which hESCs proliferate and express stemness cell 
surface markers as a result of prolonged culture on different feeder types and 
Matrigel. Studies of hESCs have demonstrated the importance of understanding the 
relationship of cells within populations and their inherent differences at single cell 
level has been discussed (Enver et al., 2005; Stewart et al., 2006; Hough et al., 
2009). The significance of such events for whole cell populations have been 
demonstrated through the formation of clones from a single hESC line and shown 
that the clones expressed different germ layer specific markers when differentiated 
(Sidhu & Tuch 2006).This highlights the importance of producing homogenous 
populations of hESCs. However, methods for accurately detecting and quantifying 
heterogeneous populations in different hESC lines have yet to be developed. 
Furthermore the use of such techniques to determine the consequences of long term 
hESC culturing using different matrices has not been demonstrated. New high 
throughput imaging and analysis technology has emerged to fill this void.  
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4.1.2 The TissueFaxs™ fluorescence image acquisition and analysis 
The TissueFaxs™ is an imaging system consisting of a Zeiss fluorescent 
microscope, computer hardware with scanning software and high resolution screens 
combined with TissueQuest™ software which allows for quantitative image analysis. 
The system uses either a plate of slide format from which tissue sections or fixed cell 
samples can be scanned as a preview (x5 objective lens), and regions of interest 
captured through image acquisition by multichannel colour technology, to allow for 
accurate visualisation of cells/tissue (x20 objective lens). Scanned images are 
imported into TissueQuest™ analysis software and quantitatively analysed using a 
number of different cell/tissue based parameters. The software allows for forward 
and back gating of individual cells/tissue sections and the setting of cut offs for 
fluorescence intensity, to give accurate analysis, similar to flow cytometry (Streit et 
al., 2006). The TissueFaxs™ has been used for a number of different applications 
including the investigation of stromal-epithelial cells in prostate cancer (Massoner et 
al., 2008), the cerebroprotective effect of T cells in experimental Stroke (Liesz et al., 
2009), the effects of macrophages on chemotherapeutic response in breast cancer 
(Shree et al., 2012). 
The TissueFaxs™ allows for microscopy based fluorescent cytometry of fixed 
colonies by automated processing of multi-labelled samples in situ. Thousands of 
images can be imported into the TissueQuest™ software, and using the software‘s 
algorithms, can be set up to recognise patterns of cells which can be analysed, 
quantified and represented by dot plots. The system is able to capture not only the 
morphology of the colonies, but the location and number of colonies present. This 
type of technique has not previously been used to characterise the differences 
between cell surface marker expression of hESCs following long term culture on 
mouse and human feeders and Matrigel/mTeSR1™ cultures. Obtaining detailed 
information from such culture conditions will emphasise the need for better 
standardisation of techniques, and give insight into how best to achieve homogenous 
populations of hESC lines, a key objective when producing uniform banks of hESCs. 
This has therefore been the focus of the studies described in this chapter. 
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Table 4.1. The similarities and differences between expression of cell surface 
markers in mouse embryonic stem cells, hESCs Embryonic Carcinoma cells 
and Embryonic Germ cells. 
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4.2 Methods 
4.2.1 Stem cell culture 
The four stem cell lines, NCL5, HUES9, RH5 and SHEF1 were cultured as described 
in Chapter 2 over 20 passages on the two mouse feeder‘s i3T3 and iMEF two human 
feeders, iMRC5 and iHDFn in standard KO-HES media. In parallel experiments, 
Matrigel was also used together with mTeSR1 media. 
4.2.2 Preparation of cells for flow cytometry 
Stem cells were cultured in flat bottomed six well plates, and treated with TrypLE™ 
Express to dissociate cells for approximately 3 to 4 minutes. Remaining hESC 
clumps were broken up and feeder cell clumps removed by careful pipetting. Stem 
cells were centrifuged at 300g for 5 minutes, supernatant removed and cells fixed in 
4 % PFA for 20 minutes at room temperature, washed 3 times using wash buffer and 
stored in wash buffer at 4°C, in 15 ml tubes until ready for staining.  
Stem cells were stained with primary and secondary antibodies according to the 
antibody list and dilutions in Table 4.2 and Table 4.3. SSEA-1, SSEA-3, TRA-160 
and TRA1-81 were grown and purified in-house (UKSCB, NIBSC) using hybridoma 
cell lines obtained from the Centre for Stem Cell Biology,  (CSCB) Sheffield by fusing 
a specific antibody producing B cell with a non-antibody producing cancer cell 
(usually myeloma or lymphoma). The antibodies produced by the hybridoma are of 
single specificity (monoclonal). Hybridomas were initially thawed and cultured in 
T175 flasks using Dmem/F12 media, for 1-2 weeks and passage once a week at 
1:20 ratio. Scale up culture of hybridomas was carried out using roller bottles 
(Corning), until 5 litres of each antibody had been produced within the spent media. 
Media was carefully twice filtered and aliquoted into 1ml aliquots and stored at -
80°C. Each hybridoma was tested for suitability using various hESC lines and 
n2102EPs, against a commercial antibody to ensure detection by flow cytometry and 
IF staining was equal. 
All staining experiments were carried out in a v bottomed 96 well plate, then 
transferred to flat bottomed 96 well plates, and the final volume adjusted to 300 µl 
using Wash buffer. The plate was loaded onto the Guava TM Flow cytometer 
(Millipore, Guava Easycyte W/SSC) for the cells to be processed. The embryonal 
carcinoma cell line n2102EP (CSCB, Andrews et al, 2002) was routinely set up as a 
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positive control (Shevinsky et al., 1982; Josephson et al., 2007) and stained on the 
same plate. The analysis was completed on the Guava using CytoSoft 3.6.1 
ExpressPlus programme. The results were exported to an Excel spread sheet to 
produce bar charts, to visually compare expression of cell surface markers between 
the different samples. 
4.2.3 Preparation of cells for in-situ staining 
Stem cells for in situ staining were cultured on flat bottomed 24 well plates (FB24), 
until 70-80% confluent. Plates of cells were then fixed in 4% PFA for 20 minutes at 
room temperature, washed 3 times using wash buffer and stored in wash buffer at 
4°C until ready for staining. 
Cells were stained with primary antibody listed in Table 4.3  for 1 hour minimum at 
room temperature in the dark (maximum overnight at 4°C) then washed in 
Washbuffer before secondary antibody staining according to Table 5.4 for 1 hour 
minimum at room temperature in the dark (maximum overnight at 4°C). The plates 
were then carefully washed and stained using DAPI nuclear stain for 5-8 minutes, 
washed using DH20 and topped up with 2 mls of Washbuffer before being placed 
onto the microscope for imaging.
The diagram below (Figure 4.1) shows the similar workflow for both techniques with 
the exception that TissueFaxs™ analysis included image selection of field of views 
(FOVs). 
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Figure 4.1.Schematic showing process of preparing samples for IF by Flow 
Cytometry (FC) and TissueFaxs™ (TF).  
  
Sample preparation:culture 
of stem cells on FB24 for TF 
and FB6 for FC, IF staining 
Image acquisition/sample  
processing on Flow 
cytometry 
Image selection of 
representative FOVs and 
filtering to remove noise  
Quantification (number of 
objects: single or multiple 
events; size of 
objects;morphological 
features; fluorescent 
intensity;spatial distribution of 
fluorescent intensity, gating 
and back gating 
Statistical 
analysis;comparison of 
experiments 
124 
 
 
Table 4.2 Details of primary antibodies and Isotype controls used for Flow 
cytometry and insitu fluorescence staining.  
 
Antibody Subtype supplier Cat 
number 
Dilution for 
TissueFaxs™  
Dilution for 
Flow 
Cytometry 
IgM Mouse 
IgM 
Caltag MGM00 1/100  1/100 
TRA-1-
60 
Mouse 
IgM 
Hybridoma Made in 
house 
1/5 1/5 
TRA-1-
81 
Mouse 
IgM 
Hybridoma Made in 
house 
1/5 1/5 
SSEA1 Mouse 
IgM 
Hybridoma MC-480 1/5 1/5 
IgG3 Mouse 
IgG3 
Abcam AB18392  1/50 33µg/ml 
(1/50) 
SSEA4 Mouse 
IgG3 
Abcam Ab16287 1/30 33µg/ml 
(1/50) 
Rat IgM Rat IgM Caltag RGM004 1/50 1/50 
SSEA3 Rat IgM Hybridoma MC-631 1/50 1/5 
 
For the majority of IF staining, hybridomas were used, as they were cultured in 
abundance at low cost (in house preparation), and could be used at the same 
concentration for both types of techniques. From the eight antibodies (and isotype 
controls) used, four were commercial, SSEA4 (Abcam), Isotype controls Mouse IgM 
(Caltag), Rat IgM (Caltag) and Mouse IgG3 (Abcam). 
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Table 4.3. Secondary antibodies used for flow cytometry and in-situ 
fluorescence staining. 
Antibody Supplier Cat 
number 
Dilution 
Mouse IgM 
+ IgG FITC 
Caltag LM30801 1/100 
Goat anti-
mouse (PE) 
IgM 
Caltag M31504 1/100 
 Alexafluor  
647 (CY5) 
Goat anti 
rat IgM 
Invitrogen A21248 1/200 
Alexafluor 
488  (FITC) 
Goat anti-
mouse IgG 
Invitrogen A11017 1/200 
 DAPI 
nucleic acid 
stain 
Invitrogen D1306 1/1000 NB: only used 
for insitu staining 
 
SSEA3, TRA-1-60 and TRA-1-81 and their respective isotype controls (see table) 
were all grown and purified in-house (UKSCB, NIBSC) using Hybridoma cell lines 
obtained from the Centre for Stem Cell Biology,  (CSCB) Sheffield. All the secondary 
antibodies used were consistent for each technique throughout this study. Only PE 
and FITC conjugated secondary antibodies could be used for flow cytometry on the 
Guava Easycyte, as it has lasers for the detection of only PE and FITC channels. 
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4.2.4 Analysis of flow cytometry results using Guava Easycyte flow cytometer 
Raw data from guava results, were exported from the Cytosoft software v.0.6 into an 
excel file and an average calculated from two technical repeats for each sample. 
With the exception of NCL5 stem cell line which was repeated 3 times (n=3), all other 
samples were repeated only twice (n=2) as a screening process to determine 
whether the Guava flow cytometer was a suitable tool to test a number of different 
stem cell lines. 
4.2.5 Statistical analysis of flow cytometry data 
Differences between cell lines and feeders were assessed by fitting a general linear 
model (GLM) using Duncan‘s method for pairwise comparisons and Two way 
analysis of variance (2 way ANOVA). 
 
Table 4.4. List of antibodies and secondary fluorophores used for in situ 
staining of hESCs by TissueFaxs™ using three different colour channels. 
ANTIBODY FLOUROPHORE CHANNEL 
NUCLEAR DAPI-BLUE 
SSEA4 CY5 RED 
SSEA3 FITC GREEN 
TRA-1-60 PE YELLOW 
TRA-1-81 PE YELLOW 
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4.2.6 TissueFaxs™ analysis for quantitative imaging 
Raw TissueFaxs™ image files were imported into TissueQuest™ analysis software. 
DAPI fluorescent channel was selected and applied as a cell identifier to initially 
recognise the cells. The in-built algorithms calculated the amount of fluorescence 
signal attached to each cell. Masks were created to identify cells, using a set of user-
defined parameters to label areas of cells; comparison to background, by area and 
grey, size of cell, overall background threshold. Parameters used to create masks 
are shown in Table 4.5 and Table 4.6. The parameters for each stem cell line 
cultured on each feeder type had to be adjusted to accurately mask, and capture the 
cells. The software then calculated the amount of fluorescence in each colour 
channel and produced dot plots which were checked to ensure that every population 
of stem cells were in the correct quadrant on the scatterplot. This was done by back- 
gating to locate single cells, to correctly identify positive/negative stained cells and 
then set cut offs, gate relevant populations (as carried out in flow cytometry) and  
remove cells which were not of interest and may have skewed the results (debris, 
doublets, bright artefacts). The TissueFaxs™ images were then copied from each 
PDF project (see Figure 4.2 for example) and their corresponding scatterplots with 
tables showing quantitative data which relate to the amount of cell surface 
expression from each image as a percentage. Each of the scatterplots and tables 
displayed are an average of the most appropriate two ‗Field of views‘ (FOVs) for 
each fluorescent channel/antibody used. Other parameters such as the size of the 
nucleus, and the number of cells/mm2 are also measured by the software. 
Tables 4.5 and 4.6 show the parameters chosen to create the cell masks for the 
fluorophores DAPI (nuclear), CY3, CY5 and FITC used in TissueFax analysis, for 
Stem cell line RH5 cultured on mouse fibroblast line i3T3 at late passage p+20. 
Unfortunately the same parameters could not be used for each sample, therefore 
parameters for each stem cell line/feeder type had to be optimised to accurately 
mask and gate the cells imaged. Figures 4.3 and 4.4 show an example of the types 
of scatterplots produced from the analysed TissueFaxs™ results. Many images were 
produced as a result of using a high throughput imaging system, therefore the best 
images were selected on a basis of their clarity and how accurately they reflected the 
other images taken from the culture conditions (i.e. stem cell line cultured on 
mouse/human feeder or Matrigel). 
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Figure 4.2. Screen print of PDF results from TissueQuest software of analysed 
result of the HUES9 cell line on iHDFn feeders at passage 20. This PDF shows 
the corresponding Scattergram and table of all acquired events and demonstrate 
SSEA3/TRA-1-81 co-staining. A large gated area of TRA-1-81 positive events is 
visible in the first scatterplot (top, left plot), denoted by the green gated region. Other 
parameters such as the size of the nucleus, and the number of cells/mm2 are also 
measured by the software and displayed in the results.  
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Table 4.5. Parameters used to create cell masks for DAPI nuclear stain for 
TissueFaxs™ analysis. 
 
Fluorophore/Parameter DAPI 
Nuclei size 10 
Discrimination by area 6 
Discrimination by grey 0 
Background threshold 12 
 
 
 
Table 4.6. Parameters used to create cell masks for CY3, CY5, and FITC 
Cytoplasmic stains for TissueFaxs™ analysis. 
 
Fluorophore/Parameter CY3 CY5 FITC 
Ring mask -1,15 -1,15 -1,5 
Max growing 75 75 75 
Offset from nuclei 5 1 1 
Background threshold Auto detect Auto detect Auto detect 
Nuclei mask yes yes yes 
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Figure 4.3. Example of scattergrams showing distribution of stem cells by their 
size and staining intensity for each channel; A: Dapi nuclear marker, B: CY5 
SSEA4, C: FITC SSEA3, D: CY3 TRA-1-60 and TRA-1-81. Following staining, 
image acquisition and detection by the TissueQuest software, DAPI nuclear marker 
was selected as the Master channel as it was easy to identify all the imaged cells. 
Each cell represents a single event (dot) on the scatterplot. All events are gated 
against the master channel for mean intensity of fluroescence staining, then 
subsequent fluroescent channels are gated against their mean intensity of 
fluorescence staining, for example FITC mean intensity (Y axis), and Dapi mean 
intensity (x axis) to form the scattergram. Data from each quadrant region, formed as 
a result of creating cut-offs and gates,  is also displayed as a table. The scatterplots 
displayed above show the variations in fluorophore intensity obtained. Gating and 
backgating are used to group the events based on their similarities of size and 
intensity, thus allowing reliable detection of informative events, which can then be 
accurately quantified. 
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Figure 4.4. Example of scattergrams showing distribution of stem cells gated 
by unique parameter settings DAPI eccentricity and DAPI compactness ratio. 
Stem cells were stained with DAPI and gated using parameters such as DAPI 
eccentricity and DAPI compactness ratio, which were calculated based on the  
shape of the cell, compared to a perfect circle (giving a value of 1) or if the cell is 
elongated, (value of 0). The parameters were used to distinguish different cell types 
on the basis of their shape, for example doublets, clumps of cells and feeder cells. 
They were also used to detect stem cells cultured on different feeder types, as it has 
been observed that some hESC lines proliferate into much larger colonies than 
others, when cultured on human feeders. 
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4.3 Results 
4.3.1 Changes in expression of undifferentiated hESC markers for the RH5 
stem cell line by flow cytometry 
Initially, changes in the expression profiles of stemness markers (SSEA3, SEEA4, 
TRA-1-60, and TRA-1-81) under the different culture conditions (RH5 cultured on 
iMEF, i3T3, iMRC5, iHDFn and Matrigel) were detected using the standard, well 
established flow cytometry method. As shown in Figures 4.5 A and B, hESC 
undifferentiated markers TRA-1-60 and TRA-1-81 were more highly expressed than 
SSEA3 and SSEA4, which, although were expressed in lower abundance, were still 
detectable. By comparison TF analysis showed much greater sensitivity across all 
samples with much higher expression levels of all the markers. In particular SSEA3 
and SSEA4 which showed relatively low levels of expression by FC, were found to 
be almost 8 or 9 times more highly expressed by TF analysis (Table 4.7). This 
clearly supports the claim that TF would be a much more sensitive and thus useful 
technique for detecting cell surface marker expression in hESCs. The Figures 
demonstrate that human feeders and Matrigel maintained higher expression of 
undifferentiated markers compared with mouse feeders. TRA-1-60, TRA-1-81 and 
SSEA3 expression increased when cultured on human feeders from early to late 
passage. A decrease in SSEA4 expression was shown from all feeder types and 
Matrigel at late passage. Expression of differentiated marker SSEA1 was highest 
from cultured on the iHDFn human feeders at early passage, but this decreased at 
late passage. Expression of undifferentiated markers from cultures on mouse feeder 
i3T3 was low, in comparison to the other feeder types. 
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Figure 4.5. Effect of Matrigel and different feeder types on undifferentiated 
marker expression in RH5 cell line at early (A) and late (B) passage. (n=2). RH5 
stem cells were cultured at early (P+5) and late passage (P+20) on mouse and 
human feeders and Matrigel, and prepared for flow cytometry as described by the 
methods (section 2.8). The data is the mean of 2 separate experiments. 
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4.3.2 Changes in expression of undifferentiated hESC markers for the RH5 
stem cell line by TissueFaxs™ image analysis 
Positive undifferentiated hESC marker expression was observed from RH5 cultured 
on iMEF mouse feeders as shown by the TissueFaxs™ images in Figure 4.6. 
Differences in morphology were clearly observed by RH5 cultured on iMEFs 
compared with human feeders (as discussed in chapter 3). As demonstrated in 
Figure 4.6D colonies of RH5 formed a doughnut shaped appearance when stained 
for SSEA3. The cells on the outside of the colony are clearly proliferating as they are 
positively stained and form a visible ring, whereas the cells within the ring may be 
older and no longer proliferating. Smaller, less visible rings of SSEA4 proliferating 
cells can also be seen in Figure 4.6C. Figures 4.6E and 4.6F show positive 
expression of TRA-1-60 and TRA-1-81, respectively. This pattern of staining was not 
observed from RH5 cultured on human feeders where the latter were better 
distinguished from stem cells. The iHDFns, unlike the mouse feeders were larger 
and more elongated (Figure 4.7A and 4.7B). Consequently, RH5 stem cells took on 
a different morphology when cultured on human feeders and grew in swirls and 
elongated colonies. Although positive SSEA4 staining was similar on mouse and 
human feeders (Table 4.7), staining patterns for undifferentiated markers SSEA3 
(Fig.4.6D and Fig.4.7D) and both TRA-1-60 (Fig. 4.6E and Fig 4.7.E) and TRA-1-81 
(Fig.4.6F and Fig.4.7F) are very different. This is most probably due to the different 
feeder types. 
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Figure 4.6. IF TissueFaxs™ images for RH5 stem cell line cultured on iMEF 
mouse feeders demonstrating expression of stemness markers at late 
passage. RH5 stem cells were cultured on iMEF mouse feeders at late passage on 24 well plates 
until confluent. Plates were fixed with 4% PFA for 20 minutes, then stained as described in the 
methods (2.9). Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour 
DAPI and positive expression of stemness markers C: SSEA4, D: SSEA3, E: TRA-1-60, F: TRA-1-81. 
All images were captured at x20 magnification. Scale bar = 100µm. 
 
Figure 4.7. IF TissueFaxs™ images for RH5 stem cell line cultured on iHDFn 
human feeders demonstrating expression of undifferentiated hESC markers at 
late passage. RH5 stem cells were cultured on iMEF mouse feeders at late passage on 24 well 
plates until confluent. Plates were fixed with 4% PFA for 20 minutes, then stained as described in the 
methods (2.9). Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour 
DAPI and positive expression of stemness markers C: SSEA4, D: SSEA3, E: TRA-1-60, F: TRA-1-81. 
All images were captured at x20 magnification. Scale bar = 100µm 
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Table 4.7. Comparison of percentage expression of undifferentiated 
markers for RH5 stem cell line at late passage by flow cytometry 
(FC) and by TissueFaxs™ image analysis (TF).  
 
STEM CELL 
LINE/FEEDE
R 
SSEA3 
by TF 
SSEA3 
BY FC 
 
SSEA
4 BY  
TF 
SSEA
4 BY 
FC 
TRA-1-
60 BY 
TF 
TRA-1-
60 BY 
FC 
TRA-1-
81 BY 
TF 
TRA-1-
81 BY 
FC 
RH5/iMEF 89.7±1
.43 
11.8 83.7±
1.27 
1.4 53.3±1
.33 
46.3 93.0±1
6.00 
46.7 
RH5/i3T3 99.6 
±1.56 
18.0 88.7±
2.44 
1.4 74.7±1
.27 
27.3 82.9±1
.28 
26.8 
RH5/iMRC5 84.6±0
.14 
32.1 94.6±
0.13 
8.6 76.9±0
.21 
74.6 99.7±0
.14 
88.5 
RH5/iHDFn 99.8±0
.17 
53.6 99.0±
0.17 
9.52 99.3±0
.72 
78.3 93.1±0
.71 
79.1 
RH5/Matrigel 87.25±
1.20 
31.3 72.90
±0.35 
6.61 77.35±
2.50 
58.3 81.54±
4.33 
72.0 
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4.3.3 Changes in expression of undifferentiated hESC markers for HUES9 stem 
cell line by flow cytometry 
Detection of positive stemness markers from HUES9 confirmed the difference in 
sensitivity between FC and TF (Figures 4.8 A and B). FC showed relatively low 
expression of the markers: SSEA3 and SSEA4, from all feeder types. But these were 
much more significantly expressed when detected by TF (Table 4.8). TRA-1-60 and 
TRA-1-81 expression was high, particularly from cultures on iHDFn at early passage, 
although cultures on Matrigel and i3T3 mouse feeders had the highest TRA-1-60 and 
TRA-1-81 expression at late passage. HUES9 cultured on i3T3 had the highest 
expression of SSEA3 at early passage. Expression of early differentiation marker 
SSEA1 was less than 10% on all four feeder types. Cultures on Matrigel also 
maintained higher expression of all undifferentiated markers at late passage. 
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Figure 4.8. Effect of Matrigel and different feeder types on undifferentiated 
marker expression in HUES9 cell line at early (A) and late (B) passage. (n=2). 
HUES9 stem cell line were cultured at early (p+5) and late (p+20) passage on 
mouse and human feeders and Matrigel and prepared for flow cytometry as 
described by the methods (section 2.8). The data is the mean of 2 separate 
experiments.  
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4.3.4 Changes in expression of undifferentiated hESC markers for HUES9 stem 
cell line by TissueFaxs™ image analysis 
Images from Figure 4.9 and 4.10 clearly demonstrate positive stemness marker 
staining from HUES9 cultured on iMRC5 human feeders and i3T3 mouse feeders. A 
very typical HUES9 morphology is shown in Figure 4.10 as this stem cell line grew in 
confluent monolayers on both feeder types. HUES9 cultured on iMRC5 human 
feeders grew in swirly monolayers and were also larger than the stem cells which 
grew on i3T3s. This affected the quality of the images which were poor, as the 
camera could not detect or accurately focus the stem cells cultured on a bi-layer. It 
also affected the type of masking required to detect and distinguish HUES9 from 
human feeders to that used to detect HUES9 grown on mouse feeders, which was 
difficult and time consuming.  
The IF images shown in Figures 4.11 and 4.12 demonstrate positive stemness 
marker staining for HUES9 cell line cultured on iMEF and iHDFn. The morphology 
observed suggest that the newly proliferating stem cells push the older cells to the 
top of the monolayer, which may explain why the top layer of cells are strongly DAPI 
stained, while those underneath stain for undifferentiated markers, as shown by 
SSEA4 the positive staining in Figure 4.12C. The monolayer culture of proliferating 
stem cells does however appear to be peeling as shown in Figure 4.11.C and 
4.11.E, despite continued expression of SSEA4 and TRA-1-60. 
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Figure 4.9. IF TissueFaxs™ images for stem cell line HUES9 cultured on iMRC5 
showing expression of undifferentiated markers at late passage. HUES9 stem cells 
were cultured on iMRC5 mouse feeders at late passage on 24 well plates until confluent. 
Plates were fixed with 4% PFA for 20 minutes, then stained as described in the methods 
(2.9). Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour 
DAPI and positive expression of stemness markers C:SSEA4, D:SSEA3, E:TRA-1-60, 
F:TRA-1-81. All images were captured at x20 magnification. Scale bar = 100µm. 
 
Figure 4.10. IF TissueFaxs™ images for stem cell line HUES9 cultured on i3T3 
showing expression of undifferentiated markers at late passage. HUES9 stem cells 
were cultured on i3T3 mouse feeders at late passage on 24 well plates until confluent. 
Plates were fixed with 4% PFA for 20 minutes, then stained as described in the methods 
(2.9). Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour 
DAPI and positive expression of stemness markers C: SSEA4, D:SSEA3, E:TRA-1-60, 
F:TRA-1-81. Scale bar = 100µm. 
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Figure 4.11. IF TissueFaxs™ images for stem cell line HUES9 cultured on iMEF 
showing expression of undifferentiated markers at late passage. HUES9 were cultured 
on iMRC5 mouse feeders at late passage on 24 well plates until confluent. Plates were fixed 
with 4% PFA for 20 minutes, then stained as described in the methods (2.9). Images taken 
by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour DAPI and positive 
expression of stemness markers C: SSEA4, D: SSEA3, E: TRA-1-60, F: TRA-1-81. All 
images were captured at x20 magnification. Scale bar = 100µm. 
 
Figure 4.12. IF TissueFaxs™ images for stem cell line HUES9 cultured on iHDFn 
human feeders showing expression of undifferentiated markers at late passage. 
HUES9 were cultured on iHDFn human feeders at late passage on 24 well plates until 
confluent. Plates were fixed with 4% PFA for 20 minutes, then stained as described in the 
methods (2.9). Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: 
colour DAPI and positive expression of stemness markers C: SSEA4, D: SSEA3, E: TRA-1-
60, F: TRA-1-81. All images were captured at x20 magnification. Scale bar = 100µm. 
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Table 4.8. Comparison of percentage expression of undifferentiated 
markers for stem cell line HUES9 at late passage by flow cytometry 
(FC) and TissueFaxs™ image analysis (TF).  
 
 
 
 
 
 
 
Stem 
cell 
line/fe
eder 
SSEA3 
BY TF 
SSEA3 
BY FC 
SSEA4 
BY TF 
SSEA4 
BY FC 
TRA-1-
60 BY 
TF  
TRA-
1-60 
BY 
FC 
TRA-1-
81 BY 
TF  
TRA-1-
81 BY 
FC 
HUES
9/iME
F 
77.9±3.
2 
31.9 84.1±0.
70 
3.4 62.1±1
.40 
69.0 92.4±2.
7 
73.3 
HUES
9/i3T3 
83.6±1.
54 
12.3 79.2±0.
91 
1.9 85.5±1
.11 
93.7 85.1±1.
11 
87.9 
HUES
9/iMR
C5 
93.2±0.
5 
13.9 94.2±6.
2 
7.3 98.6±3
.1 
73.3 95.7±3.
1 
65.4 
HUES
9/iHD
Fn  
99.5±0.
39 
13.8 93.8±0.
30 
1.3 97.0±6
.2 
52.2 80.0±3.
03 
54.3 
HUES
9/Matri
gel 
69.2±4.
11 
60.5 78±2.79 35.4 82±1.3
7 
83.5 86±0.82 82.9 
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4.3.5 Changes in expression of undifferentiated hESC markers for stem cell 
line NCL5 by flow cytometry 
Results in Table 4.9 demonstrated clear differences in expression between the 
markers. SSEA3 and SSEA4 expression was higher from cells cultured on both 
human feeders compared to mouse feeders, whereas expression of TRA-1-60 and 
TRA-1-81 were highly expressed in cells from mouse feeders compared with human 
feeders. Cells on Matrigel maintained high levels of expression of all four markers at 
late passage. Worth noting is the fact that there was considerable variation in the 
levels of markers detected between the two methods used, i.e. FC and TF. The latter 
appeared more sensitive, giving overall much higher detected levels of expression 
when compared to FC. Only expression of TRA-1-60 and TRA-1-81 from all samples 
appeared to be comparable with both techniques.  
When comparing overall undifferentiated marker expression, levels were highest in 
NCL5 cells cultured on iMEF mouse feeders, iMRC5 human feeders or feeder free 
matrix Matrigel (Figure 4.13).The highest levels of expression were however with 
NCL5 cultured on iMEF at late passage (Figures 4.13 A and B). From initial 
observation of the results, NCL5 had higher, more consistent expression of all 
markers from early to late passage compared to the other stem cell lines. Therefore, 
biological replicates were carried out and included in these results (n=3), and 
showed consistencies for this experimental set for NCL5 cell line. There was a 
decrease in expression from early to late passage from NCL5 cultured on iMRC5 
(18%). Culture of NCL5 on Matrigel was also comparable with human feeders, with 
high expression of TRA-1-60, TRA-1-81, SSEA3 and the highest expression of 
SSEA4 from all the conditions, at early and late passage.   
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Figure 4.13. Effects of Matrigel and different feeder types on undifferentiated 
marker expression in NCL5 stem cell line at early (A) and late (B) passage 
(n=3). NCL5 were cultured at early (p+5) and late (p+20) passage on mouse, human 
feeders and Matrigel until confluent. Cells were prepared for flow cytometry as 
described in the methods (section 2.8). The data is the mean of 3 separate 
experiments. 
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4.3.6 Changes in expression of undifferentiated hESC markers for NCL5 stem 
cell line detected by TissueFaxs™ analysis 
Figures 4.14 and 4.15 demonstrate positive expression of markers for NCL5 cultured 
on mouse fibroblasts iMEF (Figure 4.14) and human feeder‘s iHDFn (Figure 4.15). 
However, some of the images produced from NCL5 on iMEF at late passage were 
out of focus. As well as difficulties encountered as a result of imaging stem cells on 
feeders,  considerable cell piling was also observed (Figure 4.14.A and 4.14.B) 
despite adjustments to seeding density (passaging 1:6 adjusted to 1:12). As cells 
pile on top of each other, the camera could not be easily focused onto the cell layers 
to identify clear morphologies. Although tools to allow the re-acquirement of small 
areas were applied, the images obtained were of poor visual quality. This also made 
analysis difficult. Nonetheless, positive expression of all four stemness markers was 
detected, as shown in Figure 4.14 (C-F). 
Imaging NCL5 cells cultured on human feeders was also challenging. The cells grew 
as elongated colonies (demonstrated by Figure 4.15.D-F), which could not be image 
clearly due to piling of cells in the middle of the colonies, and thinning of cells at the 
edges where the colonies tapered off. Imaging hESCs NCL5 on iMEF mouse 
feeders was more straightforward and produced brighter colonies, as shown in 
Figure 4.14. In this case, the cells grew in recognisable patterns and were easily 
detected by the microscope with less piling. This may resulted in lower levels of 
fluorescence intensity, which meant that SSEA3 expression was not as high on 
iHDFn (65.00% ±3.02) compared with NCL5 on iMEF (98.64% ±5.81). Tight, 
distinctly-shaped stem cell colony formation was observed with NCL5 cultures on 
mouse feeder layer i3T3 as shown in Figure 4.16A and 4.17B. The images obtained 
were clear and fluorescence was easy to visualise. This is probably due to the stem 
cells proliferating on top of the mouse feeder layer rather than between the 
monolayers, making them easier to detect and image. 
NCL5s cultured on human feeders iMRC5 grew in waves and swirls between the 
human feeders, as observed with the other hESC lines. From the IF images, it is 
apparent that imaging populations of stem cells on human feeders is a more 
challenging task than on mouse feeders. Figure 4.16 of NCL5s on i3T3 feeders  
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shows much clearer and better defined pictures than images of NCL5 cultured on 
iMRC5 (Figure 4.17). In particular, expression of TRA-1-60 and TRA-1-81 on the 3T3 
mouse feeders was much brighter than those obtained on human feeders (Figure 
4.16.E and F). Therefore, the human feeder population was not easy to locate with 
the scatterplot purely on the basis of cell size. Thus, the human feeders could not be 
eliminated from the overall analysis, which was much easier for mouse feeders as 
they are much smaller than the stem cells and could be eliminated using size and 
shape parameters. This discrepancy most likely affected the intensities and 
influenced the overall mean percentage of expression of stem cell markers, as these 
cells may have been too bright or too dim and probably gated into bright artefacts or 
baseline cut-offs.  
Figures 4.15 and 4.17 also highlight the changes in morphology seen with hESCs on 
human feeders. As the colonies elongated they proliferated on the larger human 
feeder cells. Both human and mouse feeder types maintained expression of 
undifferentiated stem cell markers at late passage, although again, the images were 
not very clear and difficult to analyse as a result of culture on a feeder layer. Once 
again, the main issues faced with producing higher quality images was imaging on a 
bilayer of feeders, which could not be improved without removing the feeders. 
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Figure 4.14. IF TissueFaxs™ images for stem cell line NCL5 cultured on iMEF mouse 
feeders showing expression of undifferentiated markers at late passage. NCL5 were 
cultured on iMEF mouse feeders at late passage on 24 well plates until confluent. Plates 
were fixed with 4% PFA for 20 minutes, then stained as described in the methods (2.9). 
Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour DAPI 
and positive expression of stemness markers C: SSEA4, D: SSEA3, E: TRA-1-60, F: TRA-1-
81. All images were captured at x20 magnification. Scale bar = 100µm. 
 
Figure 4.15. IF TissueFaxs™ images for stem cell line NCL5 cultured on iHDFn human 
feeders showing expression of undifferentiated markers at late passage. NCL5 were 
cultured on iHDFn human feeders at late passage on 24 well plates until confluent. Plates 
were fixed with 4% PFA for 20 minutes, then stained as described in the methods (2.9). 
Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour DAPI 
and positive expression of stemness markers C: SSEA4, D: SSEA3, E: TRA-1-60, F: TRA-1-
81. All images were captured at x20 magnification. Scale bar = 100µm. 
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Figure 4.16. IF TissueFaxs™ images for stem cell line NCL5 cultured on i3T3 mouse 
feeders showing expression of undifferentiated markers at late passage. NCL5 were 
cultured on i3T3 mouse feeders at late passage on 24 well plates until confluent. Plates 
were fixed with 4% PFA for 20 minutes, then stained as described in the methods (2.9). 
Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour DAPI 
and positive expression of stemness markers C:SSEA4, D:SSEA3, E:TRA-1-60, F:TRA-1-
81. All images were captured at x20 magnification. Scale bar = 100µm. 
 
 
Figure 4.17. IF TissueFaxs™ images for stem cell line NCL5 cultured on iMRC5 human 
feeders showing expression of undifferentiated markers at late passage. NCL5 were 
cultured on iMRC5 human feeders at late passage on 24 well plates until confluent. Plates 
were fixed with 4% PFA for 20 minutes, then stained as described in the methods (2.9). 
Images taken by TissueFaxs™ imaging system show A: Grey scale DAPI, B: colour DAPI 
and positive expression of undifferentiated markers C:SSEA4, D:SSEA3, E:TRA-1-60, 
F:TRA-1-81. All images were captured at x20 magnification. Scale bar = 100µm. 
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Table 4.9. Comparison of expression (%) of undifferentiated 
markers for stem cell line NCL5 at late passage by flow cytometry 
(FC) and TissueFaxs™ image analysis (TF).  
 
 
 
 
 
 
 
 
 
Stem cell 
line/feeder 
SSEA3 
BY TF 
SSEA3 
BY FC 
SSEA
4 BY 
TF 
SSEA
4 BY 
FC 
TRA-1-
60 BY 
TF  
TRA-1-
60 BY 
FC 
TRA-1-
81 BY 
TF  
TRA-1-
81 BY 
FC 
NCL5/iMEF 98.6 18.7 98.32 22.6 96.74 85.28 96.75 89.9 
NCL5/i3T3 84.9 38.8 81.69 9.58 86.40 90.0 94.92 88.58 
NCL5/iMRC
5 
94.61 58.4 97.35 40.0 94.05 54.5 86.40 86.5 
NCL5/iHDFn  65.0 52.8 96.17 32.1 91.9 71.3 97.82 70.2 
NCL5/Matrig
el 
97.17 50.37 99.45 40.0 75.37 85.8 92.65 84.2 
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4.3.7 Changes in expression of undifferentiated hESC markers for stem cell 
line RH5, HUES9 and NCL5 cultured on Matrigel detected by TissueFaxs™ 
image analysis 
As described in Chapter 3, morphological changes of hESCs were demonstrated as 
a result of their culture on the feeder free Matrigel/mTeSR1 system. TissueFaxs™ 
results (Figure 4.18) show a selection of images that confirm all three hESC lines 
expressed undifferentiated hESC markers (full PDF of results for each hESC line 
shown in appendix). Qualitative and quantitative assessment of marker expression 
was significantly improved by feeder free culture. The time taken to image these 
colonies was reduced in comparison to imaging feeder dependant cultures as it was 
easy to focus the microscope to obtain good quality images. However, as already 
described from culture on feeders, hESCs do tend to grow on top of each other when 
passaged enzymatically which can cause piling. This resulted in slightly blurry 
imaging as shown in Figure 4.18; F, G and I.  
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Figure 4.18: IF TissueFaxs™ images for stem cell lines HUES9, RH5 and NCL5 
cultured on Matrigel showing expression of undifferentiated markers at late 
passage.  All three hESC lines were cultured at late passage on Matrigel coated 24 
well plates until confluent. Plates were fixed with 4% PFA for 20 minutes, then 
stained as described in the methods (2.9). Images taken by TissueFaxs™ imaging system 
show A: Grey scale DAPI, B: colour DAPI and positive expression of stemness markers 
C:SSEA4, D:SSEA3, E:TRA-1-60, F:TRA-1-81. All images were captured at x20 
magnification. Scale bar = 100µm.  
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Table 4.10. Comparison of percentage expression of 
undifferentiated markers for stem cell line RH5, HUES9 and NCL5 at 
late passage by TissueFaxs™ image analysis (TF).  
 
 
 
 
 
 
 
 
 
STEM CELL 
LINE 
SSEA3 (FITC) SSEA4 (CY3) TRA-1-60 
(CY3) 
TRA-1-81 
(CY3) 
RH5 87.25±1.20 
 
72.90±0.35 
 
77.35±2.50 
 
81.54±4.33 
 
HUES9 69.27±4.11 
 
78±2.79 
 
82±1.37 
 
86±0.82 
 
NCL5 97.17±2.8 
 
99.45±1.36 
 
75.37±0.98 
 
92.65±2.35 
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4.3.8 Detection of co-expressed stemness markers 
The co-expression of the stemness markers SSEA4/TRA-1-81 was assessed in all 
three stem cell lines cultured on the four feeders and on Matrigel, at late passage. 
This was to establish better defined populations of undifferentiated hESCs. Both 
markers were detectable in RH5 cultured on iMRC5 (Figures 4.19 A and 
corresponding scattergram Figure 4.19C at 85.74%) and in RH5 cultured on iMEF 
(Figure 4.19 B and scattergram D, at 90.29%). These markers were also co-
expressed in NCL5 cultured on iMRC5 (Figure 4.21 A and corresponding 
scattergram C at 92.09%) and in NCL5 cultured on iMEF (Figure 4.20 B and 
scattergram D, at 98.02%). Again, clearer imaging was obtained from NCL5 cultured 
on mouse feeders, compared with images on human feeders. Comparison of these 
results to the single fluorescent channel results showed similar percentages of 
detection (Figure 4.6 and Table 4.10). This demonstrates that the results obtained 
are reliable and consistent. 
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Figure 4.19. Co-expression of SSEA4/TRA-1-81 by TissueFaxs™  image and 
corresponding scatterplot in RH5 cultured on iMRC5, (A and C) and RH5 
cultured on iMEF, (B and D) at late passage. TissueFaxs™ image analysis was 
able to identify 85.74% of RH5 stem cells cultured on human feeder‘s iMRC5 as both 
SSEA4 and TRA-1-81 positive, at late passage, in comparison with culture on mouse 
feeder iMEFs, at 90.29%. The higher expression in mouse feeders was most likely 
due to difficulties in detection of positive stem cells cultured on human feeders, 
which grow as swirls, and therefore it is trickier to distinguish and detect stem cells 
from human feeders using masks as the stem cells tend to grow in between the 
feeder layers.  All images were captured at x20 magnification. Scale bar = 100µm. 
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Figure 4.20. Co-expression of SSEA4/TRA-1-81 by TissueFaxs™ image and 
corresponding scatterplot in NCL5 cultured on iMRC5 (A and C) and NCL5 
cultured on iMEF late passage (B and D).  In concurrence with Figure 4.18, stem 
cells cultured on mouse feeders showed higher levels of stemness marker 
expression (98.30%) compared with those cultured on human feeders (91.09%). Co- 
expression image B, obtained from NC5 cultured on mouse feeder at late passage 
was much clearer than image A, from human feeders. 
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4.3.9 Expression of stemness markers by TissueFaxs™ image analysis  
The results in the Table 4.11 are based on the average fluroescent intensity obtained 
from its corresponding Field of View (FOV) images. For the majority of these results, 
the events/cells have been gated by parameters Dapi area and Dapi intensity, to 
appropriately detect Dapi stained single cells. The results were then further gated to 
detect accurate positively stained events for each stemness  marker. Where no 
specific gated population was detected, an accurate percentage of expression was 
calculated by dividing the overall number of events/cells obtained from one 
scatterplot/table from Dapi (Master channel parameters) by the events sub-gated in 
the fluorescent channel.  Confidence intervals were calculated using events gated 
from commercial isotype controls, and ensure the reliability of results obtained. 
Table 4.11 demonstrates that while expression of undifferentiated hESC markers 
was detected in all late passage hESC line cultured on all four feeder types and 
Matrigel there were differences in expression, which were ranked as HIGH/LOW (cut 
off: 60% expression for all cell surface markers). Overall, SSEA3 expression was low 
for cells cultured on i3T3 and iHDFn compared with iMRC5 and iMEF. Furthermore, 
HUES9 cultured on both mouse feeders had between 10-15% lower expression 
compared with cultures on human feeders. RH5 also had slightly lower expression 
on mouse feeders when compared to both human feeders for overall stemness 
expression. Results for TRA-1-60 cell surface marker expression were slightly lower 
than the other three markers. The Table also clearly shows that overall SSEA3 and 
SSEA4 expression was low from FC compared with TF. 
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Table 4.11. Summarised comparison of stemness marker 
expression by each stem cell line detected by TissueFaxs™  image 
analysis (TF) and flow cytometry (FC) at late passage. 
 
STEM CELL 
LINE/FEEDER 
SSEA3 
BY TF 
SSEA3 
BY FC  
SSEA4 
BY TF 
SSEA4 
BY FC 
TRA-
1-60 
BY TF 
TRA-1-
60 BY 
FC 
TRA-1-
81 BY 
TF 
TRA-1-
81 BY FC 
RH5/iMEF HIGH LOW HIGH LOW HIGH LOW HIGH LOW 
RH5/i3T3 HIGH LOW HIGH LOW HIGH LOW HIGH LOW 
RH5/iMRC5 HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
RH5/iHDFn HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
RH5/Matrigel HIGH LOW HIGH LOW HIGH LOW HIGH HIGH 
 
NCL5/iMEF HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
NCL5/i3T3 HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
NCL5/iMRC5 HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
NCL5/iHDFn HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
NCL5/Matrigel HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
 
HUES9/iMEF HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
HUES9/i3T3 HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
HUES9/iMRC5 HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
HUES9/iHDFn  HIGH LOW HIGH LOW HIGH LOW HIGH LOW 
HUES9/Matrig
el 
HIGH LOW HIGH LOW HIGH HIGH HIGH HIGH 
158 
 
 
4.3.10 Statistical analysis using 2 way variance and Duncans grouping to 
compare Stem cell lines and human versus mouse feeders from early 
and late passage. 
 
Flow cytometry 
Using 2 way ANOVA to compare the differences in expression between cell surface 
markers, feeders and hESC lines,  overall significant differences were found for 
SSES3 expression, between the stem cell lines (P = 0.004) however, not as a result 
of culture on the different  feeders (P > 0.05). No significant difference were noted 
between early and late passage cultures (P = 0.449).  Similarly SSEA4 expression 
also showed overall significant differences between cell lines (P < 0.0001) but not 
the feeders (P = 0.449) and there was no overall significant differences between the 
early and late passages (P = 0.326). 
 
TissueFaxs™  
Results from TissueFaxs™ analysis of undifferentiated markers SSEA3 and TRA-1-
81 were also subject to 2 way ANOVA and GLM, as described above. Statistical 
analysis revealed no significant difference from early to late passage, and between 
feeder types (P=0.386, P=0.846), but significant differences between stem cell lines 
(P=000.1). 
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4.4 Discussion 
The characterisation of hESCs is important to the stem cell community. Flow 
cytometry is a useful tool to assess the undifferentiated state of hESCs by cell 
surface and nuclear marker expression. Although the molecular identities are 
unknown, cell surface stemness markers TRA-1-60, TRA-1-81 and SSEA3, SSEA4 
are routinely tested for in many laboratories (Adewumi et al, 2007; Chambers et al., 
2007; Jonathan S. Draper, 2004). Visual assessment of cell cultures alone, although 
useful, cannot determine the outcome of the potential use of a cell line. High content 
image-based cell screening marks a positive advancement to precisely quantify the 
IF staining within cell cultures. Although its use within the stem cell field is relatively 
new, its potential applications are endless. For example, optimising cell density for 
plating efficiencies, viability assessment, cell counting, assessing well to well 
variation between cultures and the prospects of acquiring large number of individual 
cell measurements or searching for rare cell events are all potential applications. 
From the initial results, both flow cytometry and TissueFaxs™ analysis confirmed the 
expression of undifferentiated hESC markers in all the stem cell lines cultured on 
feeders and Matrigel at late passage. However detection by flow cytometry gave 
markedly lower sensitivity, when compared with marker expression from every cell 
line processed by TissueFaxs™ analysis. SSEA3 and SSEA4 expression were 
particularly low across all stem cell lines and feeder types by Flow cytometry with 
less than 50% expression detected. Variability of SSEA3 expression in hESCs by 
flow cytometry and in situ staining has been previously reported (Adewumi et al., 
2007), however the results were qualitative (in situ fluorescence staining) and 
therefore subject to variability. Variability of FACs analysis can occur due to other 
factors such as fixation methods, which can affect the expression of antibody binding 
and could be further investigated to establish whether a more appropriate fixation 
method could improve the detection of SSEA3 and SSEA4. Also, operator error and 
gating of cell populations can affect overall flow cytometry results. This is difficult to 
standardise, and well defined cut offs have to be put in place in order to apply this 
technique as a QC test. The use of commercially available isotype controls does 
improve this variability, as gating was more reliably performed and consistent 
between experiments. However this task was difficult to perform as the same gates 
could not be applied to all the different stem cell lines used, due to variations in 
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growth and size of the stem cell lines themselves. Also, hESCs cultured on human 
feeders appeared to grow much larger than those cultured on mouse feeders. This 
also made gating difficult, as different gate templates had to be created for each 
stem cell line, and sometimes for each stem cell line cultured on each feeder type, 
due to the large variations in size. Clumping and cell death may also have 
contributed to low expression of SSEA3 and SSEA4 results by FC. It was noted that 
a number of hESC lines on feeder cultures were much clumpier when compared to 
Matrigel cultures. Manual separation of stem cells from their feeders is difficult as 
stem cells are frequently lost as a result of clump removal, making it difficult to 
prepare single cells suspensions for testing such as flow cytometry. The use of 
magnetic separation kits (MACs™, Miltenyl Biotech) does solve this problem for 
mouse feeders however at the time of writing there was no kit developed for the 
separation of human feeders from hESCs. Mouse feeders are much smaller than 
stem cells, so subsequently it was relatively easy to gate out this population from the 
main stem cell population.  
In addition, the Guava™ could only process and analyse a small number of cell 
events (3000) in comparison to other instruments, for example, BD FACS Canto™, 
which can process an average of 10, 000 events. At the time that these studies were 
carried out the UKSCB only had access to The Guava™ flow cytometer, which is 
additionally limited in its capabilities compared with other flow cytometers. It only has 
the ability to detect PE and FITC fluorophores, and the software cannot back-gate. 
As demonstrated by the results in this chapter, flow cytometry is a useful technique 
to characterise undifferentiated stem cells, particularly when a number of antibodies 
can be used together to make an informed decision on whether a stem cell line has 
maintained its undifferentiated characteristics over a number of passages. Flow 
cytometry using the Guava Easycyte ™ has the advantage that it is easy to set up 
and execute reliable experiments.  In addition, Flow cytometry should not be used as 
a single characterisation test, but instead used in conjunction with 
immunofluorescent staining to give information on spacial analysis of stem cells as 
typically, they grow as colonies.  
The results demonstrate the precision by which the TissueFaxs™ is able to detect 
single cells as events. The sophisticated gating analysis software allows the user to 
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back-gate and specifically critique and remove/re-gate individual events with much 
accuracy, compared to a flow cytometer, which is subject to false positive and false 
negative results due to debris from apoptotic cells, cell artefacts and unconjugated 
fluorescent antibody, all of which can be removed by the TissueFaxs™. The results 
obtained by TissueFaxs™ are considerably higher than the results obtained from the 
Guava however, the number of cells/events analysed is also significantly higher than 
the guava. As demonstrated by these studies, the TissueFaxs™ has demonstrated 
its ability to analyse between 15,000-40,000 events. This is probably due to a greater 
level of sensitivity and accuracy when detecting a true stem cell population from 
dead cell cells/debris/feeders etc. Improved analysis functions enabled the 
successful identification and gating of feeder populations, to allow for much more 
accurate quantification of positive staining. TissueFaxs™ quantitative imaging has a 
significant advantage over this as the results are quantitative and remove 
discrepancies in reporting results associated with qualitative fluorescence imaging. 
TissueFaxs™ demonstrated 60-90% positive SSEA3 and SSEA4 expression over 
flow cytometry. It was reported that SSEA4 staining patterns were typical of integral 
membrane components compared to TRA-1-81 and TRA-1-60, which showed a 
granular pattern of staining around the cells, characteristic of proteins deposited in 
the pericellular matrix (Adewumi et al., 2007). The use of visual and spacial analysis 
when assessing undifferentiated hESCs using TissueFaxs™ has clear advantages 
over traditional flow cytometry, as different cell populations can be better identified 
with the correct use of antibodies.  
The biggest disadvantage of the TissueFaxs™ is the inability to image in brightfield, 
to compare morphology with fluorescent images. The TissueFaxs™ is a very 
sensitive piece of equipment and slight adjustments can only be made by 
experienced staff. The microscope also struggled to image on a bilayer of cells which 
for some cell lines resulted in poor quality images. hESCs cultured on Matrigel 
significantly improved this issue and gave much clearer fluorescent images, as 
demonstrated by the results. 
Co expression of cell surface markers 
The co expression of stem cell surface markers using two antibodies was carried out 
to try and obtain a better defined population of undifferentiated hESCs following long 
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term culture on human and mouse feeders. TRA-1-81/SSEA4 positive populations of 
stem cells were detected from all three stem cell lines, and were noticeably higher 
from stem cell line NCL5 and RH5. Furthermore, differences in co-expression were 
seen as a result of culture on different feeder types. Expression of TRA-1-81/SSEA4 
was higher (8-10%) from stem cells cultured on mouse feeders compared to stem 
cells cultured on human feeders, at late passage (Figures 4.19 and 4.20). However, 
this was most likely due to the limitations in detecting stem cells cultured on human 
feeders, as they tend to grow in between the feeder layers, and therefore difficult to 
mask and detect by TissueFaxs™ analysis. Furthermore, TRA-1-81/SSEA4 co 
expression was not detected from all stem cell lines cultured in-house and human 
feeders, perhaps indicating that these markers were not co expressed in late 
passage stem cell lines. Previously, research has been conducted to demonstrate 
the role of SSEA3/SSEA4 positive cells and their importance in promoting self-
renewal within a stem cell population (Mantel et al., 2007; Stewart et al., 2006).  
The significance of co-expression of these proteins is not yet known, but may be 
useful in the identification of subset colonies and better defined colonies of 
pluripotent stem cells which typically grow in a heterogeneous population. Definition 
and ability to sort accurate undifferentiated phenotypes of stem cells from mixed 
populations potentially harbouring nullipotent or early differentiated populations, will 
be crucial for progression towards stem cell based therapies. As demonstrated by 
the results of this thesis, stem cells at late passage maintain high expression of TRA 
cell surface proteins. The selection of both SSEA3/SSEA4 positive and 
OCT4/SSEA1 (early differentiation marker) positive stem cells for example, coupled 
with the use of a cell sorter, may result in the selection of stem cells with greater 
pluripotent potential. Although the accurate identification of co expressed markers 
was not fully achieved by these studies, this highlights a limitation that requires more 
time to investigate and refine methods to successful achieve the accurate 
identification of subpopulations of hESCs. 
The ability to isolate purer stem cell populations and eliminate early differentiating 
cell populations has great importance to cell based therapy. Such assays are already 
widely used for clinical application in other disciplines, such as the selection of 
CD4/CD8 counts, when assessing haematological markers for HIV drug dosage and 
selection of CD144/CD34 cells from bone marrow, intended for patients undergoing 
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chemotherapy cycles. This is of particular importance to the UKSCB as its focus is 
quality control, hence robust testing is a high priority.  
Differences in marker expression have previously been described and SSEA3 and 
SSEA4 pinpointed as better indicators of stemness, (Ramirez et al., 2011). This is 
because the expression of other markers, including TRA-1-81 and TRA-1-60, has 
been found in long term cultures which also co-expressed early differentiation 
markers at low levels (Enver et al., 2005; Stewart et al., 2006; Ramirez et al., 2011). 
These reports concur with the results obtained in these studies and further 
emphasize the heterogeneous nature of hESCs, as well as the need to use a 
combination of cell surface markers to confirm their phenotype changes as a result 
of long term passaging and changes in culture conditions. Flow cytometry and 
TissueFaxs™ image analysis demonstrated that NCL5 had the highest percentage 
of positive stem cell marker expression in comparison to the other stem cell lines. 
This was first observed during initial trend analysis of results from the stem cell lines 
cultured and confirmed in repeat experiments. 
RH5 cultures gave higher marker expression on Matrigel and human feeders, at 
early passage, however, this decreased at late passage. HUES9 cultured on 
Matrigel demonstrated improved marker expression from early to late passage. In 
both stem cell lines, cultures on Matrigel produced higher than average results when 
compared with feeders. These differences demonstrate the successful ability of 
hESC cell lines to adapt to feeder free culturing over 20 passages, when compared 
with i3T3 and iHDFn feeders. 
Statistical analysis using 2 way variance and Duncans‘ grouping for pairwise 
comparisons demonstrated that overall, significant differences of expression of 
markers by flow cytometry were seen between stem cell lines, but not between 
feeders (mouse versus human). There was no significant difference of marker 
expression from early to late passage (only compared from flow cytometry results). 
Two way analysis of variance, carried out using the TissueFaxs™ results, concluded 
that there was no significant difference between the feeder types (mouse versus 
human), only the stem cell lines themselves, which concurred with the flow cytometry 
results. 
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Differences in marker expression as a result of culture on different matrices 
iMRC5 human feeders, iMEF mouse feeders and feeder free matrix Matrigel cultures 
gave higher expression of markers when compared with iHDFn and i3T3. The 
highest expressing markers from all stem cell lines on feeders were TRA-1-60 and 
TRA-1-81, indicating that the expression of TRA cell surface markers are maintained 
over extended passaging.  
It also confirms other findings, that human feeders provide a suitable alternative to 
mouse feeders, as they support the undifferentiated growth of hESCs as well as 
mouse feeders and have the advantage of cultures without potential animal 
pathogen contamination (Richards et al., 2002; Amit et al., 2003; Hovatta et al., 
2004).  
The results here are also in contrast to previous reports which concluded that hESCs 
cultured on human feeders expressed lower levels of SSEA3 compared with mouse 
feeders (Eiselleova et al., 2008). It has been argued that not all human feeders are 
suitable to support undifferentiated hESC growth (Richards et al., 2003). In particular 
MRC5 feeder cells have been described as unsupportive as they did not support 
hESC growth (Richards et al., 2003). This is also in contrast to the results obtained 
here, which confirm that MRC5 cells were indeed able to support hESC growth. 
These discrepancies could be due to the flow cytometry technique used to detect 
marker expression, as shown by the results obtained in these studies. The use of a 
more sensitive technique like the TissueFaxs™ may help to close the gap between 
such inconsistencies, and provide more reliable and sensitive assessment of 
stemness marker expression.  
The subtle differences in feeder supportiveness may indicate a species specific 
preference for human feeders. The differences in the way in which the stem cells 
appear morphologically i.e. stem cells grew and proliferated between the human 
feeder layers in contrast to on top of mouse feeders, demonstrate the contrasting 
mechanisms that stem cells use to attach and grow. It may also be an indication as 
to the type growth factors secreted within their extracellular matrix that each feeder 
type provides to effectively support proliferating hESCs (Eiselleova et al., 2008).  
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4.5 Conclusion  
Although previous literature has shown that the comparisons between cultures on 
mouse and human feeders revealed morphological differences in the way that stem 
cells proliferate on different matrices, these findings do not favour the use of one 
feeder type over another. Both IF techniques confirm that all three stem cell lines 
maintained expression of markers when cultured on the four feeder types and 
Matrigel using enzymatic passaging.  The only significant variable in marker 
expression over extended passage were due to the inherent difference within the 
Stem Cell lines themselves (p=0.001).  
Flow cytometry is a useful technique to assess the expression of cell surface 
markers in hESCs. The Guava Easycyte is ideal as a quick screening tool as it 
doesn‘t require complex parameter set up. Its ease of use has been demonstrated 
by these studies. However the TissueFaxs™ provides considerably more information 
on spacial analysis of marker expression in addition to accurate and more sensitive 
quantitative analysis, with comparison to flow cytometry. The culture plate platform 
allows high throughput imaging combined with effective analysis that is quantitatively 
comparable to a flow cytometer, with the added benefit of being able to visually 
assess the cells in situ and back-gate to a cell on an image, and collect large data 
sets for accurate statistical analysis.  
The use of Matrigel clearly has an advantage when applied to these techniques as it 
removes the variability and inaccuracies faced as a result of using feeders, both in 
flow cytometry and image analysis. The use of better standardised matrices in 
combination with defined media mTeSR1, and TrypLE™ Express will aid 
progression to achieving reproducible, uniform cultures for scale up methods and 
improve QC assessment methods including high throughput image analysis. 
Standardisation of these methods will better enable the field to progress, closing the 
gaps formed as a result of lab to lab variation. 
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Chapter 5.  
Real time PCR analysis of gene 
expression profiles in human 
embryonic stem cells cultured on 
different matrices 
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5.1 Introduction 
The long term culture of human embryonic stem cells relies on maintaining 
undifferentiated populations of cells. Gene expression patterns underline the basic 
differences that define the transcription of genes in human pluripotent stem cells 
(Tanaka et al., 2002; Abeyta et al., 2004; Bhattacharya et al., 2004; Korkola et al., 
2006). Many different studies have assessed the gene expression signatures of 
different hESCs (Abeyta et al., 2004; Sperger et al., 2003; Bhattacharya et al., 2005), 
(Chin, et al., 2009; Barbet  et al., 2011) and the majority conclude that although each 
stem cell line does have a unique genetic signature, they do share commonalities. 
These genes have been shown to be linked to maintenance of self-renewal, 
stemness markers i.e. present in undifferentiated cultures and genes required for 
attachment, support and growth. 
Real time PCR allows the assessment of pluripotency genes by detecting changes in 
gene expression using relative quantification when compared to a calibrator (control 
sample), and in reference to ‗housekeeping‘ control genes. These are genes which 
are required for the maintenance of basic cellular functions, and are therefore always 
expressed at a relatively constant level across many conditions.  
There is much variability between laboratories in their choice of genes to screen for 
presence of stemness, pluripotency and differentiation, although transcription factors 
OCT4 (POU5F1) and Nanog appear most commonly (Chambers et al., 2003; Matin 
et al., 2004). Other variables include number of cells analysed, appropriate selection 
of calibrator and housekeeping gene(s), quality and amount of RNA/cDNA for 
reverse transcription (RT) step. Although research has demonstrated the continued 
expression of genes for self-renewal in long term cultures of hESCs (Sato et al., 
2003; Sperger et al., 2003; Richards et al., 2004), and that the effects of maintaining 
undifferentiated cultures of hESCs on different feeder types is due to their inherent 
ability to express growth factors FGF2, BMP4 and Activin A (Eiselleova et al., 2008) 
there is little robust and conclusive data to indicate whether the type of matrices 
used for co-culture influence gene expression in hESCs over long term passaging.  
 
A few studies have discussed the low level expression of differentiation genes, 
particularly at late passage (Tanaka et al., 2002). Yoon et al (2010) showed that 
three hESC lines cultured on feeder free matrices, Vitronectin, CellStart with 
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StemPro media or Matrigel/mTeSR1, expressed similar global gene patterns to 
those cultured on iMEF mouse feeders. Furthermore, studies assessing the use of 
different feeder types and Matrigel cultured hESCs on gene expression tend to be 
focussed on already well characterised hESC lines such as H1, H7, H9 and H14 
(Carpenter et al., 2004) and only demonstrate the presence of a select few genes. 
 
Advances in high throughput genomic screening have led to the development of 
TaqMan low density array cards (TLDA, Applied Biosystems), to screen for 
pluripotency and differentiation genes. These array cards have been carefully 
designed to avoid common errors associated with setting up and conducting large 
numbers of individual PCR assays manually, as demonstrated by the international 
stem cell initiative study, ISCI (Adewumi et al., 2007). TLDA card technology utilises 
novel gene signature arrays designed especially to detect genes specific to hESCs, 
using endogenous control selection. Each well is sealed therefore the individual 
reactions are both reliable and robust, as they allow for minimal cross contamination 
between samples. TLDA cards are cycled on an Applied Biosystems 7900HT real 
time PCR system and the relative quantification software gives accurate and 
reproducible gene expression data.  The cards are designed to screen for 96 genes 
(inclusive of 6 housekeeping genes) carefully chosen for hESCs. The use of TaqMan 
probe technology ensures the highest probe specificity and easy loading of sample 
with minimal preparation. A recent study by Barbet et al (2011) demonstrated the 
sensitivity and robustness of TLDA cards to detect differences in gene expression 
between hESCs cultured on iMEFs and Mesenchymal stem cell lines (MSCs) 
committed towards mesoderm lineage. 
The aim of these studies was to construct and compare gene expression profiles 
using TLDA card data from the four stem cell lines RH5, HUES9, SHEF1 and NCL5 
cultured over 20 passages on the two mouse fibroblast lines iMEF and i3T3, the two 
human fibroblast lines iMRC5 and iHDFn, and the feeder free Matrigel matrix with 
mTeSR1 used as media. Data from early and late passage samples were compared, 
to examine if any changes in the pattern of gene expression occurred in individual 
stem cell lines as a consequence of prolonged culture on different matrices. The 
expression of germ layer specific differentiation genes was also included in the 
analysis of results. This information can be of use when profiling stem cells as they 
169 
 
can express such genes endogenously, at low levels, which can be used to indicate 
whether a stem cell line has begun to differentiate at a transcription level. 
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5.2 Methods 
 
5.2.1 Preparation of hESCs for detection of early differentiation marker SSEA1 
by flow cytometry  
Stem cell lines NCL5, RH5, HUES9 and SHEF1 were cultured on iMRC5, iHDFn, 
iMEF and i3T3 using standard KO-HES media or Matrigel with defined media 
mTeSR1, as described by methods (Chapter 2). Samples were collected at early and 
late time points using TrypLE™ Express and fixed in 15 ml tubes using 4% PFA for 
20 minutes, then pelleted and stored in WashBuffer as fixed pellets at 4°C until ready 
for flow cytometry staining as described in chapter 2 and chapter 5. Cells were 
assayed on Guava Easycyte flow cytometer and analysed using Easycyte software 
and Microsoft Excel.  SSEA1 expression in NCL5 cells was determined in three 
individual experiments but repeated only twice for RH5, HUES9 and SHEF1 due to 
time limitations.  
5.2.2 Preparation of hESCs for gene expression studies using TLDA cards 
In parallel to flow cytometry, RNA was extracted from samples collected at early and 
late time points using Rneasy kit (Qiagen) following manufacturers‘ instructions as 
outlined in general methods chapter 2. RNA samples were subsequently assessed 
for integrity using the Agilent Bioanalyser (see methods section chapter 2).  Low 
quality RNA can affect the downstream processes in PCR reactions therefore RNA 
with RNA integrity number (RIN) of 7 and above was used in the production of 
cDNA. Agilent RNA integrity chip technology gives a measure of RNA integrity RIN 
number, incorporating 18/28s and 260/230 ratios which indicate protein 
contamination and RNA degradation. Figure 5.1 shows an example of results 
obtained from Agilent Bioanalyser. cDNA was prepared using The Reverse 
Transcription Kit (Applied Biosystems) and amplified as described in general 
methods chapter 2. The TLDA cards were prepared according to manufacturer‘s 
guidelines and results were analysed using SDS2.4 and RQ manager v2.1 for plate 
to plate comparison of datasets. 
The SHEF1 cells were only cultured to a maximum of P+15 as it failed to grow well 
and maintain typical undifferentiated stem cell morphology. Results from stem cell 
lines HUES9 and RH5 were from a single sample (n+1) as this formed part of an 
initial experimental screen to demonstrate whether any correlations in gene 
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expression data were apparent. Stem cell line NCL5 grew particularly well and 
samples from this stem cell line were assayed three times (n=3) to give more 
detailed results on the specific genomic integrity of the stem cell line. NCL5 cultures 
were frozen down at early (p+5) and late passage (p+20), then re-cultured, 
expanded and fresh RNA samples obtained. Care was taken to ensure only 1-2 
passage difference between biological repeat samples. 
5.2.3 Data analysis 
Results were first examined in SDS2.4 software and gene expression reports with 
errors for example, high standard deviation or poor amplification, were omitted, to 
allow for better statistical measurements in analysis software RQ Manager. This also 
allowed for easier data handling when comparisons of data sets were performed, 
using ExpressionSuite software. Genes across all samples which were consistently 
not amplified (Ct value of 40) were also removed to allow for more accurate analysis 
of results. Samples were then grouped by germ layer/gene (Table 5.2) and 
compared in RQ Manager. Selection of reference genes (also known as a 
housekeeping gene) was also carried out by examining amplification of potential 
candidate reference genes (i.e. GAPDH and 18S) for each plate, then selecting 
which was most consistent across all the plates (GAPDH used for all samples). An 
endogenous control is a gene that is expressed constitutively and at the same level 
in all samples to be analysed. The calibrator sample for each plate and each study 
was assigned to be the stem cell line for that particular study cultured on MEFs at 
early passage as this is currently the standard culturing method (example: for NCL5 
stem cell line, NCL5/iMEF early passage). Each calibrator study was examined in 
SDS2.4 software to ensure there were no erroneous results produced for the main 
genes of interest. Normalisation of the data against a calibrator allowed for the 
correction of PCR efficiency, which when carefully selected, can be applied to 
number of result plates and therefore allowed the comparison of the results from 
different PCR runs which was used to track changes over time (early and late 
passage).   
A single preparation of the Embryonal teratocarcinoma (EC) cell line n2102EP was 
run on each card to ensure consistency across all the plates, and to allow for plate to 
plate comparison in RQ Manager. It has been demonstrated that hESCs 
demonstrate similar properties to EC cell lines (Sperger et al., 2003) and 
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consequently have been used as reference cell lines (Josephson et al., 2007).  
cDNA from the same n2102EP RNA sample was used across all plates in this 
experiment. The data produced from n2012EP was examined in SDS2.4 and RQ 
Manager to ensure consistency of results, but was excluded from data sets before 
analysis as these samples were not comparable. Samples were then analysed by 
normalising the data against the endogenous control and the calibrator sample to 
give delta ct values and relative quantification (RQ) values.   
A TLDA card containing cDNA prepared from iMEF, iMRC5, i3T3 and iHDFn was 
also run to allow for genetic profile information of the feeders used in this project. 
This information was also used to compare against stem cell lines and as a negative 
control for the majority of the genes, as feeders do not express stem cell markers. 
Further analysis was carried out using gene expression analysis software 
ExpressionSuite (v.1.01, Applied Biosystems). Table 5.2 displays all the genes found 
on a TLDA card. The genes were organised by expression in undifferentiated cells, 
maintenance of pluripotency, differentiation markers and controls.  
5.2.4 Statistical analysis 
ExpressionSuite Software was used for analysis, which contains a number of 
statistical methods to normalise the data (GeNorm coupled with Pearson‘s 
correlation) and for outlier detection, Grubbs test was used. ExpressionSuite enabled 
the comparison of multiple plates and selection of endogenous controls from all 
genes analysed, to allow for accurate and reliable consistency across plates/different 
stem cell lines. Visualization tools to appropriately display fold change, biological 
significance, and cluster plots for establishing relationships between the stem cell 
samples on a per-plate basis were also applied. Results were deemed significant if 
they resulted in at least a 3 fold change. The overall significance of genes from each 
group in Table 5.2, were subject to T tests. 2 way ANOVA was also used to compare 
each stem cell line and results grouped at early and late passage, and by feeder 
type (mouse and human) to give P values significant to 0.05.  
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Figure 5.1. PDF printout of Agilent Bioanalyser results for RNA extracted from 
NCL5 on iMEF, n2012EP and NCL5 on iMRC5. The gel image in the top left hand 
corner displays the actual sample run, including the RNA nano marker ladder (first 
sample). Each graph shows the electrogram for the individual samples. Typically, 
two large peaks are seen for each sample, corresponding to 18s/28s ratio. The 
smaller peaks found between the large peaks relate to contamination by proteins or 
chemicals, for example ethanol carryover, as shown by the second graph for 
n2102EP sample. RNA samples with an overall RIN of less than 7 were not used to 
make cDNA for RT PCR. 
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Table 5.1: List of samples collected for RT PCR 
Cell line/feeder type  Time point  for sample collection  
NCL5/IHDFN  P+5, P+25  
NCL5/IMRC5  P+5, P+25  
NCL5/I3T3  P+5, P+25  
NCL5/IMEF  P+5, P+25  
NCL5/Matrigel P+5, P+25 
HUES9/IHDFN  P+5, P+25  
HUES9/IMRC5  P+5, P+25  
HUES9/I3T3  P+5, P+25  
HUES9/IMEF  P+5, P+25  
HUES9/Matrigel P+5, P+25 
RH5/IHDFN  P+5, P+25  
RH5/IMRC5  P+5, P+25  
RH5/I3T3  P+5, P+25  
RH5/IMEF  P+5, P+25  
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Table 5.2 Genes on TLDA Stem cell pluripotency card 
Reference 
genes 
Expression in 
undifferentiated 
cells 
Correlation 
to stemness 
Endoderm Ectoderm Mesoderm 
ACTB 
RAF1 
CTNNB1 
GAPDH 
EEF1A1 
18S 
 
NANOG 
POU5F1  
SOX2 
TDGF1 
DNMT3B 
GABRD3 
GATA6 
GDF3 
 
BRIX 
CD9 COMMD3 
CRABP2  
DDX4 
EBAF  
FGF4  
FGF5  
FOXD3 
GAL 
GBX2 
GRB7 
IFITM1 IFITM2  
IL6ST 
IMP2 
KIT 
KRT1 
LEFTB 
LIFR 
LIN28 
NODAL 
NOGGIN 
PODXL 
PTEN  
REST SEMA3A 
SERPINA1 
SFRP2 
TERT TFCP2L1 
UTF1 
Xist  
ZFP42 
AFP 
SERPINA1 
LAMC1 
LAMA1 
FN1 
LAMB1 
SOX17 
PTF1A 
FOXA2 
GATA4 
TAT 
PAX4 
SST 
INS 
IPF1 
GCG 
IAPP 
FLT1 
INS 
 
NEUROD1 
NES 
PAX6 
GFAP 
ISL1 
TH 
SYP 
SYCP3 
HLXB9  
OLIG2 
FOXD3 
NR6A1 
NR5A2 
 
ACTC 
Brachury (T) 
EOMES 
WT1 
MYF5 
MYOD1 
DES 
NPPA 
HBB 
HBZ 
RUNX2 
COL1A1 
COL2A1 
PECAM1 
CDH5 
CD34 
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5.3 Results 
 
5.3.1 Expression of differentiation marker SSEA1 on gene expression in hESCs  
As the expression of undifferentiated genes in hESCs cultured long term can vary 
from passage to passage, it was important to demonstrate that the hESCs studied 
still maintained the ability to proliferate in a mostly undifferentiated homogenous 
population. The expression of early differentiation cell surface marker SSEA1 was 
therefore examined by flow cytometry at early and late passage. The expression of 
this cell surface marker is of particular importance when assessing gene expression 
from early to late passage, as this could affect the quantity of differentiation genes 
detected. Table 5.3 demonstrates that for the hESC lines HUES9 and NCL5, less 
than 10% differentiation was detected by the relatively  low expression levels of 
SSEA1 at early and late passage under the different experimental conditions. The 
RH5 cells demonstrated higher levels of SSEA1 expression at early passage but 
cells cultured on human feeders and Matrigel appeared to lose SSEA1 expression at 
later passage compared with those on mouse feeders, possibly indicating an 
increased ability to adapt on human feeders compared with mouse. NCL5 cultured 
on i3T3 at late passage also demonstrated greater than 10% differentiation 
(33.21%). Increases in SSEA1 expression at late passage will be correlated with any 
detected upregulation in genes associated with differentiation. 
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Table 5.3. Detection of early differentiation cell surface marker SSEA1 
determined by flow cytometry. 
STEM CELL LINE/FEEDER SSEA1 
expression 
by FC at early 
passage (%) 
SSEA1 
expression 
by FC at late 
passage (%) 
RH5/iMEF 19.29 19.34 
RH5/i3T3 8.49 17.62 
RH5/iMRC5 11.09 1.92 
RH5/iHDFn 52.35 3.89 
RH5/Matrigel 17.81 8.85 
 
HUES9/iMEF 0.27 0.39 
HUES9/i3T3 1.50 1.34 
HUES9/iMRC5 2.40 2.59 
HUES9/iHDFn  1.45 0.52 
HUES9/Matrigel 5.20 3.58 
 
NCL5/iMEF 4.33 3.81 
NCL5/i3T3 4.81 33.21 
NCL5/iMRC5 6.15 4.54 
NCL5/iHDFn 5.23 3.43 
NCL5/Matrigel 8.07 7.71 
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5.3.2 Changes in gene expression in the RH5 stem cell line as a result of long 
term culture on different feeders and Matrigel 
Figure 5.2 demonstrates that expression of undifferentiated genes were all 
maintained and the majority upregulated from early to late passage. Expression of 
OCT4 and NANOG increased on all feeders and Matrigel cultures at late passage, 
with the exception of RH5 cultured on i3T3 at early passage which showed unusually 
high RQ expression of OCT4, NANOG and SOX2. These were however 
downregulated at late passage. GATA6 expression was lower in cultures on both 
human feeders at early passage compared with mouse feeders and Matrigel, and 
was further downregulated at late passage. RH5 on iMEF (mouse feeder) and 
iMRC5 (human feeder) demonstrated the greatest stability of self-renewal and 
differentiation markers compared to the other feeder types.  
Differences in expression of differentiation markers were seen with RH5 cultured on 
i3T3, by significant upregulation (greater than 3 fold) of SOX17 and FOXA2 and 
downregulation of AFP and GATA4 from early to late passage. Downregulation of 
SOX17, AFP and FOXA2 was observed for all other cultures from early to late 
passage. PAX6 and OLIGO2 expression were upregulated at late passage on all 
four feeder types. Expression of Nestin, ISL1, and HLXB9 was upregulated by 
cultures on feeder lines iMRC5, iHDFn and iMEF and downregulated on i3T3s. 
Relative quantity of mesoderm genes from RH5 cultured on Matrigel was low in 
comparison to the four feeder types. RH5 cultured on iHDFn and iMRC5 human 
feeders demonstrated significant upregulation of Mesoderm genes RUNX2, DESMIN 
and COL1A1 from early to late passage.  RH5 cultures on i3T3 showed 
downregulation of RUNX2, COL1A1 and Desmin. 
Overall, RH5 cultured on human feeders appear to indicate upregulation of 
mesoderm and ectoderm genes (Figures 5.4 and 5.3), whereas RH5 cultured on 
mouse feeder i3T3 showed a preference towards endoderm as shown by 
upregulation of SOX17 and FOXA2, from early to late passage. However this could 
be specifically correlated with cell surface marker SSEA1 expression, which was 
greater than 10% from RH5 cultured on both mouse feeders. The upregulation of 
PAX6, OLIGO2, ISL1, NESTIN and GFAP as seen in Figure 5.3 may indicate a 
preference of RH5 to differentiate towards early neuronal lineage. Further 
differentiation studies are required to confirm this observation. 
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Figure 5.2. Changes in undifferentiated gene expression profile from RH5 stem 
cells induced by long term culture on mouse feeders, human feeders or 
Matrigel using TLDA cards. Relative Quantity (LOG10RQ) of selected 
undifferentiated hESCs genes from stem cell line RH5 cultured on four feeder types 
and Matrigel at early passage A and late passage B were obtained from TLDA card 
real time PCR. The data was obtained from one experiment.  
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Figure 5.3. Changes in Endoderm gene expression profile from Stem cell line 
RH5 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (log10 RQ) of selected endoderm genes from 
stem cell line RH5 cultured on four feeder types at early A and late B passage 
demonstrated downregulation of SOX17, AFP and FOXA2 was observed from all 
cultures from early to late passage, with the exception of 3T3 mouse feeders, which 
showed significant upregulation. Data is representative of one experiment. 
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Figure 5.4. Changes in ectoderm gene expression profile from Stem cell line 
RH5 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10 RQ) of selected ectoderm genes from 
stem cell line RH5 cultured on four feeder types at early A and late B passage show 
that higher levels of PAX6, OLIGO2 and NESTIN were detected from RH5 cultured 
on i3T3s and iMRC5, from early to late passage. Expression of ectoderm genes 
decreased from cultures on Matrigel, at early to late passage. Data is representative 
of one experiment. 
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Figure 5.6. Changes in mesoderm gene expression profile from Stem cell line 
RH5 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards.  Relative Quantity (LOG10 RQ) of selected mesoderm genes 
from stem cell line RH5 cultured on four feeder types at early A and late B passage 
show that expression of all mesoderm genes was higher from RH5 cultured on 3T3s 
and MRC5 compared to the other feeder types and control. Matrigel cultures gave 
consistently low expression of mesoderm genes from early to late passage. Data is 
representative of one experiment. 
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5.3.3 Changes in gene expression in HUES9 stem cell line as a result of long 
term culture on different feeders and Matrigel 
Expression of undifferentiated genes SOX2, POU5F1, Nanog, and GATA6 were 
maintained from HUES9 cultured on four feeder types at early and late passage 
(Figure 5.6). Slight downregulation of SOX2 and GATA6 was seen for HUES9 
cultured on iMRC5, iHDFn and iMEFs from early to late passage. Significant 
upregulation of NANOG from HUES9 cultured on iMEF at late passage was 
detected.  Furthermore, significant downregulation of POU5F1 and NANOG was 
seen on both human feeders.  
Overall, low expression of ectoderm genes were detected on HUES9 cultures 
(Figure 5.8). HUES9 cultured on iMRC5 had slightly higher expression of these 
genes compared to iHDFn and iMEF cultures, at early passage.  Significant 
downregulation of endoderm genes AFP and GATA4 from iMRC5 and iMEF cultures 
occurred, from early to late passage. A significant upregulation of SOX17, FOXA2 
and GATA4 was observed at late passage for HUES9 cultured on i3T3s at late 
passage (<0.1 to >1), relative to the control 
Higher levels of all mesoderm genes ACTC, WT1, RUNX2, DES and COL1A1 were 
found on both human feeders compared to mouse feeders at early passage, 
although significant downregulation of RUNX2, COL1A1 and Desmin was observed 
at late passage (Figure 5.9). Higher expression of mesoderm genes was detected in 
HUES9 cultured on human feeders compared with other germ layer specific genes. 
However these values do not indicate that the cells were differentiated as these RQ 
values were still low as was SSEA1 cell surface marker expression. This may 
provide insight that these cells could have greater potential to differentiate towards 
mesoderm in comparison to ectoderm and endoderm, if left to spontaneously 
differentiate. Cultures on Matrigel appeared to have the lowest expression of 
mesoderm genes (<1.0) from early to late passage. 
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Figure 5.6. Changes in undifferentiated gene expression profile from Stem cell 
line HUES9 as a result of long term culture on mouse, human feeders and 
Matrigel using TLDA cards. Relative Quantity (LOG10 RQ) of selected 
undifferentiated genes from HUES9 cultured on four feeder types and Matrigel at 
early A and late B passage show that undifferentiated gene expression was 
maintained from early to late passage. Cultures on human feeders gave higher 
expression of undifferentiated genes at early passage. Data is representative of one 
experiment. 
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Figure 5.7. Changes in endoderm gene expression profile from Stem cell line 
HUES9 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10 RQ) of selected endoderm genes 
from HUES9 cultured on four feeder types at early A and late B passage showed 
demonstrated low levels of endoderm genes were detected at both early and late 
passage for HUES9. Expression of AFP for RH5 on iMEF and iMRC5 cultures 
significantly decreased from early to late passage. Data is representative of one 
experiment. 
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Figure 5.8. Changes in endoderm gene expression profile from Stem cell line 
HUES9 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10RQ) of endoderm genes from RH5 
cultured on four feeder types at early A and late B passage showed that expression 
of OLIGO2 was significantly higher for HUES9 cultured on i3T3s, iMRC5 and iHDFn 
at early passage, in comparison to iMEF and Matrigel cultures. Expression of 
ectoderm genes was consistently low for Matrigel, at both early and late passage 
(<1.0). Data is representative of one experiment. 
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Figure 5.9. Changes in mesoderm gene expression profile from Stem cell line 
HUES9 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10RQ) of mesoderm genes from HUES9 
cultured on four feeder types and Matrigel at early A and late B passage showed 
upregulation of mesoderm genes ACTC, WT1, RUNX2, DES and COL1A1 at early 
passage for HUES9 cultured on iMRC5 and iHDFn, however these were markedly 
downregulated at late passage. Cultures on Matrigel appeared to have the lowest 
expression of mesoderm genes (<1.0) from early to late passage. Data is 
representative of one experiment. 
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5.3.4 Changes in gene expression in NCL5 stem cell line as a result of long 
term culture on different feeders and Matrigel 
Results for the NCL5 stem cell line were subject to biological repeats, as this stem 
cell line maintained healthy cultures at late passage (n=3). Results show that 
expression of undifferentiated genes was maintained at early and late passage 
(Figure 5.10). Fluctuations of GATA6 expression were detected from early to late 
passage in that levels in cells cultured on Matrigel appeared downregulated, 
whereas those cultured on iHDFn and iMEF were upregulated. Overall, GATA6 
expression was low in comparison to the other genes. 
Upregulation of endoderm genes FOXA2, SOX17 and GATA4 was seen from early 
to late passage for NCL5 cultured on iMEF, iMRC5 and Matrigel (Figure 5.11). 
Endoderm expression was lowest for NCL5 cultured on i3T3 at early and late 
passage. Overall, a significant increase in endoderm expression was detected for 
NCL5 cultured on iMEF and iMRC5 (Figure 5.11 B). Differences in ectoderm 
expression were apparent due to different feeder types, from early to late passage. 
NCL5 cultured on mouse feeders iMEFs and i3T3s caused significant upregulation of 
ectoderm genes, whereas a slight downregulation of NESTIN and GFAP was 
detected from iMRC5 and iHDFn, although iMRC5 also demonstrated upregulation 
of PAX6 at late passage. NCL5 cultured on Matrigel also showed upregulation of 
ectoderm genes at late passage (Figure 5.12). 
Mesoderm expression was highest for iMRC5 and Matrigel cultures, which increased 
significantly at late passage (Figure 5.13B). The lowest expression of mesoderm 
genes was detected for NCL5 on mouse feeders, iMEF and i3T3, at early and late 
passage. Expression of ACTC and RUNX2 significantly decreased at late passage 
from NCL5 cultured on all iMEF, i3T3 and iHDFn. 
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Figure 5.10. Changes in undifferentiated gene expression profile from Stem 
cell line NCL5 as a result of long term culture on mouse, human feeders and 
Matrigel using TLDA cards. Average Relative Quantity (LOG10 RQ) of selected 
undifferentiated genes from NCL5 cultured on four feeder types and Matrigel at early 
A and late B passage demonstrated that expression of stemness genes were 
maintained at early and late passage. A slight increase in POU5F1 and NANOG was 
detected at late passage. Data is representative of three experiments (n=3). 
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Figure 5.11. Changes in endoderm gene expression profile from Stem cell line 
NCL5 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10 RQ) of selected Endoderm genes 
from NCL5 cultured on four feeder types and Matrigel at early A and late B passage 
show that expression of endoderm genes were generally low at early passage and 
increased for NCL5 cultures on iMEF, iMRC5 and Matrigel from early to late 
passage. Significant upregulation of SOX17 was seen from NCL5 cultured on iHDFn 
at late passage. Data is representative of three experiments (n=3). 
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Figure 5.12. Changes in ectoderm gene expression profile from Stem cell line 
NCL5 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10 RQ) of selected ectoderm genes from 
NCL5 cultured on four feeder types and Matrigel at early A and late B passage 
showed significant upregulation of ectoderm genes was seen from cultures on 
Matrigel, iMEFs and i3T3s, from early to late passage. Downregulation of NESTIN 
and GFAP were observed in NCL5 cultured on human feeders‘ iMRC5 and iHDFn. 
Data is representative of three experiments (n=3). 
NCL5 
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Figure 5.13. Changes in mesoderm gene expression profile from Stem cell line 
NCL5 as a result of long term culture on mouse, human feeders and Matrigel 
using TLDA cards. Relative Quantity (LOG10 RQ) of selected Mesoderm genes 
from NCL5 cultured on four feeder types and Matrigel at early A and late B passage 
demonstrated upregulated expression of mesoderm genes for iMRC5 and Matrigel 
cultured cells from early to late passage. Expression of ACTC was very low from all 
conditions at late passage. Data is representative of three experiments (n=3). 
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5.3.5 Comparison of gene expression between stem cell lines cultured on 
human, mouse feeders at early and late passage. 
ExpressionSuite Software allowed the selection of appropriate reference genes by 
permitting all targets (genes) to be candidate reference genes (Figure 5.14A). This 
enabled the selection of a number of stable reference genes across all samples, with 
less than 2 fold change; therefore accurate hierarchical cluster analysis could be 
performed across all the stem cell samples. Figure 5.14B shows the Ct value for 
reference gene 18s, which demonstrated considerable variability across the majority 
of stem cell samples; therefore more stable genes such as ACTB were selected.  
The box plot shown by Figure 5.15 demonstrates a wide variation in Ct values 
across three different stem cell lines cultured on four different feeders at early and 
late passage. Data for the embryonal carcinoma cell line n2102EP is also shown 
(purple bars) as it was originally included as a control cell line and shows a wide 
range in Ct values. The box plot also showed that NCL5 and RH5 cultured on iMEF 
demonstrated an increase in Ct value from early to late passage. Cultures on both 
human feeder types appeared to be less variable compared to both mouse feeders. 
The widest variation in Ct value was seen from both human feeders iMRC5 and 
iHDFn compared to iMEF, which showed the least variation in Ct value.  
Figure 5.16 shows the delta Ct values for the three stem cell lines cultured on four 
feeder types at early and late passage, which have been ‗heat mapped‘ into arbitrary 
ranges to give an indication of high (green) and low (red) expression. Genes for 
Brachury (T), SERPINA, NPPA, NEUROD, MYOD, MYF5, KRT1, INS, HBB and 
GCG were removed due to inconsistencies with expression. Human feeders, early 
passage stem cells and the majority of NCL5 clustered to the left of the heat map, 
whereas the majority of HUES9, RH5, and stem cells cultured at late passage, on 
iMEFs, iMEF feeder line and n2102EP grouped together to the right of the heat map, 
due to the increased expression of differentiation genes.  
Stem cell lines NCL5 and HUES9 grouped together, whereas RH5 appeared to 
group by feeder type with the other stem cell lines, instead of correlating as a stem 
cell line. RH5 and HUES9 cultured on mouse feeder‘s iMEF and i3T3 at late 
passage grouped together. Early passage samples also grouped together, at the far 
left side of the heat map and included NCL5 cultured on iMEF, NCL5 cultured on 
iMRC5, NCL5 cultured on i3T3 and RH5 cultured on iHDFn. Stem cell line HUES9 
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appears in the middle of the heat map, whereas RH5 appears to be scattered across 
the heat map, indicating its spread in expression of genes as a result of the influence 
of different feeder types, from early to late passage.  Stem cell line NCL5 appeared 
to be more consistent in comparison with the other stem cell lines, cultures on iHDFn 
and i3T3s grouped together at early and late passage.  
Genes that grouped together from all samples includes those commonly associated 
with support, growth and maintenance of pluripotency i.e. COL1A2, POU5F1 
(OCT4), LAMB1, LAMA1 NOGGIN, KIT and SOX2. Differentiation genes such as 
RUNX2, COL1A1, FLT1, and GFAP also grouped together as they were 
upregulated. Self-renewal and maintenance genes Nanog, CRAPB and PODXL did 
not appear to correlate strongly amongst the stem cell lines. Interestingly, CDX2 was 
found to be highly expressed for stem cells cultured on iHDFn human feeder. 
Gene expression levels were also analysed in all four feeder cells alone, to 
determine whether expression could be detected at low levels, which could have 
contributed to increased expression within the stem cell lines they were cultured on. 
Unsurprisingly, the mouse feeders grouped together, to the far right of the heat map 
as they expressed the least amount of genes. iMEF did not express any genes, 
whereas iHDFn and iMRC5 grouped together at the far left of the heat map, separate 
from the stem cell lines, as they were found to express low levels of GATA6, KIT, 
NOGGIN and SOX2. Human feeders also expressed low levels of differentiation 
genes GFAP, ISL1, COL1A1, FOXD3, NESTIN, REST and FGF5. iHDFn expressed 
low levels of NODAL, LIFR and PAX4. With the exception of RH5, overall, the results 
demonstrate that feeder type did not contribute significantly to the difference in 
grouping. The biggest difference appears to be the stem cell lines themselves. 
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Figure 5.14. Global expression plot demonstrating the average Ct values for 
the selection of potential reference genes (endogenous control). Reference 
genes were selected from the global gene expression plot based on their stability 
(less than 2 fold change) across all samples, from all available targets in 
ExpressionSuite Software (A). Commonly used housekeeping gene 18S was not 
suitable due to large variations in Ct values from the global expression plot (B). 
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Figure 5.15. Box plot showing Ct values for stem cell lines RH5, HUES9 and 
NCL5 cultured on four different feeder types at early and late passage. Box plot 
analysis was obtained following the selection of appropriate reference gene(s) 
across all the stem cell samples, as a quality control measure to allow the 
visualisation of Ct values across all samples, grouped by stem cell line. The 
correlation between the average Ct values and each stem cell sample and the feeder 
types shows that a wide variation of Ct values was detected from all the samples 
analysed for gene expression. The samples have been colour grouped by their 
culture on specific feeder types; red for MEFs, blue for i3T3, orange for iHDFn and 
yellow for iMRC5.  
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Figure 5.17. Heat map showing correlation of genes expressed by three hESC 
lines cultured on mouse and human feeders and four individual feeder types.  
Gene expression studies from HUES9, RH5 and NCL5 cultured on four feeder types, 
iMRC5, iHDFn, i3T3 and iMEFs at early and late passage, were grouped to form a 
heat map, then analysed and compared using 2 way cluster analysis (Pearson‘s 
correlation) to show trends in gene expression. Delta Ct values have been plotted to 
represent correlations between genes expressed and stem cell lines/samples 
cultured at early and late passage, significant by 2 fold expression.  The heat map 
has been divided into three parts for easy visualisation. Figure A shows the top of 
the heat map and B shows the middle and C shows the base.  
C 
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5.4 Discussion 
Quantitative Real time PCR allows for the quantification of gene expression over 
time when compared to a suitable reference gene, irrespective of culture conditions. 
The sensitivity of the ExpressionSuite software (Applied Biosystems) enabled the 
detection of changes as low as 2 fold, which is important when attempting to 
construct detailed genetic profiles for hESCs which included the low level expression 
of germ lineage specific markers, as demonstrated by these studies.  
Use of the MIQE guideline document, the standard for outlining the minimum 
information required to report the experimental details for PCR experiments, 
including details of instrumentation, requirements for assessing RNA integrity, and 
selection of reference genes, was also applied to these studies (Bustin et al., 
2009;Taylor et al., 2010). Such details are not only useful for publishing, but will help 
provide guidelines for researchers when selecting reproducible protocols within 
publications. The selection of appropriate reference genes for normalisation of gene 
expression data sets has been discussed (Andersen et al., 2004), (Veazey & 
Golding, 2011) (Derveaux et al., 2010). For the individual stem cell lines results, 
GAPDH was chosen as a reference gene, as its values were consistent across each 
particular stem cell line cultured on the four feeder types from early to late passage. 
For global gene expression analysis, three reference genes were selected which 
provided consistency across the three different stem cell lines cultured on four feeder 
types and Matrigel. Interestingly, frequently used reference genes GAPDH and 18s, 
were not suitable for normalising the data, as they were particularly inconsistent 
across all the hESC lines. Such quality assurance measures are important to the 
UKSCB when attempting to introduce standardised testing of banked hESC lines 
which are produced for worldwide distribution. These studies also compared multiple 
genes across a number of biological variables/stem cell lines. Assaying greater 
numbers of genes allows for better statistical significance as well as more accurately 
defining the state of a population of hESCs in long term culture. 
Although early literature characterising hESC gene expression patterns using 
microarray techniques were extremely useful, and gave good insight into the genes 
necessary for maintenance of an undifferentiated phenotype, the studies drew close 
comparison on germ cell tumours and mouse ES cells which have since been well 
characterised and understood to have quite different gene expression patterns 
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(Sperger et al., 2003). Furthermore the studies unveiled a large number of genes 
which clustered together, but at the time had poorly defined functions (Sperger et al., 
2003).  It is now accepted that stem cell cultures are heterogeneous by nature (Graf 
and Stadtfeld., 2008; Narsinh et al., 2011) and understanding their characteristics 
and the genes that govern the switch to early differentiation will be key to identifying 
how to better maintain hESCs in an undifferentiated state and control the 
differentiation of cells by environmental factors which is important for developing and 
standardising robust culture conditions and testing methods. 
Differences between hESC cultured on mouse, human feeders and Matrigel 
From initial screening, overall, there was no difference in maintenance of 
undifferentiated hESC gene expression from RH5, HUES9 and NCL5 when 
comparing cultures on mouse and human feeders and feeder free matrix Matrigel, at 
early and late passage. In general, differentiation markers were absent or at very low 
levels in the hESCs cultures, therefore demonstrating that stemness was still present 
at late passage. Statistical analysis (simple t-test) of each of the data sets organised 
by stem cell line and germ layer determined that overall, there was no significant 
difference between expression of both undifferentiated and germ layer specific  
differentiation genes and the type of matrix used to culture the stem cells from early 
to late passage (stats data). This was further confirmed by 2 way ANOVA and 
General linear model (GLM, p=0.4). This is in concurrence with previous studies 
which have compared the undifferentiated gene expression of hESC growth by 
mouse and human feeder lines (Richards et al., 2003) and feeder and feeder free 
support matrices (Yoon et al., 2010). However, both studies did not employ the sole 
use of enzymes for passaging, and in particular, Richards et al. used a combination 
of mechanical cutting and Dispase to achieve clump passaging, which is more time 
consuming, labour intensive and more difficult to standardise. Also, the studies only 
compared the growth of two similarly derived hESC lines from the same research 
institute (HES-3 and HES-4), whereas the studies described here are less biased in 
this respect, as the three hESC lines are more diverse and from different institutes. 
In addition, although the gene expression studies reported positive results of 
undifferentiated hESC genes, they were not quantitative, signifying that the gene 
expression studies described here are far superior as they are not only quantitative 
but also very sensitive.   
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The studies outlined here demonstrated no significant differences of gene 
expression between both human feeder‘s iMRC5 and iHDFns, in contrast to previous 
studies, which reported that MRC5 foetal fibroblasts were not as supportive as 
foreskin fibroblasts HFF (Richards et al., 2003). Although the studies did report that 
human and mouse feeders vary in their ability to support undifferentiated hESC 
growth, which was subtly observed in chapters 3 and 4, this may have been due to 
variations as a result of mechanical/Dispase passaging, which can certainly result in 
morphological changes of hESCs from passage to passage. hESC cultures on 
Matrigel/mTeSR1 also proved to maintain the expression of undifferentiated genes in 
all three stem cell lines, and overall, gave low expression of differentiation genes. 
Although a slight increase in ectoderm gene expression was detected, this was not 
significant. 
Some less apparent differences between expression of differentiation genes were 
seen from cultures on mouse and human feeders, as RH5 cultures on both human 
feeders appear to designate low level preference of mesoderm and ectoderm 
expression whereas RH5 cultured on mouse feeders i3T3 showed a preference 
towards endoderm, as demonstrated by the upregulation of SOX17 and FOXA2, 
from early to late passage. Upregulation of endoderm genes FOXA2, SOX17 and 
GATA4 was seen from early to late passage for NCL5 cultured on iMEF, iMRC5 and 
Matrigel. Overall, a significant increase in endoderm expression was detected for 
NCL5 cultured on iMEF and iMRC5. Interestingly, slight differences in low level 
ectoderm expression were apparent due to different feeder types, from early to late 
passage. Although these observations demonstrate the subtle effects of culturing 
hESCs on different feeders, they could not be correlated with changes detected from 
all the stem cell lines, and would require directed differentiation studies to confirm 
whether these effects could be sustained. 
Additionally, low level expression of mesoderm genes was highest from NCL5 
cultured on iMRC5 and Matrigel, which increased significantly at late passage 
(greater than 3 fold increase). This may further indicate inherent preferences of stem 
cell lines to act towards specific pathways when cultured in specific way i.e. on 
human feeders which promote attachment, increase in growth factors, and even 
contribute towards the expression of stemness and self-renewal genes. Such 
consistent external events, sustained over long passage could influence gene 
203 
 
expression even at the pluripotent state (Guilak et al., 2009) and provide an 
advantage towards specific lineages when differentiation occurs. Proteomic studies 
of mouse and human feeders have revealed differences in expression of FGF2, 
FGF4, BMP4, activin A and TFGB1 (Greber et al., 2007; Eiselleova et al., 2008). 
Insulin like growth factor binding proteins (IBFBP4) is expressed by mouse 
embryonic feeders STO (Lim and Bodnar, 2002). It has also been reported that 
IGFBP3 and IGFBP6 are expressed in human foreskin fibroblasts (Prowse et al., 
2005). Furthermore, Kueh et al., 2006 reported high expression of FGF-2 and 
gremlin (a BMP4 inhibitor) from fetal skin feeder cells and not from MRC5. This is in 
contrast to the studies here, from which both HDFn and MRC5 demonstrated the 
expression of FGF4, LAMAC1, LAMB1, OCT4, NANOG and brings into question the 
sensitivity of the PCR experiments and analysis parameters used by these groups, 
as the studies here clearly demonstrate the robust and reliable real time PCR 
platform, which further validates these results. 
Gene expression levels were also analysed in individual samples of each feeder type 
used for the long term culture of the hESC lines. This was to provide information on 
whether the feeders were potentially influencing the expression of genes within the 
stem cell lines over long term culture. Interestingly a number of pluripotency and 
differentiation genes were found to be expressed in low levels by both human 
feeders, including OCT4, NANOG, NOGGIN, SOX17 LAMA1, LAMB1 and LAMC1. 
iHDFn also expressed very low levels of COL2A1 which is found in connective 
tissue. Such findings maybe of importance when deciding which feeders to use for 
IPSC derivation studies. Some may provide better starting material than other feeder 
sources, as they exhibit a greater ability for overall attachment, survival and self-
renewal. 
Upregulation of laminins, collagen and fibroblast growth factors in human feeders 
compared to mouse feeders could be significant as it may account for reasons why 
differences in undifferentiated hESC gene expression occurred. It also relates to 
similarities of integrin expression with human cells by providing a better environment 
to mimic hESC growth in vivo, as demonstrated by the co-culture of other cell types 
using human fibroblasts (Shi et al., 2002; Cheng, 2003; Bramono et al., 2010). More 
recent publications have demonstrated the expression of hESC-like properties from 
mouse embryonic feeder line i3T3 (Dadheech et al., 2013) which displayed very low 
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basal expression (between 0.001-0.01) of OCT4, NANOG and SOX2 by q-PCR. 
However, the samples were normalised to mesenchymal stem cells, therefore results 
would not be comparable with hESC lines. In contrast, the studies in this project 
were normalised to early passage hESC lines cultured on iMEF feeders and 
concluded that both the sole preparations of human feeders (without stem cells) 
expressed genes associated with stemness and self-renewal. As demonstrated by 
the heat map, neither mouse feeder iMEF nor i3T3 expressed genes associated with 
stemness or self-renewal.  This information does demonstrate that human feeders 
may be contributing to the long term maintenance of undifferentiated hESCs through 
the expression of stemness gene. Although the effects are not significant, they may 
play a role in differentiation studies. 
Differences in genes expressed for self-renewal, maintenance of 
undifferentiated cultures and potential differentiation towards specific germ 
lineages 
From the results obtained in these studies, expression of Nanog and OCT4 was 
found to be generally higher than for SOX2. This observation is consistent with one 
other report by Adewumi et al. (2007). SOX2 is thought to play a role in 
undifferentiated hESCs and is closely linked in a regulatory loop with NANOG and 
OCT4 (Kuroda et al., 2005; Boyer et al., 2005) but is also expressed in the 
neurectoderm lineage (Uwanogho et al., 1995). A recent publication suggests the 
involvement of OCT4, NANOG and SOX2 in lineage specific commitments when 
differentiated; therefore each factor controls specific cell fates (Wang et al., 2012). 
Low levels of OCT4 can induce ectoderm differentiation, whereas higher levels give 
rise to mesoderm in the presence of BMP4 (Wang et al, 2012). This may indicate a 
process of selection occurring in the three hESC lines investigated in these studies, 
as a result of long term culture and demonstrates the importance of monitoring the 
changes in expression of these master regulator genes when attempting to maintain 
undifferentiated hESC cultures for long periods of time.  
Furthermore, the expression of GATA6 was consistently low across all hESC lines 
used in these studies, GATA6 expression has been associated with early blastocyst 
formation (Koutsourakis et al., 1999) and maintenance of pluripotency and self-
renewal alongside OCT4, NANOG and SOX2 (Adewumi et al., 2007), as well as 
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being upregulated during visceral endoderm formation (Fujikura et al., 2002).  
Although these studies suggest that this gene was not useful in determining the 
undifferentiated state of hESCs cultured in long term passaging using different 
matrices, it does illustrate that using a number of different genes to characterise 
hESCs provides greater confidence when attempting to determine overall cell state. 
Such detailed characterisation is crucial to the consensus as to which specific 
detectors should be used when characterising hESC lines as they are all quite 
individual, and will help to better standardise the use of PCR.  
Correlations in gene expression profiles between stem cell lines 
Expression of early differentiation marker SSEA1 was higher overall, from RH5 
compared with the other cell lines, indicating that a higher proportion of these 
cultures were spontaneously differentiated (overall greater than 10% but less than 
20%). Early indications from the initial gene expression studies may suggest that 
RH5 stem cell line show a preference to differentiate towards early neuronal lineage, 
as demonstrated by upregulation of OLIGO2 and PAX6, and ISL1. Further 
differentiation studies are required to confirm this observation, although this stem cell 
line has already been shown to differentiate to neural lineage through semi directed 
differentiation (M.Gillet, PhD thesis, UCL, 2010). Such suggestions demonstrate that 
some cell lines have inherent preferences to differentiate towards specific germ 
lineages, even when maintained on different feeder types in a mostly undifferentiated 
state, which has been described by other reports (Osafune et al., 2008); however 
without correlation to what percentage of cells were actually differentiated, either by 
cell surface marker SSEA1 or other marker of differentiation. 
Global gene expression analysis by heat mapping revealed that NCL5 and HUES9 
grouped together on both mouse and human feeders, whereas RH5 appeared to 
group by feeder type. Early passage samples also grouped together, at the far left 
side of the heat map and included the majority of NCL5 cultures. HUES9 stem cell 
lines appear in the middle of the heat map, whereas RH5 appears to be scattered 
across the heat map, indicating its spread in expression on different feeder types, 
from early to late passage.  Overall comparison of all three hESC lines show that 
NCL5 appeared to demonstrate more consistent gene expression profile, as cultures 
from both human and mouse feeders (iHDFn and i3T3) grouped together at early 
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and late passage. This further demonstrated slight correlation as a result of cultures 
from mouse and human feeders. 
Genes that grouped together at the top of the heat map included those related to 
adhesion, attachment and housekeeping genes i.e. LAMB1, LAMC1, ACTB, 18S, 
CTNNB1. Genes that clustered in the middle included those involved in regulation of 
self-renewal, pluripotency and housekeeping genes DNMT3B, ZFP42, SOX2, and 
LIN28. NANOG clustered with CRABP2. This demonstrates the shared intrinsic 
properties of different hESCs which has previously been reported (Adewumi et al., 
2007; Sperger et al., 2003). Differentiation genes SOX17, FOXA2, CD34 clustered at 
the base of the heap map and were more strongly expressed by RH5 and HUES9 
cultured on i3T3s, iHDFns and iMEFs, as well as late passage cultures. The 
differences in gene expression between stem cell lines have been described as 
stochastic and heterogeneous by nature (Abeyta et al., 2004; Liu et al., 2006; 
Allegrucci & Young, 2007; Osafune et al., 2008). Hierarchical cluster analysis 
allowed the comparison of such events, particularly to correlate the expression of 
genes as a result of culture on different matrices which may potentially influence 
their microenvironment, which in turn can affect their genetic profiles. The results 
from this study do confirm that early passage stem cell lines group separately to late 
passage stem cell lines, suggesting changes in gene expression as a result of long 
term passaging. Although all the stem cell lines continued to express undifferentiated 
genes at late passage, even when cultured on different feeder types, they were also 
beginning to express low levels of differentiation genes, shared by other late 
passage stem cell lines cultured on mouse and human feeders (HUES9 and RH5 
cultured on iMEFs, iHDFn and i3T3s at late passage), however this was not 
statistically significant. This was consistent with morphological and cell surface 
marker expression results obtained from previous chapters, as all matrices and cell 
types suggested undifferentiated stem cell growth over extended passage. 
Real time PCR is useful for comparing genetic differences between stem cell lines, 
as it is sensitive enough to detect changes as low as 2 fold, which may be useful for 
determining the genetic profile of a hESC line that may be primed to differentiate 
towards a particular germ layer. However, if carrying out PCR on single stem cell 
line, TLDA cards may not be the most cost effective option, and standard, single 
assay PCR in 96 well plate formats would be much more appropriate. A paper by 
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Bock et al (2010) details the genetic characterisation of twenty hESCs and twelve 
IPSCs through the establishment of genome wide reference maps of DNA 
methylation and gene expression. The data was then used to develop score cards 
specifically to indicate whether a stem cell line has differentiated towards a specific 
germ layer.  This information would be extremely useful, as with the TLDA cards it 
removes the guess work required to predict which genes to screen for, and is a 
much more standardised and robust method of comparing many PCR assays. The 
paper also suggests the development of an ES reference cell line, which could 
significantly enhance the standardisation and robustness of gene expression assays 
by real time PCR. In these studies early hESC cultures from iMEF were used as 
control lines. Although this is the best representative of what is currently used as a 
gold standard culture in most laboratories, and also takes into consideration the 
heterogeneity of each hESC line, iMEFs do express low levels of certain genes, as 
mentioned earlier, which could bias the overall results. Reassuringly, screening of 
iMEFs and i3T3 mouse feeders by TLDA cards revealed very little expression of 
genes present on the TLDA card, therefore demonstrating that hESC cultures on 
iMEFs were a better choice than using cultures from human feeders or Matrigel as 
an alternative control. 
The studies carried for this project conclude that late passage cultures of hESCs do 
exhibit changes in gene expression profiles. Such changes were more consistently 
demonstrated across the different stem cell lines in this chapter, in comparison with 
the previous chapters, where differences in morphology and stemness marker 
expression by immunofluorescence were more inherent to the specific cell line 
and/or matrices. Cultures should therefore be regularly screened for a range of 
genes specific to stem cell maintenance as well as those genes involved in 
transcription. This detailed characterisation will allow for the sensitive and robust 
detection of better defined undifferentiated cultures for future studies, particularly 
when deciding which tests to use for potency assays and assuring mechanisms of 
actions (MOAs) when assessing stem cells for therapeutics in early clinical trial 
studies (Bravery et al., 2013). 
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5.5 Conclusion 
 
Although slight differences were seen between the expression of pluripotency genes 
from individual stem cell lines, there was no significant difference between mouse 
and human feeders and Matrigel. Both feeder types and Matrigel maintained 
stemness marker expression in three stem cell lines from early to late passage. This 
is consistent with data obtained from the previous chapters, which confirmed 
undifferentiated hESC cultures by morphology and expression of stemness cell 
surface markers at early and late passage. Overall, the expression of differentiation 
genes from undifferentiated stem cell cultures was lowest from Matrigel cultures. 
Differences involving the expression of genes between different stem cell lines 
appear to be inherent. This is further demonstrated by the early detection of low level 
germ layer specific markers in undifferentiated cultures, at late passage. This would 
suggest that even when undifferentiated, there may be a predetermined preferential 
cell fate within each stem cell line, and would need to be confirmed by directed 
differentiation studies. This preference could be used to the advantage of stem cell 
researchers, with the selection of stem cell lines for particular differentiation studies.  
TLDA cards are easy to prepare and run. They remove the inconsistencies 
frequently found when performing large PCR experiments as the same amount of 
cDNA is loaded onto each card giving robust and reliable data which significantly 
reduces processing error, in comparison to setting up 96 individual PCR reactions 
per sample. They provide a large amount of information on the genetic status of a 
stem cell line using small amounts of cDNA (50 ng), and have proved to be 
particularly sensitive and useful for comparing the genetic integrity of hESCs over 
extended passaging, and identifying trends in gene expression, as demonstrated box 
plot diagrams and global gene expression heat maps.  The analysis of gene 
expression profiles between different stem cell lines on different matrices, help to 
provide a detailed insight into their characteristics as a result of changes in their 
environments over long term passaging. A better understanding of the impact of 
these changes will help to develop more robust culture methods.   
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Chapter 6. 
In vitro directed differentiation of 
human embryonic stem cells to 
early endoderm, mesoderm and 
ectoderm progenitors. 
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6.1 Introduction 
The ability of cells to differentiate into the three germ layers endoderm, mesoderm 
and ectoderm, is key to demonstrating the pluripotency of human embryonic stem 
cell lines. The pluripotent capacity of cultured human embryonic stem cells has 
traditionally been assessed in vivo, by teratoma formation assays (Damjanov, 2005; 
Pal et al., 2007). Although still the gold standard method of testing, this technique is 
notoriously variable, costly and has caused much debate in the stem cell field (Muller 
et al., 2010). In vitro directed differentiation assays, which work by using growth 
factors and small molecules in nutrient enriched media, to drive differentiation 
towards a particular germ lineage and blocking pathways to the other germ layers, 
have gained prominence in stem cell research and suggested as a suitable 
alternative, particularly when trying to progress research without the use of animal 
models (Dressel et al., 2013).  
An extensive amount of research has been focused towards the development of 
differentiation protocols with varying success. Most protocols have been focused 
towards the differentiation of therapeutically relevant derivatives such as 
hepatocytes, cardiomyocytes and dopaminergic neurons.  Many different methods of 
starting differentiation have been reported for instance, differentiation by aggregates 
including embryoid body formation (Kurosawa, 2007), and on adherent plates 
(D'Amour et al., 2005). These assays try to mimic differentiation pathways in vivo to 
give a greater yield and purity of differentiated cell types. It has been argued that EB 
formation is supposed to be a better method of differentiation as it is thought to 
mimic processes in vivo., The selection of appropriately sized EB aggregates has, 
however, been shown to influence differentiation (Bauwens et al., 2008; Hong et al., 
2010) and therefore requires standardising. 
Other protocols have been developed to give rise to specific cell types by stage 
specific processes, for example, dopaminergic neural differentiation of human 
pluripotent stem cells by dopaminergic neuron induction, differentiation, specification 
and maturation (Chambers et al., 2004) and cardiomyocyte differentiation by careful, 
stepwise cell signalling using BMP4 and Wnt/Activin A (Sa & McCloskey, 2012; 
Kattman et al., 2011; Burridge et al., 2011).  
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The use of novel growth factors and small molecules alongside new information on 
differentiation pathways play a significant role in the development of new 
differentiation protocols (Chambers et al., 2009; Surmacz et al., 2012; Song et al., 
2012). Some protocols describing differentiation to neuroectoderm are heavily 
influenced by dual inhibition of SMAD signalling (Chambers et al., 2009) which uses 
a drug, SB431542, and Noggin, both of which have been previously used for the 
neural conversion of hESCs. 
A publication by D‘amour et al. demonstrated the in vitro differentiation of hESCs to 
endoderm by Wnt signalling from adherent cultures, which is differentially expressed 
at critical stages during liver development in vivo (Hay et al., 2008) and Activin A 
growth factor, which works by suppression of signalling from phosphatidylinositol 3-
kinase (PI3K) protein (Mclean et al., 2006; D‘amour et al., 2005). Both protocols 
utilise mechanisms to block signalling pathways that are important to both 
maintaining pluripotency and promoting differentiation and report dramatic changes 
in gene expression profiles (D‘amour et al; Chambers et al., 2009). However, both 
reports show only upregulation of very select lineage specific genes following in vitro 
directed differentiation of adherent flat cultures.  
Scientists are aware of the effect that microenvironment can contribute in promoting 
differentiation, and although it is too early to control all the variables, many published 
techniques describing in vitro differentiation methods detail the use of specific 
matrices that aid the induction of differentiation through cell-matrix interactions. Poly-
L-orthinine (PLO), vitronectin, and fibronectin (Prowse et al., 2010; Hu et al., 2009; 
Chen et al., 2012; Passier & Mummery, 2005; Lecina et al., 2010)  have all been 
reported to give rise to the formation of specific progenitor types including glial-like 
neurons and visceral endoderm (Iskovitiz-Eldor, 2002; Reubinoff et al., 2001, Braam 
et al., 2009). Feeders have also been shown to aid differentiation in hESCs. The co-
culture of hESCs with stromal cells to promote differentiation to haematopoietic cells 
has been used for many years (Vodiyanik et al., 2005). Visceral endoderm (VE) like 
cells from mouse has been used for cardiomyocyte induction (Mummery et al., 
2003), and although the co-culture proved successful in the production of 
cardiomyocytes from hESCs, the exact function of the mouse VE was not clarified, 
as effects of FGFs were not discussed, and it was thought that activation of BMP4 
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signalling, important for formation of mesoderm, was also not the sole contributor of 
the VE cells (Mummery et al., 2003). 
The establishment of robust and standardised differentiation methods to efficiently 
demonstrate pluripotency is important to all research labs maintaining cultures of 
undifferentiated hESCs on a routine basis. Currently there is no published work 
describing the direct comparison of in vitro differentiation assays from adherent plate 
based methods and embryoid body formation. Moreover, it is not clear how 
differentiation may be regulated following prolonged culture of stem cells on specific 
matrices. The studies outlined in this chapter therefore demonstrates three simplified 
directed differentiation protocols that use an adherent plate method, for the formation 
of early neural, mesoderm and endoderm progenitors, to efficiently establish the 
pluripotent capacity of NCL5 stem cell line pre-cultured on human feeders iMRC5, 
mouse feeders iMEF and feeder free matrix Matrigel following extended passaging 
using TrypLE™ Express (20 passages). These directed differentiation studies are 
the first to be developed in the host laboratory. To give a reliable account of the 
differentiation potential of NCL5, non-directed differentiation studies by embryoid 
body (EB) formation from Matrigel cultures was also assessed, following 7 day 
growth in Knockout serum replacement media (KSR). This method was adapted 
from the low adherent spin plate method described by Ng et al., 2008. The method 
here describes the use of aggrewell™ spin plates from Stem Cell Technologies 
(Antonchuk, J., 2013). 
 
 
 
 
  
213 
 
6.2 Materials and Methods 
6.2.1 Formation of Embryoid bodies using Aggrewell™ and culture in KSR  
Embryoid bodies were formed by single cell dissociation using TrypLE™ Express  for 
5 minutes, then Ro kinase inhibitor Y-27632 (RoK)  at 10µM was added, before 
determining the optimum cell number for using the Aggrewell plates (2.4x106 cells 
per well). RoK increases survival of single cells and improves aggregation by 
reducing dissociation induced-apoptosis and increasing cloning efficiency (Stem Cell 
Technologies Technical manual Aggrewell™, Watanabe et al., 2007). The plate was 
spun down to allow aggregates to form which, following 24 hour incubation, formed 
uniform EBs. These were then cultured in EB formation media (see Table 6.1) using 
non adherent 10 cm2 petri dishes for 7 days. Images were taken on day 7 to assess 
EB health and record whether they had grown in size or changed in morphology. The 
images in Figure 6.2 demonstrate the successful formation of NCL5 into Embryoid 
bodies using aggrewell 800 plates, giving 3000 EBs per well. Embryoid bodies were 
collected by careful pipetting and transferred through a 20µm reversible sieve (Stem 
Cell Technologies) to remove single cells, then centrifuged at 300 g for 3 minutes to 
pellet cells. Supernatants were removed and RNA extracted as described in the 
general methods chapter (section 2.10.1). The cDNA was produced as described in 
general methods chapter (section 2.10.3). RT-PCR was prepared in 96 well plate 
format, and ran on the Quantstudio Thermocycler (Life Technologies) using germ 
lineage specific Taqman probes (Life Technologies, see appendix).  
 
Table 6.1 Reagents used for the culture of EBs 
Reagent  Supplier concentration 
KRS knockout Invitrogen  
Glutamax Invitrogen 1% OF 5Mm 
FCS Biosera  2% 
NEAA Invitrogen 0.1% 
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6.2.2 In vitro directed differentiation of NCL5 using flat based cultures 
Stem cell line NCL5 at late passage (p50 to p53) were cultured on Matrigel using 
MTeSR1 Media, iMEF mouse feeders and iMRC5 human feeders, to 70-80 % 
confluency over 5-7 days. Two wells from each culture were TrypLE™ Express  
treated to give single cells (yielding on average 5x105 cells/mL), then plated onto 
Matrigel coated plates in KSR media supplemented with RoK. Cells were incubated 
and allowed to reach 70-80% confluency (approximately 2 days) before treatment 
with lineage specific media (growth factors and small molecules). Media was 
changed every 2 days, and cells were imaged to record changes in morphology 
throughout the differentiation process. Cells were collected for RT PCR at day 7, by 
scraping using Falcon cell scraper, then centrifuging at 300 g for 3 minutes to pellet. 
The supernatant was removed and cells underwent RNA extraction and cDNA 
production (general methods section). RNA from NCL5 cultured on its original matrix 
at early passage (generally, p35) were used as controls and stored at -80°C until 
used for RT PCR. PCR plates were sealed and centrifuged at 300g for 5 minutes 
then loaded onto Viia7 Real time PCR Thermocycler.  
 
6.2.5 In vitro Endoderm differentiation 
Endoderm differentiation was carried out using hESCs transferred to Matrigel (as 
described above) in the presence of Activin A and Wnt3a, as described by D' Amour 
et al. (2005). At 70-80% confluency their standard media KSR was replaced with 
KSR supplemented with 1%, Activin A and Wnt3a for 3 days, as shown in Table 7.2. 
After 3 days Wnt3A was removed.  The cells were cultured for 7 days, then collected 
for real time PCR to assess for the upregulation of SOX17, FOXA2, Brachyury, AFP, 
CXCR4, ISL1, GSC and DCN.  
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Table 6.2 Reagents used for in vitro endoderm differentiation 
Reagent  Supplier concentration 
KRS knockout Invitrogen  
Glutamax Invitrogen 1% OF 5Mm 
FCS Biosera 0.2%, 2% 
Activin A R & D systems 100ng/ml 
Wnt3A R & D systems 25ng/ml 
 
6.2.4 In vitro neuroectoderm differentiation 
Neuroectoderm differentiation was carried out using adherent plate method based on 
the publication by Chambers et al. (2009). The stem cells were seeded at 2x105 
cells/mL and reach 70-80% confluency (1-2 days) on Matrigel in KSR and then 
cultured in neural media containing KSR, noggin, Dorsmorphin and SB431542 made 
up as indicated in Table 7.3. The media was changed every other day, for 7 days. 
Stem cells were monitored each day for morphology changes and collected for Real 
Time PCR on day 7 to assess for the upregulation of neural genes SOX1, PAX6, 
Hes5, OXT2, FOXG1, NEUROD1 and down regulation of stemness markers OCT4 
and Nanog.  
 
Table 6.3. Reagents used for in vitro neuroectoderm differentiation 
Reagent Supplier concentration 
KRS knockout Invitrogen  
SB431542 Tocris 10 uM 
Dorsmorphin Tocris 600 nM 
Noggin Invitrogen 50 ng/ml 
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6.2.6 In vitro Mesoderm differentiation 
hESCs were prepared for in vitro differentiation as described above. At 70-80% 
confluency, cells were treated with BMP4/Activin A in KSR for 7 days (So et al., 
2011). The media was changed every 2 days. Cells were assessed for 
morphological changes and images recorded on day 0, 3, and 5. Samples for RT 
PCR were collected at D7. RT PCR plates were prepared as described above, with a 
defined set of specific probes. HAND1, Pecam1, Col1a1, Brachyury, FGB, BMP4, 
GATA4, Desmin, Vimentin, PDGFRa and PITX1 were chosen by preliminary 
screening of other early in vitro differentiated hESCs in house, and recent literature 
searches. cDNA was made as described in general methods chapter. Samples were 
prepared for Real time PCR with relevant TaqMan probes and gene expression 
Master Mix (Applied Biosystems) as shown in table 6.4. 
 
 
Table 6.4. Reagents used for in vitro mesoderm differentiation 
Reagent  Supplier concentration 
KRS knockout Invitrogen  
Glutamax Invitrogen 1% OF 5Mm 
BMP4 R & D systems 40 ug/ ml 
Activin A R & D systems 10 ng/ml 
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6.2.3 Analysis of real time PCR results 
Visualisation and pre-analysis was carried out using the QuantStudio software.  PCR 
runs were normalised to the reference gene GAPDH, and calibrator sample, to 
determine delta delta Ct values and results visually examined to remove non 
amplified genes/genes above 40 cycle limit. Further analysis was completed on 
Gene Expression software (life Technologies, version 1.1). Samples were grouped 
and normalised by three stable reference genes, then analysis of results carried out 
by heat map using two way Pearson‘s correlation, to show trends in gene 
expression, organised by germ lineage, significant to 3 fold change.  Results were 
also imported into GraphPad Prism (version 5) software and organised into bar 
graphs to give (geometric) mean relative quantity of gene expression (RQ), 
comparable to a calibrator sample which was automatically set to a value of 1, by the 
QuantStudio software (normal i.e. NCL5 cultured on iMEF feeders, early passage). 
 
 
Table 6.5.  Gene expression Mastermix  
 Gene expression Mastermix 10 
H20 7 
cDNA 2 
Probe 1 
Total volume per well 20 µL 
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6.2.7 Data analysis 
Relative quantification values (RQ) were determined by comparison of delta Ct 
values with a calibrator sample. This was taken as the undifferentiated hESC line 
cultured on feeder type/matrix at early passage i.e. NCL5 cultured on Matrigel p35 
and was set to a value of 1. Initial data was collected from Quantstudio software (Life 
Technologies). RQ values were exported into Prism and SD/MEAN RQ values 
calculated and displayed in bar graphs. Results were also imported into 
ExpressionSuite (Life Technologies) for the comparison of gene expression from 
different matrices, and for the construction of heat maps and volcano plots, to give 
visual comparisons of the different matrices and expression of germ lineage specific 
genes. 
6.2.8 IF staining using TissueFaxs™ 
SOX17, DCN, Vimentin, Hand1, PAX6 and Nestin were all used to confirm the 
presence of early progenitor cells following directed differentiation to all three germ 
layers (Abcam, 1/100 dilution). 
 
Late passage NCL5 from the three different culture conditions were cultured in 24 
well Matrigel coated plates until confluent. Each plate was treated with endoderm, 
mesoderm and ectoderm specific media, as described above, for 7 days. The media 
was changed every 2 days. After 7 days, spent media was carefully removed, cells 
washed in PBS and fixed/permeabilised in cold acetone: methanol solution (1:1) for 
8 minutes. Cells were then carefully washed in PBS, and then blocked with 10% 
FCS (in PBS) for 10 minutes. Cells were carefully washed again, before incubation 
with germ layer specific primary antibody, overnight at 4°C. Following primary 
antibody incubation, cells were carefully washed twice with PBS then incubated with 
1/200 dilution of goat anti-mouse FITC conjugated secondary antibody, Abcam for  
Vimentin and Nestin,  (CY5) rabbit anti-mouse, DCN and Hand1 for 2-3 hours at 
room temperature. Cells were again carefully washed in PBS, counter-stained with 
DAPI nuclear stain for 3-5 minutes before washing in H20, then carefully 
resuspended in 200 µL of WashBuffer. Images were acquired on the TissueFaxs™ 
fluorescence imaging system and analysed using TissueQuest™ software to give 
quantitative assessment of germ lineage specific cell markers.  
219 
 
 
6.3 Results 
6.3.1 Non directed differentiation of stem cell line NCL5 from Embryoid bodies 
The photographs in Figure 7.1 demonstrate the successful formation of EBs from 
Aggrewells, following 7 days of culture in KSR media.  The EBs obtained at day 1 
appeared well formed and mostly symmetrical (Figure 6.1A). However, after 5 days 
in culture EBs attached as small aggregates to the dish and displayed signs of 
proliferation, becoming slightly larger in size (Figure 6.1B). On day 7 the EBs were 
beginning to disassociate and appeared shrunk (Figure 6.1C).  
RT PCR gave interesting results, as expression of all endoderm genes were 
downregulated. Only ectoderm genes NEUROD1 and SOX1 and mesoderm gene 
HAND1 were upregulated after 7 days but there was consistent expression of 
stemness genes OCT4 and Nanog over this period (Figure 6.2). This may indicate 
that the cells did not fully differentiate to all three germ layers as aggregates. The EB 
experiments were eventually discontinued and flat based in vitro directed 
differentiation experiments set up to assess the robust formation of all three germ 
layers in NCL5.  
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Figure 6.1. Morphology of EBs in KSR media from the stem cell line NCL5 at 
day 1 (A), 5 (B) and 7 (C).  Late passage NCL5 cultured on Matrigel were subjected 
to EB formation in Aggrewell plates as described in the methods sections. EBs were 
transferred to 10 cm2 dishes for 7 days of culture in KSR media. Images were taken 
at x4 magnification using a phase contrast light microscope. Scale bar = 50 µm. 
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Figure 6.2. Gene expression profile of EBs derived from the NCL5 stem cell 
line after 7 days of culture in KSR media.  EBs made from NCL5s cultured on 
Matrigel at late passage were assessed for the expression of germ layer specific 
differentiation genes by real time PCR. The results are the geometric average of 
three individual experiments.  
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6.3.2 Flat based in vitro directed differentiation of NCL5 stem cells to early 
endoderm 
Differences in morphology as shown in Figure 6.3 at day 3, 5 and 7 from late 
passage NCL5, which had previously been cultured from iMEF mouse feeders (A), 
iMRC5 human feeders (B) and Matrigel (C).  Considerable cell death was observed 
from all cultures at day 1 and 2 when initially subjected to the differentiation media. 
By day 3 cultures appeared to have recovered and were proliferating. Although 
hESCs continued to proliferate mostly as discreet colonies, changes around the 
edges of colonies were apparent, as individual cells became more angular and 
square in shape. The morphological changes were more obvious at day 5. hESCs 
also appeared to proliferate as large flat colonies, becoming sheets at day 7 with 
considerable cell piling and some cell death. Morphological changes were still visible 
and cells were much more angular from all three culture conditions. More piling and 
differentiation was seen from NCL5-iMRC5 (Figure 6.3 A) in comparison to the other 
two conditions, potentially indicating increased proliferation. 
Gene expression studies demonstrated upregulation of the majority of endoderm 
genes by NCL5 cultures from all three matrices. The highest upregulated genes on 
all three matrices were GSC, FOXA2 and AFP but ISL1 and SOX17 were 
significantly upregulated (Figure 6.4) in cells cultured on both feeder types (100 log10 
fold or greater). Endoderm gene expression was lower in Matrigel cultures when 
compared to cultures from both human and mouse feeders, with the only exception 
being the expression of Brachyury which was significantly higher. Interestingly, 
transcription factors POU5F1 and NANOG were downregulated but only in iMEF 
mouse feeder cultures. Upregulation was found from iMRC5 human feeder and 
feeder free Matrigel hESC cultures. This may indicate a heterogeneous population of 
hESCs therefore not all cells underwent directed differentiation. 
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          DAY 3      DAY 5    DAY 7 
 
Figure 6.3. Morphological changes of stem cell line NCL5 following in vitro 
directed differentiation to endoderm from prolonged culture on iMEF mouse 
feeders (A), iMRC5 human feeders (B) and Matrigel (C) at day 3, 5 and 7.  
Images are representative of 3 independent experiments and were taken with a light 
phase contrast microscope at x4 objective. Scale bar =50µm. 
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Figure 6.4. Gene expression profile in the NCL5 stem cell line following in vitro 
directed differentiation to early endoderm.  NCL5s cultured on iMEF mouse 
feeders, iMRC5 human feeders and feeder free Matrigel at late passage were plated 
as single cells onto Matrigel coated plates, then subjected to flat based in vitro 
directed differentiation for 7 days. Cell pellets were collected for real time PCR 
analysis using germ layer specific probes as described in the methods. The results 
are the geometric average of three individual experiments. The results are 
representative of 3 independent experiments. 
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6.3.3 Flat based in vitro directed differentiation of NCL5 stem cells to early 
mesoderm 
Striking morphological changes were seen as a consequence of in vitro directed 
differentiation over 7 days (Figure 6.5). NCL5s from both feeders appeared as 
discreet colonies at day 3, with observed changes at the edges. Matrigel cultures on 
the other hand grew as single cells, with areas of large flattened sheets of cells 
forming. At day 5 changes were very apparent with populations of cell colonies 
forming. Some individual cells were almost squamous in appearance with very 
prominent nuclei, others grew in swirls and piled, forming thick long differentiated 
structures. Matrigel and NCL5-iMEF cultures appeared to proliferate much faster 
than NCL5-iMRC5 cultures. At day 7, differences between all three culture conditions 
were seen. Small, thickened structures were visible from Matrigel cultures. NCL5-
iMEF cultures were much flatter but overgrown with small darkened areas of 
differentiation which appeared to be forming 3D structures. NCL5-iMRC5 cultures 
were more overgrown than the other two culture conditions with ring like structures 
forming as a result of cells proliferating and piling to form structures.  
The gene expression data showed upregulation of DESMIN, BMP4 and significantly 
high upregulation of HAND1 and PTX1 (greater than 100 log fold) were detected 
from all culture conditions, relative to the control (Figure 6.6). Almost all other genes 
were upregulated from both feeder cultures. Significant upregulation of FGB was 
also seen from both feeder cultures. Slight downregulation of Nanog was detected 
from all culture conditions. Matrigel and iMRC5 cultures maintained expression of 
OCT4, relative to the control. 
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DAY 3   DAY 5   DAY 7 
 
Figure 6.5. Morphological changes of stem cell line NCL5 following in vitro 
directed differentiation to mesoderm from prolonged culture on iMEF mouse 
feeders (A) iMRC5 human feeders (B) and Matrigel (C)  at day 3, 5 and 7 . 
Images are representative of 3 independent experiments and were taken with a light 
phase contrast microscope at x4 objective. Scale bar = 50 µm. 
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Figure 6.6. Gene expression of stem cell line NCL5 following in vitro directed 
differentiation to early mesoderm. NCL5 at late passage cultured on iMEF mouse 
feeders, iMRC5 human feeders and feeder free Matrigel were plated as single cells 
onto Matrigel coated plates, then subjected to flat based in vitro directed 
differentiation for 7 days. Cell pellets were collected for real time PCR analysis using 
germ layer specific probes, as described in the methods. The results are the 
geometric mean of three individual experiments. Variations in mesoderm gene 
expression were detected from late passage NCL5 cultured on three matrices, at day 
7. Cultures on Matrigel had lower expression compared with both feeders.  
Significant upregulation of FGB, HAND1 was seen from all cultures. iMEF mouse 
feeders and  iMRC5 demonstrated upregulation of most mesoderm genes (n=3). 
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6.3.4 Flat based in vitro directed differentiation of stem cell line NCL5 to early 
neuroectoderm 
Images from Figure 6.7 show that NCL5 from iMRC5 feeder cultures appeared much 
sparser at day 3 (B), in comparison to the other two matrices. NCL5-Matrigel cultures 
displayed less defined colonies (C), in comparison to NCL5-iMEF colonies, which 
still appear as discreet colonies (A) comprised of small flat cells. By day 5 changes in 
morphology were more apparent in all cultures. hESCs were more visible as single 
cells, smaller in size compared with individual stem cells and with larger nuclei. 
Cultures from Matrigel appeared more settled than feeder cultures, proliferating well 
with little cell death. More cell death was seen from NCL5- iMEF cultures. On day 7 
cell piling was visible from NCL5-iMRC5, though proliferating cells underneath still 
displayed characteristic changes. NCL5-iMEF cultures appeared to have stabilised, 
with not much death visible. Stem cell cultures from Matrigel had begun to detach in 
some areas, with others displaying early neural rosette formation. 
Quite varied gene expression was detected across the three matrices, with 
upregulation of FOXG1 in all cultures (Figure 6.8). Upregulation of NESTIN, PAX6, 
B3T, NEUROD1 and HES5 were detected from both feeder cultures. Differences 
between human feeder and mouse feeder cultures unveiled the highest upregulation 
of ectoderm genes FOXG1 and NESTIN from NCL5-iMEF cultures, whereas 
NeuroD1 and SOX1 were further upregulated from NCL5-iMRC5 cultures. 
Expression of POU5F1 and Nanog were only downregulated from Matrigel cultures. 
Matrigel cultures gave significant upregulation of FOXG1, with little upregulation of 
other genes. Whereas both feeder cultures displayed upregulation of all ectoderm 
genes with iMRC5 cultures showing higher upregulation in comparison to iMEF 
cultures. Downregulation of OCT4 and NANOG was only demonstrated by Matrigel 
cultures. 
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  DAY 3   DAY 5   DAY 7 
 
Figure 6.7. Morphological changes in stem cell line NCL5 following in vitro 
directed differentiation to ectoderm from iMEF mouse feeders (A) and iMRC5 
human feeders (B) and Matrigel (C)  at day 3, 5 and 7. Images were taken with a 
light phase contrast microscope at x4 objective. Scale bar = 50 µm. 
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Figure 6.8. Gene expression of stem cell line NCL5 following in vitro directed 
differentiation of NCL5 to early ectoderm. NCL5 at late passage cultured on iMEF 
mouse feeders, MRC5 human feeders and feeder free Matrigel were plated as single 
cells onto Matrigel coated plates, then subjected to flat based in vitro directed 
differentiation for 7 days. Cell pellets were collected for real time PCR analysis using 
germ layer specific probes, as described in the methods. Clear differences in 
upregulation of ectoderm genes were detected as a result of culture on different 
matrices. (n=3).  
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6.3.5 Effects of different matrices for prolonged culture of NCL5 stem cells on 
gene expression from three germ layers using Heat map analysis 
 
Comparison of genes expressed from each germ lineage from differentiated NCL5 
previously cultured on mouse feeders iMEF, human feeders, iMRC5 and feeder free 
matrix Matrigel was performed using ExpressionSuite software. Gene significance 
was set to <3 fold, based on the average change between endogenous controls from 
each sample type.  Figure 6.9 A reveals different expression profiles from all three 
differentiated samples at day 7 (D7). All endoderm genes were upregulated across 
all three samples, with stronger upregulation of the genes FOXA2 and GSC from 
NCL5-iMEF and NCL5-Matrigel samples. 
Expression of ectoderm genes revealed slight correlation across the samples from 
different matrices, demonstrated by upregulation of SOX1, HES5 and PAX6. 
Expression of OTX2 was downregulated in NCL5-iMEF and NCL5-Matrigel, with 
NCL5-iMRC5 showing very slight upregulation (Figure 6.9 B).  
Expression of mesoderm genes showed greatest correlation compared with the 
other germ layers. Pearson‘s‘ correlation revealed all three samples showed linked 
expression of mesoderm genes, with NCL5 from both feeder types iMRC5 and iMEF 
showing closer correlation than NCL5-Matrigel, which had a more distinct gene 
expression profile from the other two samples. Expression of Brachyury was strongly 
upregulated in all samples, followed by upregulation of FGB, Pecam1, PDGFRA, 
Desmin and DCN. Differences in HAND1, Vimentin and COL1A1 were detected, with 
downregulation of the latter two genes. 
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Figure 6.9. Heat map demonstrating correlation of differentiated gene 
expression to endoderm (A), ectoderm (B), and mesoderm (C), from late 
passage NCL5 stem cells cultured on Matrigel, iMEF and iMRC5.  
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6.3.6 TissueFaxs™ analysis of expression of protein markers for each germ 
lineage following in vitro directed differentiation 
Fluorescent images of nuclear and cell surface markers were assessed following in 
vitro directed differentiation to all three germ layers. Positive expression of markers 
was observed from all cultures. Expression of mesoderm markers Vimentin and 
Hand1 and endoderm markers DCN, FOXA2 and SOX17 were strongest. 
Expression of PAX6 and NESTIN were detected (Figure 6.10), but with weaker 
expression from NCL5-iMRC5 cultures. Although Nestin gene expression was found 
to be low in Matrigel cultures, it was expressed at protein level. Very obvious 
changes in morphology were observed. However, piling from all cell cultures was 
detected, which made image acquisition and analysis difficult.  
TissueFaxs™ images also allowed the comparison of morphology across the three 
different matrices. Initially no obvious differences could be seen when imaging. 
However, differences in the parameters applied to detect each matrix type had to be 
applied during TissueFaxs analysis, indicating that subtle changes were apparent as 
a result of influences from their culture environments. Figure 6.10 showed that 
NCL5-iMEF and NCL5-iMRC5 differentiated cells were slightly larger and elongated, 
whereas overall, Matrigel cells were smaller. Furthermore, the amount of 
differentiated cells for each germ lineage marker was quantified using TissueQuest. 
Figure 6.10 also revealed that all three matrices displayed greater than 60% positive 
expression of germ lineage specific markers. NCL5-iMRC5 exhibited the lowest 
expression of SOX17, HAND1and NESTIN and NCL5-Matrigel, the highest 
expression. 
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             iMEF        iMRC5        MATRIGEL  
                    
     
hESC-Matrix Endoderm  
% SOX17 (A) 
Mesoderm  
% HAND1 (B) 
Ectoderm  
% NESTIN (C) 
NCL5-iMEF 84.60 83.30 82.19 
NCL5-iMRC5 58.11 60.88 75.15 
NCL5-MATRIGEL 91.20 78.80 94.20 
 
Figure 6.10. TissueFaxs analysis of differentiation markers expressed in NCL5 
stem cells pre-cultured on iMRC5 human feeders, iMEF mouse feeders and 
feeder free matrix Matrigel.  Panel A shows early endoderm marker SOX17, Panel 
B the mesoderm marker HAND1 (purple) (Green) and Panel C the ectoderm marker 
Nestin. The results are representative of two independent experiments. Cells imaged 
at x20 objective. Scale bar: 100µm. 
A 
B 
C 
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6.4 Discussion 
In vitro differentiation assays are useful and important for demonstrating the 
pluripotent nature of hESCs by formation of early progenitor cells from all three germ 
layers. Quantitative methods real time PCR and TissueFaxs™ image analysis 
proved successful for the assessment of human feeders‘ iMRC5, mouse feeders‘ 
iMEF and feeder free Matrigel, to support the pluripotent nature of NCL5 at late 
passage (p58) as they were still able to differentiate. Following a 7 day in vitro 
directed differentiation assay, stemness genes were down regulated and 
differentiation genes upregulated for endoderm, mesoderm and ectoderm. This 
demonstrated that that all conditions supported the directed differentiation of NCL5 
towards each germ layer, which is in concordance with the papers from which these 
methods were derived (D‘amour et al., 2005; Chambers et al., 2009; Sa et al., 2011). 
Results confirmed that NCL5 formed consistently good EBs. Non directed 
differentiation in KSR media after 7 days showed upregulation of ectoderm 
transcription factor genes Neurogenic differentiation 1 (NEUROD1) and Sex 
determining region Y-box 1 (SOX1). Neurod1 is involved in regulating expression of 
the insulin gene. SOX1 expression is restricted to neuroectoderm. Mesoderm gene 
Heart and neural crest derivatives-expressed protein 1 (HAND1), was also 
significantly upregulated (<3 fold). HAND1 is uniquely expressed in trophoblasts. 
Upregulation of ectoderm genes was consistent with results from chapter 6 in the 
undifferentiated NCL5 cultures from Matrigel at early and late passage. However, all 
endoderm genes were down regulated. Furthermore OCT4 expression was not 
downregulated and Nanog only slightly downregulated. This demonstrated that EBs 
were not a suitable starting material for these differentiation studies. This may have 
been due to NCL5 lack of ability to form aggregates at such late passage, due to 
acquirement of chromosomal aberrations, as shown in chapter 4. Longer EB studies 
may demonstrate greater upregulation of germ lineage specific markers, as effects of 
high FGF levels from Matrigel/mTeSR1 and feeders may also slow or lessen the 
effects of non-directed differentiation as aggregates. Many differentiation protocols 
use spontaneous differentiation experiments to demonstrate a heterogeneous 
differentiation population following the formation of EBs (Xu, C., et al, 2001. However 
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some reports have shown that expression of germ lineage specific genes can vary 
up to 400 fold between EBs formed for non-directed differentiation experiments at 
day 16 from different hESC lines (Osafune et al., 2008). 
Differences between the gene expression of differentiated NCL5 pre cultured on 
feeder and feeder free matrix were observed. Although gene expression studies 
showed most ectoderm, mesoderm and endoderm genes were upregulated, each 
NCL5 condition exhibited individual gene expression profiles as a result of prolonged 
culture on different feeder type.  
Differences in the correlation of samples from different matrices were dependant on 
the expression of germ layer specific genes. Only mesoderm gene expression 
proved to show a greater correlation across the three samples, possibly indicating 
that they all utilise signalling mechanisms which act on the same pathway, or that the 
strength of the inducing factors used were sufficient to overcome the inherent 
differences between the NCL5 cultures as a result of prolonged culture on different 
matrices.  Statistical analysis demonstrated stronger correlation of mesoderm gene 
expression from mouse and human feeder cultures, when compared with Matrigel 
cultures. This is probably due to the secretion of growth factors from feeders which 
could be enhancing the differentiation towards early mesoderm. Profiling of feeders 
from chapter 6 revealed the expression of FGFs, and laminins by human feeders 
when compared to mouse, which clearly demonstrates the difference in ability to 
support undifferentiated hESC growth and also influence in vitro differentiation. It is 
not surprising that interactions with FGFs and Activin A secreted from feeder sources 
can have varied effects on gene expression profiles, as both types of growth factors 
are known to have close involvement in Wnt and SMAD signalling pathways 
(Rajasekhar and Vemuri., 2009). The results demonstrated that the intrinsic effects 
of prolonged culture on different feeders were sustained, even when the cells were 
transferred to Matrigel for one passage. To our knowledge this has not been 
reported before and is a novel finding. 
The use of feeders in co culture has previously been explored and suggested as a 
better alternative to synthetic matrixes as they are thought to more closely mimic in 
vivo interactions as a result of stronger integrin binding and better reorganisation of 
ECM proteins. This results in both faster upregulation of germ layer specific gene 
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expression and morphological changes, when compared to synthetic matrices, as 
shown in Figure 6.6. This may also account for the differences in germ layer specific 
gene expression between NCL5 cultured on three different matrices, as NCL5s 
cultured on feeders showed a much wider range of germ lineage specific marker 
expression as well as overall higher expression, compared to Matrigel. This 
demonstrates that differences in differentiation propensity are not limited to 
differentiation into germ lineage. Such findings have already been shown by 
differences in frequency of EB formation between HUES3 and HUES1 cell lines 
(Osafune et al., 2008). Striking differences in morphology and of germ layer specific 
genes expression were confirmed as a result of consistencies between biological 
repeats, and the decision to use a greater number of differentiation genes than those 
which are commonly published for such an assay. The results show that iMRC5 
human feeders and iMEF mouse feeders demonstrated upregulation of a greater 
number of mesoderm, endoderm and ectoderm genes, in comparison to Matrigel 
cultures. Matrigel cultures gave stronger upregulation of mesoderm and endoderm 
genes with a greater number of endoderm genes expressed in comparison to the 
other germ layers. Ectoderm genes were relatively low, with the exception of FOXG1 
which was highly expressed. When compared to chapter 6, undifferentiated hESCs 
on Matrigel demonstrated slight tendency toward ectoderm differentiation, as these 
genes were slightly upregulated. 
The influence of using different matrixes to induce and enhance differentiation 
towards specific germ layers has been explored. Matrices such as Vitronectin 
(Prowse et al., 2010, Mummery et al., 2008) and co-culture with stromal cells have 
been shown to increase differentiation potential to haematopoietic lineage. To our 
knowledge, this the first study to demonstrate the influence of iMRC5 human feeders 
and iMEF mouse feeders in comparison to Matrigel, to increase differentiation ability 
to different germ layers.  
Proteomic analysis of human feeders has revealed the expression of col1a1 and 
BMP4, both of which have been shown to be upregulated in mesoderm 
differentiation.  Furthermore, analysis of mouse feeders has shown higher levels of 
activin A compared with human feeders, which expressed higher levels of FGF2 
(Eiselleova et al., 2008). Such differences over long term culturing have resulted in 
the difference in genes expressed following in vitro differentiation in the experiments 
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described here as these growth factors play synergistic roles in blocking and 
enhancing specific germ lineages. Understanding the signalling effects of co-culture 
cells on differentiating hESCs in vitro is vitally important for understanding the 
mechanisms that hESCs differentiate in vivo, so the properties of the feeders can be 
better exploited. The process of differentiation is thought to be stage specific, 
therefore by mimicking the supporting or co-culture cells, a better understanding of 
the signalling required to induce such changes can be more accurately repeated in 
vitro, helping to progress this area of research. Such research has been recently 
revisited, to investigate the differentiation of hESCs to mature pancreatic islet cells 
using endothelial coculture (Jaramillo & Bannagi., 2012). This illustrates the benefits 
of co-culture in spite of consistent efforts to use feeder free matrices, as scientists 
clearly recognise that fibroblasts can be used to mimic external micro environmental 
signalling cues for successful differentiation. 
The studies performed here demonstrate the sustained benefits of coculture 
achieved by pre-co-culture of hESCs with feeders, even after transfer to Matrigel for 
one passage. This reduces the method time as it removes the need for adjusting 
cultures onto feeder free matrices before initiating differentiation. More simplistic and 
straight forward culturing methods need to be progressed for standardisation and 
clinical application, particularly when screening a number of different hESC lines. 
NCL5s cultured on Matrigel did exhibit changes in morphology that were typical for 
early endoderm and neural differentiated cells. However, at mRNA level this 
expression was low, particularly when compared to NCL5 cultured on mouse and 
human feeders.  
hESCs cultured on Matrigel have been reported to take longer to differentiate 
compared to those cultured on mouse feeders (Xu et al., 2005). Some degree of this 
observation was demonstrated in these studies. Although NCL5s from pre-cultured 
Matrigel did exhibit both morphological and genetic changes consistent with directed 
differentiation, the cultures did not show as increased upregulation of differentiation 
markers compared with pre-cultured hESCs from both mouse and human feeders. 
Other explanations as to why Matrigel cultures were not as successful in promoting 
differentiation reside with the components within Matrigel/mTeSR1 media. High 
levels of bFGF have been shown to inhibit differentiation (Xu et al., 2005). Although 
Matrigel does consist of ECM, there may be smaller, but more important growth 
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factors and proteins which are lost during commercial preparation, which although 
are not necessary for maintaining undifferentiated cultures, may play an important 
role in supporting the transition towards specific differentiation pathways. Cell-cell 
interactions and adhesion and anchoring molecules found in fibroblasts also 
influence self-renewal (Kueh et al., 2006). A lack of these interactions as a result of 
culturing hESCs long term on Matrigel may account for such differences in gene 
expression profiles, observed during progenitor formation. Recommendations would 
be to adjust the time in differentiation media, with perhaps longer wnt3a/Activin A 
treatment to allow for greater upregulation of endoderm genes SOX17, FOXA2. This 
protocol may require finer adjustments to allow for better success of endoderm 
differentiation on hESCs cultured on Matrigel in comparison to feeders.  
Heat map analysis also revealed differences in expression level from NCL5 cultured 
on different Matrices. For neural differentiation, overall, greater up regulation of 
differentiation genes was seen from NCL5 cultured on iMRC5 human feeders 
compared to iMEF mouse feeders and feeder free Matrigel. More consistent results 
were seen from NCL5 on iMEF after endoderm differentiation compared with NCL5 
iMRC5 and Matrigel. However, NCL5 cultured from iMRC5 demonstrated 
upregulation of Brachyury indicating that mesoendoderm differentiation was 
occurring. This may explain the much lower levels of early endoderm gene 
expression compared to NCL5 cultured on iMEF mouse feeders. Altered endoderm 
gene expression observed from NCL5 cultured on both mouse and human feeders 
may indicate differences in pathway regulation when undergoing endoderm 
differentiation. This would require further investigation to establish the cause of these 
differences. 
In vitro differentiation to mesoderm progenitor consistently demonstrated 
upregulation of HAND1 and vimentin by gene upregulation and IF staining, in 
comparison with other genes. Vimentin has also been used as a marker of epithelial 
to mesenchymal transitions (EMTs) that take place during embryogenesis and 
metastasis. It codes for an intermediate filament protein and has been shown to 
influence shape transitioning, increase in cell motility, and increase in focal adhesion 
dynamics (Mendez et al., 2010). Increased expression of vimentin by both feeder 
cultures compared with Matrigel may be an important characteristic of feeders which 
aid differentiation by reorganisation of the cell matrix and cells themselves. This 
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again suggests that feeders provide contact and communication with hESCs that is 
vital for their adhesion. 
These studies demonstrate the ability to simplify and better standardise three in vitro 
differentiation methods and translate its use in other hESCs on different feeders/ 
matrices at late passage following a 7 day protocol.  The adherent method provided 
an easy method to differentiate cells and its success may be due to better 
penetration of cells with growth factors, in comparison to forming EBs. The reduced 
ability to differentiate as EBs may be due to the age of the cell line. Though 
prolonged passaging had not reduced the ability to form aggregates as they readily 
form EBs, it may have decreased their ability to function as aggregates. Although 
these studies successfully validate the adherent plate method, which is fast and cost 
effective, decreased ability to form EBs may have important implications for use in 
clinical applications as aggregate formation has been widely adopted, and therefore 
warrants further investigation.  
Improvements to the protocols to increase homogenous yields of early germ layer 
specific differentiated hESCs would undoubtedly be useful to researchers, 
particularly if this can be achieved over a shorter time span than current methods, 
which require around 21-28 days. The use of quantitative methods to evaluate the 
success of differentiation protocols was demonstrated by TissueFaxs™ and 
quantitative real time PCR. The progression of such an outdated and inconsistent 
test will undoubtedly propel the field into establishing robust studies such as the 
ones described here. As the UKSCB plays an important role in supporting the wider 
stem cell community, the success of this work will be further implemented into 
routine characterisation testing of banked hESCs to give researchers more 
information of hESCs obtained, as well as increasing their value as research tools. 
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6.5 Conclusion 
The standardisation of differentiation methods is important for demonstrating the 
pluripotent capacity of hESCs used in long term studies, by different laboratories. 
Late passage NCL5 cells from all three matrices demonstrated successful in vitro 
differentiation using a straight forward adherent plate method, to all three germ 
layers after 7 days. Such work is highly robust and reproducible, with the benefit of 
using media and matrices commonly used in the majority of laboratories. 
Differences between mouse and human feeders and Matrigel were apparent upon 
directed differentiation in vitro. Overall, cultures from both feeder types better 
supported differentiation towards all three germ layers in comparison to Matrigel 
cultures, with particular attention to early ectoderm. These studies reveal how the 
effects of using different feeder types contribute to the differentiation of hESCs 
towards early progenitors of all three germ layers in vitro. Furthermore it highlights 
the variability of using different matrices for long term culture of hESCs on 
pluripotency. Contribution of this work is important to the wider stem cell community 
as currently there is no recommended method of differentiating cells in vitro. 
Establishing robust differentiation assays is not a simple task. Microenvironment 
plays an important but variable role which is key to the success of producing early 
progenitor cells. The continuation of this work using other hESC lines will help to 
strengthen the robustness and reproducibility of these relatively simple but effective 
assays to form progenitor cells from all three germ layers in a reliable way. As these 
studies are the first of their kind, it will also serve to demonstrate that prolonged 
culture of hESCs on different matrices can be sustained through in vitro directed 
differentiation assays. 
Cell health has been a key contributor to the accomplishment of this work. The use 
of Matrigel, defined components, small molecules, growth factors all provide better 
starting materials towards the development, standardisation and overall success of 
these assays. 
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Chapter 7. 
Analysis of chromosomal changes 
in hESCs using comparative 
genomic hybridisation: effects of 
long term passaging using mouse, 
human feeders and Matrigel. 
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7.1 Introduction  
 
Human embryonic stem cells (hESCs) carry normal diploid karyotypes at early 
passage (Baker et al., 2007; Mayshar et al., 2010) but this may change in prolonged 
culture and affect their defining characteristics as stem cell lines, including their 
potential to differentiate. The precise chromosomal changes may vary between cell 
lines and with the culture conditions, including the matrix on which the cells are 
grown, the process by which they are propagated or their duration in culture. For 
instance, a gain on chromosome 17q has been shown in three hESCs (H1, H7 and 
HES3) as a result of long term culture over 30 passages (Allegrucci et al., 2007). 
The gain was observed in cells grown on MEF feeders or on a fibronectin feeder free 
matrix, passaged either with EDTA free trypsin or manually using a glass pipette 
(Draper et al., 2004). A similar gain on chromosome 17q as well as chromosome 20 
has also been reported in eight out of nine hESCs lines including H1 and HES3 
cultured over 20 passages by both feeder (irradiated MEFs) and feeder free methods 
(Matrigel) (Maitra et al., 2005).  
In contrast, studies with SHEF1, SHEF3 and HS181 continuously propagated with 
Collagenase IV and cultured on Matrigel have shown that these cells maintain a 
normal karyotype up to passage 10, after which the SHEF3 and HS181 gained an 
extra chromosome 12, as detected by Spectral Karyotyping (SKY). The same hESC 
lines cultured on human feeders, HFF by both manual and enzymatic passaging in 
KO-HES media, maintained a stable karyotype for 30 passages (Catalina et al., 
2008). In another study using feeder free conditions the hESCs H1, H7 and H9 
maintained a normal karyotype on Matrigel and Laminin for up one year 
(approximately 42 passages) (Xu et al., 2001; Stojkovic et al., 2005). The reasons for 
these discrepancies are currently unclear but raise serious concerns about 
establishing the chromosomal stability of stem cells from different culture methods 
and the implications this may have on experimental data obtained using these cells. 
It is however clear that karyotype changes may occur, but the precise changes or 
how these relate to the cell type and/or the culture conditions remains to be 
established in a comprehensive and comparative study.  
In addition to the above, the method for assessing chromosomal stability needs to be 
standardised and suitable protocol established which can be exploited routinely in 
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both specialist and non-specialist laboratories. Currently, the majority of research 
into chromosome stability of stem cells has been investigated by traditional 
cytogenetic methods including G banding (Bongso et al., 1994; Brimble et al., 2004; 
Hanson & Caisander, 2005). This technique involves the preparation of metaphase 
spreads from proliferating cultures, which are then fixed and stained with Giemsa 
stain. The metaphase spreads are identified, examined and counted (at x40 
objective). Typically, fixed cell suspensions (from different cell types, but mostly from 
whole blood samples) are sent to a specialist cytogenetic laboratory where G 
banding is performed on a small number of cells by a trained cytogeneticist under 
high magnification (x100 objective). The adoption of this method from a clinical 
setting involves the partial digestion of chromosomes using trypsin and staining with 
Giemsa to reveal dark bands on the chromosomes that are rich in Adenine and 
Tyrosine, which are paired and analysed for overall chromosomal stability. The 
availability of participating clinical cytogenetic laboratories to process stem cell 
samples for G banding is not readily available in most laboratories, making it difficult 
for scientists to routinely determine changes in the stability of stem cell lines. Also, 
the preparation of metaphase spreads from stem cell lines has been problematic, 
leading to inconsistent results.  
Although other methods such as spectral karyotyping, single nucleotide 
polymorphism (SNP) analysis and fluorescent in situ hybridisation (FISH) have  been 
assessed for routine karyotyping (Catalina et al., 2007; Meisner & Johnson, 2008), 
these techniques are limited in resolution, particularly for the detection of small 
changes less than 50kB. Furthermore, such techniques only report detailed analysis 
on a few cells which are supposed to be reflective of a whole culture. Thus, 
developing a sensitive and robust protocol which could be used routinely for 
karyotyping would prove invaluable, and this has been one key objective at UKSCB 
which was addressed as part of this thesis focusing on optimising the routine and 
reproducible use of Array Comparative Genomic Hybridisation (aCGH). The latter is 
a much more sensitive technique which has been applied in  clinical settings (Cleide 
et al., 2008) for comprehensive assessment of chromosome stability. This technique, 
coupled with accurate information on specific chromosome aberrations, can link to 
gene databases to give detailed assessment of the clinical significance and 
consequences of specific losses or gains of chromosome(s).  
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The studies described in this chapter were therefore aimed at detecting changes in 
copy number variations (CNVs) and in establishing how such changes might be 
affected by the culture conditions. Furthermore, the far-reaching nature of the 
experiments carried out should also validate aCGH for in-house use as an 
established method for routine detection of changes in chromosomal stability in stem 
cells.  
In these studies stem cell lines NCL5, RH5, HUES9 and SHEF1 were selected as 
they are not well publicised lines. Therefore information on their basic characteristics 
may help to diversify the hESC lines currently in use, which would prove useful to the 
wider stem cell community. Each cell type was cultured on mitotically inactivated 
human feeders (iHDFn and iMRC5) and mouse feeders (iMEF and i3T3s) as well as 
on feeder free matrix Matrigel in mTeSR1 media, and cultured for 20 passages. 
Samples were prepared for G banding analysis, outsourced testing by The Doctors 
Laboratory (TDL) and aCGH using the Perkin Elmer spectral BAC array, specific for 
the detection of chromosome changes within the whole genome. The results from 
both techniques would provide a useful comparison of which is more sensitive, 
reliable and robust.  
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7.2. Method 
7.2.1 Stem cell culture 
Stem cell lines RH5, HUES9, NCL5 and SHEF1 were routinely maintained in 
continuous culture and when required, plated onto two inactivated mouse feeder 
lines iMEF and i3T3, two inactivated human feeder lines iMRC5 and iHDfn with 
standard KO-HES media, and on synthetic matrix Matrigel with mTeSR1 media. 
Each line was cultured over twenty passages using TrypLE™ Express, as described 
in general methods sections 2.4. 
7.2.2 Sample preparation for metaphase spread analysis 
Samples were prepared from the cell lines mentioned above for metaphase spread 
analysis (in-house) as described in general methods, section 2.4 
7.2.3 DNA extraction 
DNA was extracted for each condition from confluent early (p+5) and late passage 
(p+25) cultures using DNeasy extraction kit according to manufactures‘ protocol as 
described in general methods, section 2.4.  
7.2.4 aCGH  
aCGH was carried out as described in the methods (section 2.0) and involved five 
main steps: labelling, hybridisation, washing, scanning and data analysis. The arrays 
used were Perkin Elmer constitutional BAC 4.0 consisting of 1200 bacterial artificial 
chromosomes (BAC) clones spaced at one Mega Base intervals on a clear glass 
slide (compared with traditional karyotyping at 10MB intervals). This system has 
been validated for research use and has whole genome coverage, which is important 
for detecting novel karyotype changes. The array preparation was set up in a clean 
room to minimise exposure of the dyes to contaminants.   
The ‗reference sample‘ used was the early passage of each stem cell line on their 
respective feeder/matrix. Therefore, the ‗test‘ sample was the culture pellet collected 
at p+20 (extended passage). Thus, a more accurate assessment of chromosome 
change could be determined over the 20 passage culture process. The samples 
were also subject to dye-swap wherein the test and reference dyes were prepared in 
a reverse reaction and swapped, which further ensures validity of the results. 
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A maximum of 6 arrays were prepared during one experiment, to minimise exposure 
to light and ozone and also minimise the number of human errors due to complex 
processing and long incubation steps. 
The prepared arrays were scanned using the Perkin Elmer Scan array and 
corresponding Perkin Elmer software. Figure 7.1.A shows an example of a prepared 
array, enlarged tile of individual BAC arrays (7.1.B) and a ratio plot (7.1.C).  
7.2.5 Data analysis 
The fluorescent scanner captured data from the array and SpectralWare® software 
converted the scanner output data into an intensity ratio profile. The software 
analysed copy number changes and displays the location of the changes within the 
genome.  
 
A number of analysis parameters were used to ensure the results obtained were 
reliable, including normalisation of the array spots, background correlation of the 
arrays, and threshold detection with lower and upper limits to ensure ratio-metric 
analysis for both dyes and standard deviation of the average spot intensity 
(2.5xSTDEV). 
The results obtained from aCGH analysis were exported as word documents, and 
diagrams for visualisation of karyotypes. The term karyotype refers to a display of 
the chromosomes of a cell by lining them up, beginning with the largest and with the 
short arm oriented toward the top of the karyotyping sheet. The fluorescent scanner 
captures data from the array and SpectralWare® software converts the scanner 
output data into an intensity ratio profile. The software analyses copy number 
changes and displays the location of the changes within the genome. The spot 
fluorescence intensity is averaged by adjusting the PMT voltage for each dye colour. 
The spots were then aligned and tagged as good or bad. Any misaligned spots, bad 
spots or debris/dye artefacts were manually adjusted or removed from the analysis. 
The aligned arrays were then converted into GPR files and analysed as ratio plots 
(Figure 7.1C) using the One Click™ software for CNV analysis version 4.0. 
Visualisation of individual chromosomes and adjustment of ratio plots were 
performed using this software, as well as creating tables of results with specific 
details of cell line karyotypes. 
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Figure 7.1.  (A) Example of a prepared and scanned BAC array containing 1200 
clones, (B) enlarged image of array tile showing individual BAC spots which 
correspond to specific genes and (C) example of a ratio plot for chromosome 
19 from One click CNV software.  
Sample and reference DNA were labelled in a two colour, ratiometric experiment and 
carefully hybridised to an array slide. The clones were covalently coupled to glass 
microscope slides, and spotted in duplicate. Once each slide had been scanned the 
corresponding sample which has been dye swapped was overlayed (CY5 and CY3), 
as shown in Figure 7.1. (A).The changes observed were for samples from original 
stem cell cultures at early passage compared with samples at late passage to give a 
karyotype over twenty passages. A red line on top and blue line on the bottom 
demonstrates a loss in chromosome number. A blue line on top and red line on the 
bottom indicates a gain in chromosome number, as demonstrated for chromosome 
19 (Figure 7.1.C) as a subtle gain, from 13.3 of the P arm to 13.42 of the q arm. 
Chromosomes are arranged by short arm, p and long arm q, and divided by the 
centromere. 
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7.3. Results 
7.3.1 Karyology results by G banding analysis 
Results for karyotyping by G banding analysis (outsourced by The Doctors‘ 
Laboratory, TDL) are displayed in Table 7.1. Samples originally prepared from all 20 
conditions (i.e. NCL5, HUES9, RH5 and SHEF1 cultured on iMEFs, i3T3s, iHDFns, 
iMRC5 feeders and Matrigel) were reported as ‗not analysed‘ by G banding despite 
metaphase spreads being successfully visualised in-house (see list below Table 
7.1). Previous karyology results from G banding analysis of distribution cell banks 
(DCB) and master cell banks (MCB), where available, were also included to look for 
consistencies in results reported. Although most of the results displayed in Table 7.1 
conclude a normal karyotype, smaller aberrations were detected from many of the 
samples, but were assumed to be artefacts, despite the reporting of several 
chromosomal aberrations from SHEF1 MCB (7 aberrations in 5 cells) to SHEF1 DCB 
(1 aberration in 1 cell). Some increased chromosomal counts were reported. For 
example stem cell line RH5 cultured on iHDFn human feeders was reported as 
tetraploid (cells with four sets of chromosomes), however, only 4 cells were 
analysable. RH5 cultured on iMEF mouse feeders was also found to have gains on 9 
chromosomes. RH5 samples taken from project banks i.e. for these studies, cultured 
on iMEF and human feeders iHDFn and iMRC5 (all highlighted in bold), were all 
reported as having isochromosomes, a chromosome that has lost one of its arms 
and replaces it with an exact copy of the other arm. This was observed on the long 
arm (q arm) of chr.17. The inconsistencies found as a consequence of using this 
technique highlighted greater focus on the aCGH studies to more reliably 
characterise the stem cell lines cultures on different matrices, to give complete data 
sets. 
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Table 7.1. Stem cell line karyotypes by G banding analysis.  
Cell line/feeder type karyotype comment 
RH5/iHDFn, late passage Complex tetraploid Only 4 cells analysable, varied 
chromosome counts.  Isochromosomal on 
long arm of 17. 
RH5/iMEF late passage 
(Project bank) 
77,XXX, Gain on 1, 3, 6, 
10q, 12, 13, 17, 20, 21 
Isochromosomal on long arm of 17. 
RH5/iMRC5 late passage Not possible Increase chromosomal count. 
Isochromosomal on long arm of 17. 
SHEF1/iMEF MCB Normal, karyotype 46, XY 5 abnormal cell anomalies detected, 
thought to be artefactual, loss of chr.1, 3, 
5, 6, 13, 19, 21. 
SHEF1/iMEF DCB Normal karyotype, 46, XY 8 cells available for analysis, 7 cells 
displayed model ‗normal‘ karyotype, 1 cell 
displayed loss of chr.21. 
HUES9/iMEF DCB Normal karyotype, 46, XX 17 cells displayed model ‗normal 
karyotype,‘ 3 cells displayed translocation 
2;18 and break on 21q, 13p, loss of chr.13 
and chr.18 (44, XX), assumed to be 
artefactual anomalies. 
HUES9/iMEF (project 
bank  created 3 
passages after DCB) 
Normal Karyotype, 46, XX 6 cells displayed model ‗normal karyotype,‘ 
2 abnormal cells displayed aberrations 
attributed to harvest artefact: loss of chr.10 
and loss of chr.4 and 14.  
 
The following samples did not show any analysable results:  
NCL5-iMRC5, NCL5-iHDFn, NCL5-i3T3, NCL5-iMEF 
SHEF1-iMRC5, SHEF1-iHDFn, SHEF1-i3T3, SHEF1-iMEF 
HUES9-iMRC5, HUES9-iHDFn, HUES9-i3T3 
RH5-i3T3 
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7.4.0 Chromosomal changes detected by aCGH in the SHEF1 stem cell line 
Despite sufficient sample preparation being carried out, no results were available for 
SHEF1 stem cell line cultured on feeders, due to the inability to properly scan the 
arrays. All the arrays for this cell line had extremely high background.  SHEF1 
cultured on Matrigel only sustained healthy cultures to passage p+11, which resulted 
in karyological changes detected on chromosomes 3, 6, 9, 10, 11, 12, 14, 15, 16, 17, 
by aCGH. Morphological indications from chapter 3 suggest that this stem cell line 
was not as healthy and viable in comparison to other three stem cell lines, which 
may explain the large number of detected aberrations. Therefore no further studies 
were carried out using this stem cell line. 
 
 
7.4.1 Chromosomal changes detected by aCGH in stem cell line NCL5 cultured 
on iMRC5 human feeders.  
The columns in Table 7.2 display the type of aberration detected (loss or gain), the 
chromosome number, the exact position of the aberration on the chromosome 
(number of base pairs from Start to End), the standard deviation, copy number 
variations (CNVs) linked to the aberration detected, the number of corresponding 
publications and the number of known genes found within the chromosome region. 
The results show two gains on chromosome 19 on the q and p arm and a loss of 
chromosome 20 which spans the length of the whole chromosome, from 20p13 to 
20q13.33. All changes detected were associated with greater than 99 genes, 
indicating their potential significance. These changes are further represented by the 
ideogram (Figure 7.2), which highlights the difference in sizes of the two small gains 
on chromosome 19 in comparison to the whole chromosome loss on chromosome 
20.  
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Table 7.2. Chromosomal changes in stem cell line NCL5 cultured on 
iMRC5 human feeders. 
Type Chr Start End SD Start 
Cyto 
End Cyto CNVs Genes 
Gain 19 11,841,463 23,197,810 0.061 19p13.2 19p12 22 Pub. 
G:128 
L:377 
>99 
Gain 19 42,638,332 61,437,252 0.063 19q13.1
2 
19q13.43 29 Pub. 
G:569 
L:1067 
>99 
Loss 20 35,996 62,463,816 0.093 20p13 20q13.33 28 Pub. 
G:490 
L:1318 
>99 
 
 
Figure 7.2. Karyotype of chromosomal changes in stem cell line NCL5 cultured 
on iMRC5 human feeders. NCL5 were cultured on mitotically inactivated human 
fibroblasts derived from foetal lung iMRC5, for twenty passages using TrypLE™ 
Express. DNA samples were taken from early and late passage. A whole 
chromosome loss was detected on chromosome 20 (red vertical line) over twenty 
passages. This change is denoted by the continuous red line and two small gains 
(green vertical lines) detected on the p and q arm of chromosome 19. No other 
chromosomal changes were detected from this sample.  
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7.4.2 Chromosomal changes detected by aCGH in stem cell line HUES9 
cultured on iMRC5 human feeders 
Culture of HUES9 on the human feeder iMRC5 resulted in seven changes, including 
one partial chromosome loss at chr.7 q arm and six whole chromosome gains at 
chr.12, 13, 16, 17, 19 and 20 as shown in Table 7.3. This is further depicted by the 
karyotype shown in Figure 7.3 and 7.4 which demonstrates the spread of changes 
across the chromosomes. The changes in chromosomes 12, 17 and 19 all occur at 
position p13.3, as shown in the table below. However, the size of the chromosome 
change differ slightly, with gains on chromosomes 19 and 20 ending on the q arm 
position 13 and gains on chromosomes 12 and 16 ending on the q arm at position 
q24.3. 
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Table 7.3. Chromosomal changes in stem cell line HUES9 cultured 
on iMRC5 human feeders.  
 
Type Chr Start End SD Start 
Cyto 
End Cyto CNVs Genes 
Loss 7 98,027,648 159,179,376 0.168 7q22.1 7q36.3 30 Pub. 
G:789 
L:2699 
>99 
Gain 12 2,047,581 133,096,600 0.221 12p13.33 12q24.33 30 Pub. 
G:1029 
L:3973 
>99 
Gain 13 17,768,610 114,890,800 0.184 13q11 13q34 29 Pub. 
G:615 
L:2467 
>99 
Gain 16 1,030,472 88,783,720 0.228 16p13.3 16q24.3 31 Pub. 
G:1816 
L:2475 
>99 
Gain 17 -675,750 79,079,008 0.201 17p13.3 17q25.3 30 Pub. 
G:1334 
L:2503 
>99 
Gain 19 -156,484 64,003,664 0.207 19p13.3 19q13.43 30 Pub. 
G:1236 
L:2424 
>99 
Gain 20 -156,484 63,297,896 0.165 20p13 20q13.33 28 Pub. 
G:490 
L:1318 
>99 
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Figure 7.3. Karyotype of chromosome changes detected in stem cell line 
HUES9 cultured on iMRC5 human feeders. The diagram shows that six whole 
chromosome gains were detected by aCGH analysis, as shown by the solid green 
lines. A single, partial loss on chromosome 7 was detected on q arm. This loss was 
found to span the q arm from 7q22.1 to 7q36.3, as also demonstrated in Table 4.2. 
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            (a) 
 
(b) 
 
 
Figure 7.4. Spectral ratio plots for individual chromosomes 7 (a) and 12 (b). 
These figures highlight the significant differences in the ratio of dye swap (blue and 
red line), which correlate to the magnitude of change on the individual 
chromosomes. For normal chromosomes, both lines should be indistinguishable. 
The closer the lines are to the centre, the more balanced the ratio, the less 
chromosome change detected. A loss or partial chromosome loss is seen if the red 
line is detected on the top of the spectral ratio view, as demonstrated by the spectral 
view result for chromosome 7 from stem cell line HUES9 cultured on iMRC5 (Figure 
a). The p arm of chromosome 7 is relatively discreet and can be described as 
balanced, however, the q arm is clearly different, as the red line moves to the top of 
the ratio line and the blue line is clearly separated. A gain or partial chromosome 
gain is apparent if the blue line is seen on the top of the spectral ratio view, as 
demonstrated by spectral views for chromosome 12 (Fig 7.4 (b)), where the red and 
blue lines are both visibly distinguishable and the red line can also be seen below 
the ratio line, spanning the entire length of the chromosome. This spectral ratio plot 
was marked as significant. 
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7.4.3 Chromosomal changes detected by aCGH in stem cell line RH5 cultured 
on iMRC5 human feeders  
A number of different changes on various chromosomes were detected for RH5 stem 
cells cultured on iMRC5 feeders. The data shown in Table 7.4 highlights a loss of 
Chromosome 7, 17, 19 (whole chromosome), and 22 (partial loss) and gains of 
chromosome 12 (q arm) and 20.  An example of a whole chromosomal loss on 
chromosome 19 is shown in Figure 7.5(a). The thick red continuous line indicates a 
whole chromosome loss, as determined by the analysis parameters mentioned 
above (methods, data analysis). The corresponding ratio plot figure (7.5b) further 
highlights the size of the chromosomal change and the specific points at which the 
loss occurred; 19.p13.3 to 19q13.43. This loss spans across almost the entire 
chromosome. 
Table 7.4. Chromosomal changes in stem cell line RH5 cultured on 
iMRC5 human feeders.  
 
Type Chr Start End SD Start 
Cyto 
End Cyto CNVs Genes 
Loss 7 105,512,36
8 
158,860,864 0.188 7q22.2 7q36.3 30 Pub. 
G:660 
L:2388 
>99 
Gain 12 56,970,240 100,205,776 0.092 12q14.1 12q23.2 27 Pub. 
G:140 
L:742 
>99 
Loss 17 32,235,100 46,968,912 0.176 17q12 17q21.33 26 Pub. 
G:524 
L:738 
>99 
Loss 19 100,156 63,490,380 0.192 19p13.3 19q13.43 30 Pub. 
G:1236 
L:2400 
>99 
Gain 20 5,168,808 22,556,208 0.075 20p12.3 20p11.21 26 Pub. 
G:168 
L:303 
62 
Loss 22 35,381,776 49,322,644 0.18 22q12.3 22q13.33 23 Pub. 
G:158 
L:471 
>99 
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           (a) 
 
Figure 7.5 (a). Diagram showing chromosome 19 in stem cell line RH5 cultured 
on iMRC5 human feeders. This diagram was obtained from one click software for 
CNV changes and its corresponding ratio plot was prepared, marked as ‗significant‘ 
and selected by the same software (b). The thick continuous red line denotes a 
significant change and shows the loss of a whole chromosome. 
            (b) 
  
 
Figure 7.5 (b). Spectral ratio plot of Chromosome 19 in stem cell line RH5 
cultured on iMRC5 human feeders. For a normal chromosome, the red and blue 
lines are normally indistinguishable. The lines demonstrate the differences in the 
ratio of dye swap (blue and red line), which correlate to the magnitude of change on 
the individual chromosomes.  The closer the lines are to the centre, the more 
balanced the ratio, therefore the less chromosome change detected. From the 
spectral ratio plot Chromosome 19 has undergone a significant loss, as both red and 
blue corresponding dye lines are clearly distinguishable from the ratio line, with the 
red line predominately above the blue line.  
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7.4.4 Chromosomal changes detected by aCGH for Stem cell line NCL5 
cultured on iMEF mouse feeders 
The results in Table 7.5 shows 11 chromosome changes detected in NCL5 cultured 
on iMEF over 20 passages. These included chromosome gains on chr.3, 16, 17, 19, 
22 and losses on chr.4 (partial), 5, 10, 12 (partial, q arm),13 and 20. Correlation of 
sizes and position of changes detected vary, as further demonstrated by Figure 7.6, 
with very small deletions (less than 15MB) on chromosomes 4, 5, 10 (all associated 
with less than 40 genes which suggests these changes were less significant), and a 
small gain on chromosome 3 (9MB) associated with greater than 99 genes, 
indicating its potential significance. Furthermore, losses on chromosomes 5 and 12 
start at the same position on the q arm, q14.1. Gains on chromosome 19 and 22 
both end on the q arm 13.3 and 13.4. 
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Table 7.5.Chromosomal changes detected by aCGH for stem cell 
line NCL5 cultured on iMEF mouse feeders  
 
Reg. Type Chr Start End SD Incl. Start Cyto End Cyto CNVs Genes 
1 Gain 3 46,693,78
4 
55,311,86
4 
0.111 100% 3p21.31 3p14.3 20 Pub. 
G:45 
L:496 
>99 
2 Loss 4 43,043,78
8 
55,502,96
8 
0.115 100% 4p13 4q12 23 Pub. 
G:75 
L:161 
38 
3 Loss 5 91,099,20
0 
106,325,8
72 
0.095 100% 5q14.3 5q21.3 25 Pub. 
G:119 
L:473 
33 
4 Loss 10 105,458,3
76 
115,223,5
36 
0.078 100% 10q24.33 10q25.3 19 Pub. 
G:185 
L:164 
27 
5 Loss 12 58,826,98
0 
99,277,40
0 
0.087 100% 12q14.1 12q23.1 27 Pub. 
G:126 
L:720 
>99 
6 Loss 13 52,554,50
4 
112,608,7
92 
0.115 100% 13q21.1 13q34 29 Pub. 
G:252 
L:1507 
96 
7 Gain 16 55,812,81
2 
74,910,71
2 
0.157 100% 16q13 16q23.1 23 Pub. 
G:320 
L:323 
>99 
8 Gain 17 32,875,70
2 
79,719,61
6 
0.178 100% 17q12 17q25.3 29 Pub. 
G:786 
L:1496 
>99 
9 Gain 19 -413,124 64,709,42
0 
0.211 100% 19p13.3 19q13.43 30 Pub. 
G:1236 
L:2424 
>99 
10 Loss 20 10,879,06
1 
24,994,29
4 
0.091 100% 20p12.2 20p11.21 25 Pub. 
G:158 
L:274 
63 
11 Gain 22 15,623,85
4 
49,723,82
0 
0.154 100% 22q11.1 22q13.33 29 Pub. 
G:1042 
L:1137 
>99 
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Figure 7.6. Karyotype of chromosomes for stem cell line NCL5 
cultured on iMEF mouse feeders.  
The diagram displays the distribution of changes across the chromosomes. Mainly 
losses (red bars) were seen across chromosomes 1-13 and gains (green bars) 
across chromosomes 16-22. Indications by size and visual display of position by 
ideogram may suggest a number of small balanced translocations (an even 
exchange of chromosomal material without the loss/gain of genetic information). 
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7.4.5 Chromosomal changes detected by aCGH in Stem cell line HUES9 
cultured on iMEF mouse feeders  
Table 7.6 shows a partial loss of the q arm of chromosome 7, a partial gain of p arm 
on chromosome 12 and whole chromosome gains seen on chromosomes 14, 16, 
and 17 in HUES9 cells cultured on MEF mouse feeders over 20 passages. These 
changes are also reflected in the ideograms and spectral ratio plots in Figures 7.7 
and 7.8 which demonstrate specifically the magnitude of the changes detected in 
chromosomes 7 and 12. All changes detected were associated with greater than 99 
genes, suggesting that they were significant. 
 
Table 7.6. Chromosomal changes in stem cell line HUES9 cultured 
on iMEF mouse feeders. 
 
Reg. Type Chr Start End SD Incl. Start Cyto End Cyto CNVs Genes 
1 Loss 7 83,058,21
6 
159,497,8
72 
0.224 100% 7q21.11 7q36.3 30 Pub. 
G:849 
L:3119 
>99 
2 Gain 14 19,848,82
0 
106,576,2
24 
0.098 100% 14q11.2 14q32.33 27 Pub. 
G:843 
L:1921 
>99 
3 Gain 16 -
1,390,810 
89,594,48
0 
0.113 100% 16p13.3 16q24.3 31 Pub. 
G:1818 
L:2475 
>99 
4 Gain 17 -
1,308,105 
78,935,11
2 
0.138 100% 17p13.3 17q25.3 30 Pub. 
G:1334 
L:2503 
>99 
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Figure 7.7. Karyotype of chromosomes for stem cell line HUES9 
cultured on iMEF mouse feeders.  
A single, partial chromosome loss was detected on chromosome 7q, with three 
chromosome gains found on 12p, 14q and a whole chromosome gain on 16.  
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               (a)  
  
        (b) 
 
 
Figure 7.8. Spectral ratio plots showing chromosome 7 (a) and 12 
(b) of stem cell line HUES9 cultured on iMEF mouse feeders.   
The detection of a large loss on Chr.7 q arm is shown in figure (a), with the 
remaining spectra of the p arm appearing indistinguishable. A significant gain on 
Chr.12 p arm can also be seen. The spectra on the remaining q arm appears to be 
separating, however it is not enough to suggest a full gain of the chromosome, but 
may be indicative of further changes that may be occurring, particularly when 
comparing both part of normal chromosome spectra for chromosomes 7 and 12. 
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7.4.6 Chromosomal changes detected by aCGH in stem cell line RH5 cultured 
on iMEF mouse feeders 
Table 4.7 shows the aCGH results obtained for RH5 cultured on mouse feeder iMEF. 
Eight aberrations were detected, and mainly consist of losses spanning from the p to 
q arm, correlating with greater than 99 genes. Losses detected on chromosomes 5, 
10 and 11 show similarities, as all were found to start at p15.3. Figure 7.9 (a) 
demonstrates a gain on chromosome 12 which has been previously described in 
stem cell lines. Although this change was relatively small, it may indicate a culture 
advantage over other stem cell lines. It also demonstrates the sensitivity of the 
technique to detect such slight changes. 
Table 7.7. Chromosomal changes in stem cell line RH5 cultured on 
iMEF mouse feeders. 
 
Type Chr Start End SD Start Cyto End Cyto CNVs Genes 
Gain 1 61,430 245,483,616 0.125 1p36.33 1q44 31 Pub. 
G:2424 
L:5996 
>99 
Loss 5 514,438 181,737,280 0.105 5p15.33 5q35.3 31 Pub. 
G:1909 
L:5767 
>99 
Loss 7 245,716 158,422,496 0.082 7p22.3 7q36.3 31 Pub. 
G:1628 
L:5325 
>99 
Loss 10 -317,642 135,449,904 0.081 10p15.3 10q26.3 30 Pub. 
G:1161 
L:4049 
>99 
Loss 11 -1,187,003 134,450,272 0.09 11p15.5 11q25 32 Pub. 
G:1098 
L:4455 
>99 
Gain 12 67,014,816 90,372,616 0.056 12q15 12q21.33 24 Pub. 
G:90 
L:463 
75 
Loss 14 19,076,912 106,598,672 0.105 14q11.1 14q32.33 27 Pub. 
G:1028 
L:2005 
>99 
Loss 20 431,346 62,996,168 0.074 20p13 20q13.33 28 Pub. 
G:489 
L:1306 
>99 
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Figure 7.9. Diagram showing chromosome 12 for stem cell line RH5 cultured 
on iMEF mouse feeders. The green line indicates a gain on the q arm. Although 
this change is relatively small, it is significant to long term culture of stem cell and 
associated with clonal events. 
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7.4.7 Chromosomal changes detected by aCGH in stem cell line RH5 cultured 
on mouse feeder line i3T3. 
Table 7.8 shows the results obtained from RH5 cultured on i3T3 mouse feeders. 
Culture on this mouse feeder type resulted in the least amount of chromosomal 
changes from this stem cell line when compared to the changes observed from 
cultures on iMEF mouse feeders.  A re-occurring loss of chromosome 10 and 20, 
and gains on chromosomes 1 and 22 was seen.  Table 7.8 also shows the size and 
position of the loss detected on chromosome 20, which at first, appears to be the 
same as the size and position of the gain on chromosome 22. However when 
checked against the actual start and end, the size in base pairs are different. Figure 
7.10b shows the specific loss on chromosome 20, also demonstrating that RH5 had 
generally, noisy spectra for all its chromosomes, which could cause difficulties when 
analysing small changes from the results.  All changes were associated with greater 
than 99 genes, suggesting they could be significant. 
Table 7.8. Chromosomal changes for RH5 cultured on mouse 
feeder line i3T3. 
 
Type Chr Start End SD Start 
Cyto 
End Cyto CNVs Genes 
Gain 1 -
2,586,066 
251,339,456 0.085 1p36.33 1q44 31 Pub. 
G:2549 
L:6138 
>99 
Loss 10 -602,043 136,788,240 0.084 10p15.3 10q26.3 30 Pub. 
G:1161 
L:4049 
>99 
Loss 20 -348,964 62,784,620 0.082 20p13 20q13.33 28 Pub. 
G:490 
L:1318 
>99 
Gain 22 -172,453 50,425,876 0.085 22p13 22q13.33 30 Pub. 
G:1151 
L:1180 
>99 
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                    (a) 
  
 
          (b) 
  
Figure 7.10. (a) and (b). Diagram and ratio plot for chromosome 20 from RH5 
cultured on mouse feeder line i3T3. These cultures incurred a loss on 
chromosome 20, which spans the whole chromosome length. This spectra would be 
described as quite noisy, as the blue and red dye lines appear to come together at 
various positions across the chromosome e.g. p12.1 and q13.1, but with an obvious 
aberration. Slipping of the dye lines at the end of the chromosome may be indicative 
of telomere degradation. 
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7.4.8 Chromosomal changes detected by aCGH in stem cell line NCL5 cultured 
on i3T3 mouse feeders 
The results from Table 7.9 show six chromosome changes consisting of a loss of the 
majority of chromosome 12, a whole chromosome gain on 20 and a loss of most of 
the q arm of chromosome 22 (2 aberrations).  
 
7.4.9 Chromosomal changes detected by aCGH in stem cell line HUES9 
cultured on i3T3 mouse feeders 
Chromosome changes were seen from HUES9 cultured on i3T3 on chromosome 14 
as a whole gain, a whole loss of chromosome 19 and a whole gain on chromosome 
20, as shown in Table 7.9. 
 
7.4.10 Chromosomal changes detected by aCGH in hESCs as a result of 
prolonged culture on i3T3 mouse feeders 
A summary of all the results obtained from stem cell culture on mouse feeders i3T3s 
is shown in Table 7.8. Two similarities in chromosomal aberrations were found from 
stem cell lines NCL5, HUES9 and RH5 cultured on mouse feeders i3T3s for 20 
passages; a gain on chr.20 shared by all three stem cell lines, and a loss on chr.22 
shared by NCL5 and RH5. HUES9 had the least number of changes consisting of 2 
gains and 1 loss. Both NCL5 and RH5 resulted in 4 aberrations, with mostly losses 
seen from NCL5. Both losses and gains were detected from RH5. Detailed results 
for Stem cell lines RH5 cultured on i3T3s are shown in Table 7.9, Figures 7.10 (a 
and b). 
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Table 7.9.  aCGH results showing chromosomal changes for hESC 
lines NCL5, HUES9 and RH5 cultured on i3T3 mouse feeders 
 
Red indicated a loss in chromosome and green represents a gain in chromosome.  
Stem cell line chromosome Type of change 
(gain/loss) 
NCL5  12, 20, 21, 22 Losses 
HUES9 14, 19, 20 Gains 
RH5 1, 10, 20, 22 Both 
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7.5.0 Chromosomal changes detected by aCGH in hESCs as a result of culture 
on iHDFn human feeders 
A considerable number of changes were detected in the stem cell lines cultured on 
the iHDFn human feeders as shown by summary Table 7.10. All three stem cell lines 
RH5, NCL5 and HUES9 demonstrated a change on chromosome 12 which in the 
RH5 and HUES9 lines was detected as a gain, and in NCL5, as a loss. Other 
similarities in chromosomal aberrations include the changes on chr.7 and 17 shared 
by HUES9 and RH5, and a loss on chr.18 shared by NCL5 and RH5. The number 
and type of aberration detected from each stem cell line was also interesting. Both 
NCL5 and HUES9 cultures had 5 aberrations; RH5 resulted in mostly losses 
whereas mostly gains were detected from HUES9 cultures (4 gains, 1 loss). RH5 
had the greatest number of changes (8) in comparison to the other stem cell lines. 
Interestingly changes from NCL5 cultured on iHDFn resulted in all (small) losses. 
Detailed results shown in Table 7.10 and Figure 7.11 further depict these very small 
losses in stem cell line NCL5. 
7.5.1 Chromosomal changes detected by aCGH in stem cell line NCL5 cultured 
on iHDFn human feeders. 
The results in Table 7.11 shows five chromosome losses consisting of a small loss 
on the q arm of chr.12, a small loss on q arm of chromosome 13, a (partial) loss of q 
arm of chr.16 and two small losses on chromosome 18 and 21. All aberrations were 
detected on the q arm of each chromosome. Three out of the five changes occurred 
at position q21. All the losses linked with 64 genes or less and were less than 21MB. 
Losses on chromosomes 13, 18, and 21 were linked with less than 10 genes, 
suggesting that these changes may not have been significant. 
7.5.2 Chromosomal changes detected by aCGH in stem cell line RH5 and 
HUES9 cultured on iHDFn human feeders. 
RH5 cultured on iHDFn human feeders incurred 8 chromosome changes in total over 
20 passages, consisting of a number of whole losses and gains including gain on 
chr.6 and chr.12 and loss of Chr.7, 11, 14, 17 and 18.  
HUES9 cultured on human feeders iHDFn over 20 passages revealed a loss of the q 
arm on chromosome 7 and small gains on chromosomes 12, 19, 22. A large gain on 
chromosome 17 was also seen (Figure 7.12).  
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Table 7.10.  aCGH results showing chromosomal changes for hESC 
lines NCL5, HUES9 and RH5 cultured on iHDFn human feeders 
Red indicated a loss in chromosome and green represents a gain in chromosome. 
Stem cell line Chromosome Type of change (gain/loss) 
NCL5 12, 13, 16, 18, 21 Losses. 
HUES9 7,12,17,19,22 Mostly gains 
RH5 6,7,10,11,12,14,17,18 Mostly losses 
 
 
 
Table 7.11. Chromosomal changes in stem cell line NCL5 cultured 
on iHDFn human feeders.  
 
 
 
Reg. Type Chr Start End SD Incl. Start Cyto End Cyto CNVs Genes 
1 Loss 12 82,447,76
8 
88,720,904 0.17 100% 12q21.31 12q21.33 16 Pub. 
G:21 
L:215 
16 
2 Loss 13 61,608,48
8 
73,527,664 0.187 100% 13q21.31 13q22.1 26 Pub. 
G:95 
L:627 
9 
3 Loss 16 52,749,94
4 
59,236,024 0.221 100% 16q12.2 16q21 17 Pub. 
G:126 
L:116 
64 
4 Loss 18 20,334,48
0 
23,550,496 0.494 100% 18q11.2 18q12.1 6 Pub. L:6 7 
5 Loss 21 15,489,74
5 
21,194,192 0.277 100% 21q21.1 21q21.1 22 Pub. 
G:95 
L:129 
7 
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Figure 7.11. Karyotype showing chromosomes for NCL5 cultured 
on human feeders iHDFn.  
The aberrations detected in NCL5 cultured on iHDFn were all very small losses (red 
bars), as reflected in Table 7.10. Also, the majority of the losses occurred between 
chromosomes 12 to 21.This result demonstrates the sensitivity of aCGH as a 
technique, as it is able to detect very small chromosomal aberrations; the largest 
change detected was 14KB and the smallest was 3KB. None of the changes 
detected were marked as significant. 
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4.6.0 Chromosomal changes by aCGH in hESCs as a result of prolonged 
culture on Matrigel  
Similarities and differences in chromosome changes were seen from stem cell lines 
NCL5, HUES9 and RH5 cultured on Matrigel over 20 passages. Aberrations on 
chromosome 4 were shared by NCL5 (gain) and HUES9 (loss). Changes on 
chromosome 6 were also shared by HUES9 (loss) and RH5 (gain). A small loss on 
chromosome 12, spanning from the p-arm to the q-arm was also shared by HUES9 
and RH5 (Figure 7.12). NCL5 and HUES9 displayed the least amount of changes (4 
aberrations detected) in comparison with RH5 cultured on Matrigel. However, 
changes from NCL5 were all partial or small changes, consisting of both losses and 
gains, whereas aberrations from HUES9 were mostly whole chromosome losses. 
RH5 also consisted of both losses and gains (7 aberrations), including loss of 
chromosome 17q arm, as detected by G banding analysis. These results show that 
NCL5 was more stable on Matrigel in comparison to the other two stem cell lines. A 
summary of these changes are displayed in summary Table 7.12.  
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Table 7.12. aCGH results showing chromosomal changes for hESC 
lines NCL5, HUES9 and RH5 cultured on Matrigel.  
 
Stem cell line chromosome Type of change 
(gain/loss) 
NCL5  1q23.2-24.3 
4q14.1-15.1 
9q23.23.1 
18p24.3-22.1 
Both, all partial, mostly of q 
arm 
HUES9 4q22.1-22.3 
6p12.1-q11.4 
11q24.22-24.32 
12p11.21-q11.12 
Mostly losses 
RH5 2p31.1-p46.9 
5p19.6-p28.1 
6p25.7-p29.9 
7p22.9-31.1 
9p23.1-21.1 
12p11.21-q11.12 
17q20.7-24.2 
Both 
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(a) 
 
          (b) 
 
 
Figure 7.12. Spectral ratio plot for chromosome 12 from HUES9 (a) and RH5 (b) 
cultured on Matrigel. These cultures incurred a loss on chromosome 12, p arm 
between p11.21 and q11.12, which spans across the centromere of the 
chromosome. This spectrum would be described as noisy, as the blue and red dye 
lines appear to come together at various positions across the chromosome. This 
type of noise was also visible on spectra from other RH5 chromosome ratio plots.   
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7.7. Overall summary of aCGH results 
 From the results obtained thus far, the numbers of changes detected 
were different for each stem cell line. The results concur that the stem 
cell lines with the largest number of changes were RH5 and HUES9. 
 
 Chromosome changes detected that were common to RH5 on both 
mouse and human feeders included 7, 10, 12 and 20. Changes detected 
that were common to RH5 on mouse feeders included chr.1, 10, 12 and 
for RH5 on human feeders; 7, 12, and 17.  
 
 Chromosome changes detected that were common to HUES9 cultured 
on both mouse and human feeders were 7, 12, 17, 19 and 20. Of these 
changes, 3 were common to RH5 cultured on human feeders, 7, 12 and 
17. No direct correlations of changes were seen on mouse feeders.  
 
 NCL5 had the least number of changes overall, compared with the other 
stem cell lines, however a high number of changes were seen from 
NCL5 cultured on MEF (11 changes) though many of these changes 
were small. Chromosome changes detected that were common to NCL5 
cultured on both mouse and human feeders included chr.12, 19 and 20. 
No changes were common to NCL5 cultured on human feeders, and 
three changes were common to culture on mouse feeders; chr.12, 20 
and 22. Only an aberration on chr.18 was common to NCL5 cultured on 
HDFN and Matrigel.  
 
 Chromosomal changes that were common to all three stem cell lines 
cultured on both feeder types were chr.12 and 20. A loss on 
chromosome 7 was common to HUES9 and RH5. Chromosomal 
changes consistent with culture on Matrigel across the three stem cell 
lines demonstrated losses and gains on chr.4 (partial, q arm), 6 and loss 
on chr.9 and 12.  
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7.5 Discussion 
Monitoring the karyotypic stability of human embryonic stem cell lines is of 
paramount importance to the quality assurance of stem cell lines, so their true 
potential in regenerative medicine can be realised (Josephson, 2007). The major 
concern for the use of hESCs in cell replacement therapies is safety, as there is a 
possibility that the cells may become tumorigenic (Fox, 2008). Therefore, as 
tumorgenic cells are associated with genomic alternations, it is extremely important 
that the chromosomal stability of hESCs is monitored during their culture, and 
detected appropriately. The UKSCB is working towards ensuring that the 
environment i.e. media and conditions used to culture, as well as methods used to 
propagate and expand a line are well controlled and documented. More importantly, 
it is also aiming to routinely determine the effects of culture conditions on 
chromosomal stability and has therefore embarked on researching methods to better 
characterise karyotypes of stem cell lines alongside the routine release criteria 
testing it carries out.  
Karyology testing has previously been performed using traditional metaphase spread 
preparations and the method has been adopted from other cell types for G banding 
analysis in a clinical setting. However, considerable inconsistencies were found 
when applied to stem cell lines cultured in-house. G banding is carried out using 20 
to 30 chromosome spreads, yet final banding analysis is sometimes based on as 
little as 3 to 5 cells which can be biased and is not representative of whole 
populations of cells. 
Despite successful preparation of stained metaphase spreads from a number of 
project samples which were confirmed by a Biologist in-house, many of the 
metaphase spread preparation were not successfully analysable for G banding. This 
may have been due to incorrect processing. Most of the cell types processed at TDL 
are from routine clinical blood and tissue samples. Preparing metaphase spreads 
from hESCs requires subtle but important differences in processing methods 
compared to other cell types, as hESCs are more fragile (Personal communication 
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with cytogeneticist from Cell Line Genetics, USA). Those results which were 
successfully analysed by outsourced G banding analysis did give interesting results. 
Many of the smaller aberrations reported from the stem cells lines used in this 
project were considered artefacts.  It is known that smaller cell aberrations can be 
detected by a Clinical cytogeneticist when performing G banding analysis from 
human blood samples, but not always reported (Barber et al., 2005), as they are 
such a frequent occurrence within the human population and are not considered 
significant (Personal communication with D Baker, Cytogeneticist, Sheffield). It is 
questionable whether such small aberrations may affect a small biological system 
such as a stem cell population, in contrast to a human. Also, it raises questions as to 
how to determine cut-offs for reporting small changes. There are also concerns 
about the sensitivity and robustness of the technique which favoured the 
investigation and development of alternative methods. 
For this purpose, the UKSCB has assessed the suitability of aCGH which was a 
focus of this thesis. This method is reportedly more sensitive and provides more 
reliable information changes in whole cell populations and requires relatively small 
amounts of DNA. aCGH has already been employed in other clinical settings 
(Schaeffer et al., 2004; Shinawi & Cheung, 2008; Shaffer et al., 2007) and its 
sensitivity was much greater compared with G banding. aCGH also provides more 
reliable information with regards to whole population changes of stem cells in culture, 
even though it requires relatively small amounts of DNA.  
The results show that RH5 had the highest number of detected changes over 20 
passages. The observation that some stem cell lines have a tendency to acquire 
more karyotypic changes over time than others is consistent with other groups 
(Maitra et al., 2005). NCL5 exhibited the least amount of changes when comparing 
both human, mouse feeders and Matrigel cultures, although NCL5 cultured on iMEFs 
mouse feeders and iHDFn human feeders both demonstrated  more than 9 changes, 
most of these were very small aberrations. These changes were therefore not 
marked as significant, as they were not linked with more than 50 genes. This method 
of reporting was recommended by Perkin Elmer (Personal communication). 
Chromosomal changes common to all three stem cell lines cultured on feeders were 
found on Chr.12 and 20. Both these changes have already been reported in other 
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stem cell lines and claimed to be associated with long term passage (Draper et al., 
2004;Lefort et al., 2008). Changes on chromosome 20 have been linked to BCL2l1,  
a gene thought to drive culture adaptation in ES cells (Amps et al., 2011).  
Furthermore, gain of chromosome 20q, as shown in these studies, has also been 
noted in yolk sac carcinoma and germ cell tumors which contain EC cells (Baker et 
al., 2007). A few interesting correlations were found as result of culture on mouse 
and human feeders overall, particularly between RH5 and HUES9. Changes on 
chromosomes 7, 12, 17 and 20 were detected from both mouse and human feeders. 
Other groups have researched into the selective advantage of changes specific to 
chromosome 12 populations in hESCs (Draper et al., 2004; Mayshar et al., 2010) 
specifically trisomy 12, which has been shown to give hESCs a clonal advantage 
(Amit et al., 2000) (Gertow et al, 2007) and found that once transplanted in vivo, 
these cells were negatively selected. By nature, hESCs have poor clonal efficiency 
(>1%), therefore selective pressures give rise to increased clonal efficiency through 
changes in karyotype (e.g. trisomy 12) over long term passaging (Ludwig et al., 
2006). Furthermore, injection of these cells lead to the development of early renal 
precursors, however, no conclusions were made as to why this occurred, despite the 
lack of trisomy 12 stem cells found in vivo. Also, Mayshar et al (2010) demonstrated 
that a human IPSC line with aneuploidies had elevated levels of Nanog, a 
transcription factor and regulator of pluripotency (Chambers et al., 2003). This may 
infer a growth advantage over other cells in vitro, if expressed phenotypically as high 
levels of Nanog have been associated with repression of specific differentiation 
towards neuronal crest and Neuroectoderm (Wang et al., 2013). More recently Amps 
et al (2011) demonstrated the tendency of an ethnically diverse group of hESCs (125 
lines) to acquire changes due to prolonged culture, particularly in chr.1, 12 17 and 20 
confirmed by SNP arrays. Such large studies do confer the effects of long term 
passaging of hESCs on chromosomal stability. 
Overall, changes were detected on both feeder types and appeared to be more 
inherently correlated with the individual lines themselves. Stem cell line NCL5 had 
the least amount of changes when cultured on iMRC5 and iHDFn human feeders 
and Matrigel. HUES9 exhibited mostly a gain in chromosomal material overall, and 
had the least amount of changes when cultured on iMEF, i3T3 mouse feeders and 
Matrigel. RH5 exhibited both losses and gains and also had the least number of 
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aberrations when cultured on i3T3 mouse feeders. Subsequently the same number 
and similar changes were detected from RH5 cultured on iMRC5 and Matrigel 
(chr.20 and 22). iHDFn human feeders and iMEF mouse feeders both gave rise to 
hESC cultures with a greater number of chromosomal changes, whereas cultures on 
iMRC5 human feeders and i3T3 mouse feeders both had the least. A study by 
Eiselleova et al (2008) suggested that the ability of a feeder layer to promote the 
undifferentiated growth of hESCs is attributed to its characteristic growth factor 
production. Although this was interesting data, there was no information on the effect 
of chromosomal stability with relation to culture on feeder types. Furthermore, as 
with most literature confirming hESC stability, techniques such as G banding and 
FISH have been used, which give overall status of a hESC line based on the 
chromosomal status of a small number of cells, or only examine a particular set of 
chromosomes (Richards et al., 2003; Ellerstrom et al., 2007;Eiselleova et al., 2008). 
Comparison studies to demonstrate the undifferentiated growth of hESCs by mouse 
and human feeders Ellerstrom et al (2007) concluded that human feeders supported 
hESC growth better than mouse feeders but confirmed that hESCs cultured for 20 
passages still remain normal with diploid karyotype. However, analysis was carried 
out using FISH and was specific for chromosomes 12, 13, 17, 18, 20, 21, x and y. 
This does not rule out changes that may have occurred due to low resolution of the 
technique, or discrepancies in the way results were reported for hESC lines, as 
shown by the G banding results obtained in these studies. 
There is very little literature that robustly demonstrates the contribution of different 
culture on feeder types to the chromosomal stability of hESCs. These results 
conclude that there was no significant difference between hESCs cultured on mouse 
and human feeders. Although these studies cannot offer an explanation for many of 
the smaller aberrations detected, they do provide a reference data set for further 
work. Studies have demonstrated that karyotypic abnormality can affect a stem cell 
lines ability to differentiate (Fazeli et al., 2010) This has also been demonstrated in 
neural derivatives of hESCs which carried a chromosome 1q deletion and therefore 
cold not integrate and expand when engrafted in rat models (Varela et al., 2012).  
It is well known that a number of chromosomal aberrations have a known effect on 
humans when present in a larger proportion of CNVs. For example a loss at 
chromosome 17p11.2 is associated with Smith-Magenis syndrome (90% of all 
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detections).  Clinical presentations include brachycephaly, midface hypoplasia, 
speech delay with or without hearing loss, psychomotor and growth retardation, and 
behavioural problems. Similarly, Trisomy on chromosome 21 is associated with 
Downs‘s syndrome and detection of trisomy on chromosome 13 is linked with loss of 
life within the first month. Of the infants which survive, approximately 80% will 
develop congenital heart disease. Another chromosomal change often associated 
with disease is the loss at chromosome 13q12-13q21 which results in a loss of a 
gene called Rb, linked to tumor formation, Retinoblastoma.  
Several chromosomal changes were detected by aCGH in a number of the cell 
samples analysed in these studies, and included a loss of chromosome 13, 21 and 
17p. These changes may have a significant impact on the use of abnormal stem cell 
lines for future therapeutic applications, particularly those changes which are linked 
with low copy number variations, as a small alteration in chromosomal stability can 
have detrimental effects in a human. Thus application for clinical trials using cell lines 
should undergo stringent scrutiny for lines harbouring such changes and it should be 
reliably demonstrated that these changes are not present or any that exist would not 
have a profound effect on the animal/human subject (Weissbein et al., 2014 ;Ben-
David and Benvenisty., 2011; Goldring et al., 2011).  
Furthermore, it has been documented that many aberrations occur in humans, 
without phenotypic effects (Barber, 2005; Kowalczyk et al., 2007). Therefore it is 
important to be aware of the fact that chromosomal changes can occur and that a 
cytogeneticist in a clinical setting would not report these as they are known to be 
asymptomatic. It is also thought that such changes would not have severe 
consequences with regards to stem cell cultures; therefore if the same aberrations 
are detected they should not be reported (personal communication, D.Baker, 
Cytogeneticist).  Guidance from cytogeneticists would surely aid in making decisions 
for how best to report aberrations detected by aCGH and for deciding the ultimate 
use of hESCs in a therapeutic setting. 
Limitations to aCGH include the inability to detect changes such as balanced 
chromosome translocations. Although a number of samples analysed may 
demonstrate the presence of balanced translocations (Figure 7.6), aCGH would 
need to be coupled with other techniques such as single nuclear polymorphisms 
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(SNPs) or fluorescent in situ hybridisation (FISH) to confirm specific changes, 
particularly in long term cultures. aCGH also requires an experienced person to set 
up and run assays over 3 days which is very laborious. Both results and analysis can 
be operator variable due to complex preparation and it is an expensive technique to 
set up and maintain.  
To more accurately conclude the results discussed here, further repeat testing can 
confirm whether some of the results obtained, particularly smaller, non-significant 
changes, were as a consequence of culture due to matrix or long term passaging. 
This study demonstrates the importance of standardising culture and passaging 
methods. Selection and outgrowth of advantageous population of stem cells can 
occur rapidly in culture (Mayshar et al., 2010; Nguyen et al., 2012).  Suitable 
suggestions would be to pool samples from culture vessels (i.e. a 6 well plate or 
flask), then passage cells to ensure a heterogeneous population is selected and 
passaged on. 
 
The wide variation in derivation methods of stem cell lines has also been a cause of 
explanation as to why some stem cell lines differ karyotypically to others (Inzunza et 
al., 2005; Hanson & Caisander., 2005). This does serve as a reminder that human 
embryonic stem cells are artefacts or transitional cells between very immature and 
differentiated cell types which only exist in the body for very short amounts of time. It 
is also a reminder of how little we understand about the similarities between in vitro 
cultured stem cells and in vivo stem cells, The sensitivity in detecting partial 
chromosome losses and by aCGH as demonstrated by these studies, has been used 
to investigate rates of aneuploidy and mosaicisms in preimplantation embryos, and 
has uncovered de novo changes (Mertzanidou et al., 2012). In addition, it has been 
reported that blastocysts (from which stem cells are derived) harbour chromosomal 
changes such as trisomys, tetraploidys and aneuploidys (Clouston et al., 2002; 
Fragouli et al., 2008). It has also been speculated that blastocysts might outgrow or 
‗self-correct‘ these changes through different mechanisms such as repair, apoptosis 
of aneuploid cells and preferential selection of diploid cells (Gonzalez-marrino et al., 
2003; Los, et al., 2004; Robberecht et al., 2010). Such theories maybe true of what 
also occurs in long term cultured hESCs and does warrant investigation as to what 
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precisely in their microenvironment triggers these smaller aberrations, to better 
establish how to prevent them from occurring in vivo. 
Some of the changes which are linked to prolonged culture may have already been 
established in these stem cell lines prior to their deposit and banking. All three hESC 
lines used for these studies were deposited at over twenty passages. Stem cell 
banks have no control on the passage number of a cell line deposited and are 
obliged to accept hESC lines with appropriate consent.  
Furthermore, the number of passages it takes to bank a stem cell line is rarely 
consistent and therefore difficult to minimise. For these reasons, stem cell lines may 
already be genetically unstable before they are banked. This may have an effect on 
their potential for clinical applications. Some hESCs line may only be suitable for 
disease modelling or research based toxicity assays up to a particular passage 
where they have demonstrated genetic stability. Many researchers will work with 
lines for only 10 passages per project/experiment before returning to a small seed 
stock of early passage stem cells as they are concerned about such implications, 
and such practice has been recommended (Coeke et al., 2009). Nonetheless, cells 
used in therapeutic applications have already been shown to harbour aberration, for 
example MRC5 cells used in vaccine manufacture (Rosolowsky et al., 1998). 
However the aberration did not affect the cell lines ability to function as it was found 
in low frequency. What is important is whether the aberration is expressed in a large 
number of the overall population, and how the specific change(s) affects the function 
and ultimate use of the cell line in future studies e.g. how the cells may behave in 
vivo following transplantation.  The accurate screening and detection of large and 
small aberrations will help to make informed decisions as to which stem cell lines 
and conditions are best for progressing research towards therapeutic applications.  
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7.6 Conclusion 
 
The use of human embryonic stem cells as sources for cellular therapeutics is 
quickly approaching. When maintained in long term culture, stem cells show a loss of 
chromosomal integrity. Common abnormalities include whole chromosomal gains 
and losses. However aberrations detected as a result of hESCs cultured on different 
feeders did not demonstrate a difference due to mouse or human feeders.  Cultures 
from Matrigel did however, demonstrate overall better chromosomal stability. The 
data show that the PerkinElmer aCGH platform was far more reliable and sensitive 
compared with traditional G banding, which is currently used for clinical applications. 
aCGH provides all of the necessary tools for the detailed analysis of the common 
chromosomal changes associated with the long term culture of hESCs. 
 
Further consensus is required for reporting results with minor chromosomal changes 
as these may not be consistent with phenotypic changes found in humans unless it 
provides useful information for deciding what cell lines to use in clinical practice. 
Used in combination with FISH or SNP arrays to confirm specific aberrations, aCGH 
can provide robust and sensitive chromosomal analysis of stem cell lines. 
 
As chromosomal stability becomes a focal point in hESC culture, the need for clear 
reporting guidelines will become a necessity to ensuring useful results are reported. 
The consequences of genetic changes in hESCs may require researchers to be 
selective when deciding which stem cell lines to use in a therapeutic setting.  The 
study of stem cell lines with genetic aberrations is of interest as some have 
demonstrated a growth advantage over other lines. Observations of spontaneous 
changes in culture which disappear or reappear at later passage indicate a need to 
monitor smaller karyological changes more closely, particularly when assessing their 
suitability for clinical application. 
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Chapter  8 
General discussion 
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Chapter  8 
8.1 General discussion 
The application of stem cells for cell therapies is promising. In order for this potential 
to be fully realised, researchers require access to well characterised hESCs from 
qualified cell sources.  While there are a number of stem cell banks that are solely 
dedicated to research banking and distribution worldwide (Taiwan Stem Cell Bank, 
WISC Bank Wisconsin, USA, Spanish Stem Cell Bank, Cellartis in Sweden), their 
methods of culture, cryopreservation and testing all vary as a result of local 
requirements, research objectives and available funding. Although the time and effort 
required to bank hESCs is considerable and requires much experience and 
investment to set up and maintain, the benefits ensure that research grade and now 
clinical grade hESC lines can be banked and made available to the wider stem cell 
community, saving researchers time and money. Clinical grade hESC lines have 
already been derived under cGMP conditions (Stephenson et al., 2012; Ilic et al., 
2012) and the move towards using human feeders and in particular clinical grade 
human feeders has been qualified for supporting hESC derivation and culture 
(Prathalingam et al., 2012).  
The recent development and use of xeno free media and matrices is also a step 
forward to progressing the move towards better standardised culturing methods and 
therapeutic applications. Scale up methods and advances in the development of new 
substrates have also been focused towards supporting the delivery of uniform and 
quality control tested clinical grade hESCs (Crocco et al., 2013; kunova et al., 2013; 
Serra et al., 2012). However their reproducibility has yet to be demonstrated.  As 
early clinical trials have already begun (Brindley & Mason., 2012; Schwartz et al., 
2012), research has once again been focused on progressing the development of 
robust methods to culture and characterise hESCs, to continue their momentum 
towards therapeutic and pharmaceutical applications.  
The UKSCB conducts focused research activities in cell banking, cryopreservation, 
stem cell characterisation and safety testing. This is in line with The Code of Practice 
developed by the Steering Committee and is key to the translation of research for 
clinical applications. The UKSCB has many research collaborations focused around 
these activities and the standardised and robust characterisation of hESCs has 
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played an important role in the delivery and completion of many projects e.g. ISCI 
and ESNATs.  
hESCs require culturing using standardised methods that are both reliable and 
robust, and maintain phenotypic and genetic stability. This thesis was also focused 
on improving the current characterisation methods of hESCs. The methods chosen 
to assess the ability of feeders to maintain undifferentiated hESC growth were based 
on the ISCI study (Adewumi et al., 2007). The emphasis placed on qualifying new 
technologies such as TissueFaxs™ and aCGH was not an easy task, however, 
proved far more sensitive than previous techniques used in- house and in turn gave 
rise to more reliable results. Although there have been several comparative studies 
of mouse and human feeders to support hESC growth, the studies described here 
provided a much more detailed analysis of these effects on different hESC lines. The 
overall effects of culture on different mouse and human feeders and Matrigel from 
early to late passage are summarised in Table 8.1. aCGH revealed that hESCs do 
acquire aberrations in prolonged culture however the detailed differences in 
chromosomal aberrations of hESCs NCL5, RH5 and HUES9 have not previously 
been reported. Although no significant differences were found between cultured 
hESCs on mouse and human feeders, particular emphasis on the detection of novel 
partial losses and gains were achieved, as a result of using more sensitive 
techniques compared with G banding. 
As the drive towards using hESCs for therapeutics increases, the thorough 
assessment of Matrigel and feeders provides researchers with clear reasoning of the 
effects of using different matrices for hESC culture. hESCs are notoriously difficult to 
culture and expand, and as part of the UKSCB wider remit to support the stem cell 
community, these findings can be appropriately communicated through the adaption 
of banking methods for scaling up of research and therapeutic grade hESCs. The 
genetic stability of hESCs was compromised by long term passaging and not the use 
of TrypLE™ Express. Subsequently, this enzyme has now been incorporated into 
routine stem cell culture and banking procedure within the UKSCB helping to speed 
up passaging compared with manual dissection and to better standardise one 
element of an already varied method. Furthermore, the use of Matrigel for hESC 
banking and scale up has also been validated, which will provide a global resource 
of feeder free hESCs, helping to give researchers more choice on starting material of 
288 
 
hESC lines and also, removing variability and potential risk of contamination with 
mouse retroviruses that could occur as a result of using MEFs. 
Table 8.1.  hESC self-renewal, genetic stability and differentiation from early to 
late passage on different matrices. 
 
Matrices/feeder 
type 
hESC 
morphology 
Expression 
of cell 
surface 
stemness 
markers 
Expression 
of stemness 
genes 
Genetic 
stability (late 
passage only) 
In vitro 
differentiation 
(late passage 
only) 
iMEF mouse 
feeder 
Same Maintained Maintained 4 
chromosomes 
affected (5, 7, 
12, and 20 
Differentiation to 
all three germ 
layers achieved 
i3T3 mouse 
feeder 
Same Maintained Maintained 2 
chromosomes 
affected (gain 
on 20, loss on 
22) 
 
iMRC5 human 
feeder 
Changed 
(Elongated 
colonies) 
Maintained Maintained 4 
chromosomes 
affected 
(losses/ gains 
detected on 
chr. 7, 12, 19, 
20) 
Differentiation to 
all three germ 
layers achieved 
iHDfn human 
feeder 
Changed 
(Elongated 
colonies) 
Maintained Maintained 4 
chromosomes 
affected 
(losses/gains 
detected on 
chr. 7, 12 17, 
18) 
 
Matrigel 
synthetic matrix 
Same Maintained Maintained 4 
chromosomes 
affected (loss 
on chr. 4, 9, 
12 and gain 
on 6. 
Differentiation to 
all three germ 
layers achieved 
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Morphology changes as a result of culture on human feeders and Matrigel 
From very early cultures it was noticeable that all four hESCs underwent changes in 
morphology, as they adapted to culture on both human feeders and feeder free 
matrix, Matrigel. Such changes gave indications as to the way in which the cells 
began to adapt to new environments. This was also apparent from IF staining, as 
differences in the proliferation were detected by sensitive imaging system 
TissueFaxs™. Notably, the effects of culturing hESCs on human feeders‘ iHDFn and 
iMRC5 led to the growth of elongated colonies. This insight cannot be gained as a 
result of IF staining by flow cytometry, and is important when assessing suitable 
cultures for passaging, as most scientists are precocious when deciding which 
colonies to dissect/enzyme passage and will routinely regard any new changes as 
differentiation.  
Characterisation of hESCs cultured on feeder and feeder free matrices 
As summarised in Table 8.1, quantitative analysis of IF stained images for stemness 
markers coupled with statistical analysis, concluded that no significant difference 
was found between mouse and human feeders, from early to late passage. The main 
differences in expression were due to stem cell line differences. This provided good 
indications that cultures were maintained in an undifferentiated state over 20 
passages on all feeder types and Matrigel. Although there are no defining criteria for 
percentage of cell surface marker expression that can be applied to determine a 
culture is truly undifferentiated, this may become an important decision, particularly 
when applied as a more robust QC test for clinical grade stem cell lines. The co-
expression of markers by TissueFaxs™ would be better to identify purer populations 
of undifferentiated hESCs. This could potentially improve the selection of hESCs for 
differentiation studies, as stem cells with reduced heterogeneity have been shown to 
dominate and further inhibit the directed differentiation of whole cultures of hESCs 
(Stewart et al., 2006; Canham et al., 2010). This would also aid the production of 
uniform undifferentiated cultures required for scale up in therapies, as it is extremely 
important to provide good starting material before differentiating cells, as shown in 
the final chapter.  
Real time PCR using TDLA cards demonstrated the continued expression of 
undifferentiated genes in all four cell lines cultured on all four feeders from early to 
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late passage, with only slight differences as a result of hESC culture on mouse and 
human feeders. Feeder free matrix Matrigel/mTeSR1 has also demonstrated 
consistent maintenance of undifferentiated hESC growth at early and late passage, 
with expression of very low level differentiation genes. Statistical analysis of results 
revealed that human feeders and Matrigel maintained the gene expression of stem 
cell markers as proficiently as mouse feeders. Furthermore,  the use of hybridomas 
for low cost, in-house undifferentiated cell surface marker testing by IF staining using 
novel instrument TissueFaxs™, for high throughput quantitative imaging analysis, 
was particularly important, as it enabled the progression of well-established but 
qualitative staining technique towards with a quantitative method, comparable with 
standard flow cytometry. These studies demonstrated that the TissueFaxs™ was 
more sensitive, thus suggesting a robust and improved novel system for determining 
cell surface marker expression of undifferentiated hESCs.  
As shown in chapter 5, low expression of endoderm transcription factor genes SRY-
Related HMG-box (SOX17) and Forkhead Box-A2 (FOXA2), were found in 
undifferentiated NCL5 cultures from all three matrices. SOX17 modulates 
transcriptional regulation via the WNT3A and inhibits Wnt signalling. FOXA2 is found 
on chromosome 20p11.21 and play an important role in hepatocyte function. This 
may indicate that these genes were endogenous to the stem cell line and 
downregulated as a consequence of further directed gene expression towards 
endoderm lineage. The use of later endoderm genes may aid in detecting whether 
this suggestion may be true.  
Differentiation potential of hESCs cultured on feeder and feeder free matrices 
As most of the studies concluded that differences in characterisation testing were as 
a result of inherent differences between the hESC lines themselves, a final test of 
pluripotency was demonstrated by the most stable hESC line from these studies, 
NCL5 cultured on iMEF, MRC5 and Matrigel. Although all conditions demonstrated 
and confirmed the ability to differentiate towards all three germ layers, differences 
were shown between the conditions. NCL5 cultured on iMRC5 indicated a 
preference to form mesoderm by TissueFaxs IF and RT-PCR and morphology, 
whereas NCL5 cultured on iMEFs and Matrigel showed a preference towards 
endoderm. 
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Stability of hESCs in long term culture 
Chromosome changes are mostly related to disease and syndromes in humans. 
However, it should always be considered that although a line may contain 
chromosomal changes, a number of CNVs may be required for the change to be 
expressed as a phenotype. A number of chromosome changes have been identified 
in humans, with no known phenotype (Barber, 2005). In addition, stem cell lines 
have been shown to change as a result of prolonged culture (Maitra et al., 2005; 
Andrews et al., 2011). Chromosomal aberrations detected in these studies by aCGH 
from the three hESCs cultured on both mouse, human feeders and Matrigel include 
12, 17, 19, and 20. These changes have already been documented and are 
associated with prolonged culturing. Additionally, a gain on Chromosome 12p-arm 
has been linked with maintenance of stem cell function through activation of key 
stem cell genes, SOX2, TDGF1, EBAF, ZFP42, FGF and NODAL (Karkalla et al., 
2006). This change was detected in HUES9 cultured on iMRC5 from early to late 
passage (aCGH, chapter 4) and can be correlated with a slight downregulation of 
SOX2 gene expression, although this was not significant. The functional effects of 
this change would need to be confirmed through gene knockout studies, to confirm 
whether the change was linked with downregulation of SOX2 or whether it requires 
the involvement of other stemness genes.  
Furthermore, the expression of GATA6 was consistently low across all hESC lines 
used in these studies. GATA6 expression has been associated with early blastocyst 
formation (Koutsourakis et al., 1999) and maintenance of pluripotency and self-
renewal alongside OCT4, NANOG and SOX2 (Adewumi et al., 2007), as well as 
being upregulated during visceral endoderm formation (Fujikura et al., 2002). GATA6 
has been linked to chromosome 18q11.2-18q.11.1, which was detected as a loss in 
NCL5/iHDFn from early to late passage by aCGH (chapter 7). This could potentially 
lead to a functional loss in development of smooth muscle which may have 
consequences later for the potential use of NCL5 in disease modelling if required to 
differentiate towards mesoderm lineage. Although the studies in chapter 6 suggest 
that this gene was not useful in determining the undifferentiated state of hESCs 
cultured in long term passaging using different matrices, it does illustrate that using a 
number of different genes to characterise hESCs provides greater confidence when 
attempting to determine overall cell state. Such detailed characterisation is crucial to 
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the consensus as to which specific detectors should be used when characterising 
hESC lines as they are intrinsically individual, and will help to better standardise the 
use of PCR for such applications. 
Identifying the effect of chromosomal changes in hESCs for their intended purpose 
would be greatly beneficial to the stem cell community. Such studies have been 
conducted, particularly with regards to the ability of hESCs with chromosomal 
instabilities, to differentiate. Indeed the studies conducted in this thesis demonstrated 
that although stem cell line NCL5 had acquired chromosomal aberrations, this did 
not impede its ability to differentiate to all three germ layers and form progenitor cells 
(chapter 6).   
Additionally, a gain on Chromosome 12p-arm has been linked with maintenance of 
stem cell function through activation of key stem cell genes, SOX2, TDGF1, EBAF, 
ZFP42, FGF and NODAL (Korkola et al., 2006). This change was detected in 
HUES9 cultured on iMRC5 from early to late passage (aCGH, chapter 7) and can be 
correlated with a slight downregulation of SOX2 gene expression, although this was 
not significant. The functional effects of this change would need to be confirmed 
through gene knockout studies, to confirm whether the change was linked with 
downregulation of SOX2 or whether it requires the involvement of other stemness 
genes.  
Also, studies detailing differentiated hESCs to neural derivatives report the 
development of chromosomal aberrations following 50 passages (Varela et al., 
2012). Following implantation into rat models, the neural stem cell cultures 
harbouring the chromosome 1q translocation also failed to integrate and expand, 
and was further demonstrated as a re-occurrence in other cultures (Varela et al., 
2012). Recently, a publication demonstrated that stem cells cultured in vivo 
displayed more karyotypic changes compared with those cultured in vitro. Such 
research does warrant further investigation, but also questions the long term stability 
of hESCs, particularly for preclinical studies, which require hESCs to be cultured in 
vitro, potentially differentiated then engrafted or injected into hosts. These studies 
are also a strong reminder of the endogenous nature of hESCs, which, in their 
natural state, exist as transient populations in vivo.  
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Differences between feeders 
Explanations as to why differences between human and mouse feeders occurred 
may be due to the different sources of feeders. MRC5 are derived from human foetal 
lung. Foetal tissue has been previously shown to support undifferentiated hESC 
growth (Richards et al., 2003). HDFn fibroblasts are derived from neonatal foreskin. 
Foreskin derived fibroblasts have also been documented to support stem cell growth 
(Kueh et al., 2006). MEF and 3T3 fibroblasts are derived from mouse embryos. 
NIH3T3 have been used to culture keratinocytes used in skin transplantation. 
Although MEFs and 3T3s are very similar, their slight differences are enough to 
produce differences in proliferation within a stem cell line. This is probably due to the 
secretion of different proteins, growth factors and hormones which enable and 
promote successful attachment and growth of stem cells (Eiselleova et al., 2008). 
These differences were subtle throughout the characterisation of undifferentiated 
cultures from early to late passage, but when late passage NCL5 were differentiated 
to all three germ layers in vitro for 7 days, the differences between each matrix was 
clearly demonstrated.  Differences in levels of Activin A, fibroblast growth factors 
(FGFs), laminin and collagen, secreted by each feeder type, or in the case of 
Matrigel/mTeSR1, incorporated within the ECM and media, will have undoubtedly 
influenced the microenvironment of NCL5 over long term passaging. Although all 
three matrices supported in vitro differentiation to all three germ layers, clearly 
different matrices showed preferences to different germ layers. Although the co 
culture of hESCs to improve differentiation has been demonstrated (Pekkanen-
Mattila et al., 2012), these studies represent the first comparison of the three 
matrices discussed here as a result of pre-culture on different matrices over 20 
passages. Such differences need to be further demonstrated with other cell lines and 
exploited to perhaps be incorporated into the design of better substrates, to further 
enhance the differentiation potential to specific lineages, for example MRC5 or MEF 
towards mesoderm. It also highlights the point that there is still more to be uncovered 
in terms of how microenvironment can be better mimicked for improving in vitro 
differentiation. 
Inherent differences between stem cell lines 
Information about inherent differences between stem cell lines is important to 
researchers so they can make better informed decisions about which lines are best 
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to use in terms of growth rates, stability, and ability to expand and differentiate over 
time. At this early stage in human embryonic stem cell research it may be right to 
argue that all characterisation information detailing differences between hESC lines 
be reported, until firm decisions can be made on the criteria for hESCs to be used in 
therapies. The results from this thesis certainly support other reports that hESC lines 
are different from each other, particularly when passaged for extended periods of 
time. However, it may be that from the thousands of lines which have now been 
derived, only a select few will be taken forward for clinical use. This is more 
dependent on how focused the move towards personalised medicine becomes, and 
whether IPSCs prove to be an equal alternative to hESCs. 
The sensitive QC testing used in these studies demonstrates the importance of 
characterising stem cell lines, as they are all individual. Most of the subtle 
differences arise due to their individuality and how they attach, adapt and proliferate 
as a result of changes in their microenvironments.  These studies also provided 
further insight into how microenvironment influences differentiation in vitro. A better 
understanding of these changes can help to improve culturing conditions as well 
developing more robust characterisation testing. This is important to the wider stem 
cell community, as the progression to clinical application is imminent. 
The future of stem cells in therapy 
Studies for phase I/II clinical trials using stem cells have already begun. One major 
hurdle is the development of suitable potency bioassays, to confirm that the 
manufactured cell product is still functioning as specified. Such assays may be in the 
form of testing for phenotypic markers or gene expression studies (Bravery et al., 
2012). Most likely they will be a combination of both. The studies carried out here 
demonstrate the work required to standardise such assays. Refining these culture 
methods/systems and incorporating them with xeno free counterparts such as 
mTeSR2 media will help to support the culture of clinical grade hESC lines. In 
combination with sensitive and robust techniques, equipment/platforms, the 
development of potency assays for clinical trials can be realistically achieved, and 
the dream of using hESCs in a therapeutic setting, a closer reality. 
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Final conclusion and future work  
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Conclusion 
 
These studies have demonstrated the use of human feeders and Matrigel to 
maintain the undifferentiated growth of hESCs via robust and sensitive 
characterisation testing. Although the maintenance of stemness genes and cell 
surface markers were evident, hESCs undergo chromosomal changes in long term 
culture. In vitro differentiation studies using stem cell line NCL5 show that this did not 
affect their ability to form progenitors from all three germ layers. Human feeder 
MRC5, mouse feeder MEF and feeder free matrix Matrigel maintained the 
expression of stemness markers from three hESC lines and supported the 
differentiation of stem cell line NCL5 in vitro. However differences were observed in 
their propensity towards specific pathways. Although such insights have been 
demonstrated by other matrices and feeder types, this is the first comparing cultures 
on iMRC5 human feeders, iMEF and Matrigel.   
The variations between different stem cell lines ability to adapt to new matrices 
highlight the intrinsic differences between the lines themselves and can provide an 
insight to how these cells behave in vitro. Unfortunately, it does make standardising 
culture methods difficult and even as the field progressing rapidly, with the 
development of many commercial media and matrices that are defined and xeno 
free, they are usually shown to work only with a select few stem cell lines. These 
studies stress the importance of exploring the suitability of different matrices/feeders 
and stem cell lines by comparison studies, as contributing such information to the 
wider stem cell community can only enhance knowledge on the selection of suitable 
cell lines and their conditions, as well as highlighting the importance of developing 
and continually improving the culture process and characterisation testing, for 
progressing their unique potential in disease and clinical therapies. 
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Future work 
  
These studies have provided insight and considerable contribution to knowledge for 
the stem cell community by demonstrating 1) the smaller chromosomal abnormalities 
acquired in hESCs (by aCGH) as a result of long term culture, 2) the morphological 
changes that occur as a result of culture on human feeders in comparison to mouse 
and their effects on cell surface marker expression, 3) the effects of hESC 
differentiation on gene expression and morphology as a result of long term culture on 
different matrices, and 4) the potential applications of more sensitive characterisation 
techniques for the development of potency assays in early clinical studies. This 
thesis has generated new data which requires further investigation to answer 
important questions and conclude particular aspects of this research. 
• Confirm detected aCGH changes using Single Nucleotide Polymorphism 
(SNP) arrays, in particular for chromosomes 7, 12q, 17q and 20, as aCGH produces 
huge amounts of information, it is important to determine what information is 
important. 
• Demonstrate the ability of different hESC lines to differentiate towards all 
three germ layers using Matrigel and MRC5 human feeders. Further extended 
differentiation assays towards specific cell types may provide a better insight into the 
effect of culture on pathway selection using human feeders and Matrigel. This could 
also be combined with knockout studies to identify and confirm pathway selection as 
a result of secreted growth factors from feeders. 
• Further QC testing to give proteomic and carbohydrate analysis of MRC5 and 
MEF feeders to identify the exact proteins/growth factors that support hESC growth 
(e.g. FGF2) could allow for the development of a combined ECM which could then 
be completely defined, Xeno free hESC culturing system. Demonstrating the 
supportiveness for such a matrix could then be validated, incorporated into routine 
banking of hESCs and would add considerable value to the stem cell lines banked 
by UKSCB, including advancing the scope for clinical applications. 
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Appendix 1 
 
Applied Biosystems, Inc. (http://www.appliedbiosystems.com)
Taqman Low Density Array configuration: Human Stem Cell4385225
Appendix-1
Spreadsheet showing primer details of genes on TLDA card
Assay Map:
Hs99999903_m1 Hs006063 Hs00173490_m1 Hs00217848_m Hs00156373_m
Hs00277509_m1 Hs002327 Hs00255287_s1 Hs00241459_m Hs00544355_m
Hs00158126_m1 Hs001740 Hs00196158_m1 Hs00300550_m Hs00158620_m
Hs00742896_s1 Hs008298 Hs00603586_g1 Hs00234119_m Hs00194498_m
Hs99999903_m1 Hs006063 Hs00173490_m1 Hs00217848_m Hs00156373_m
Hs00277509_m1 Hs002327 Hs00255287_s1 Hs00241459_m Hs00544355_m
Hs00158126_m1 Hs001740 Hs00196158_m1 Hs00300550_m Hs00158620_m
Hs00742896_s1 Hs008298 Hs00603586_g1 Hs00234119_m Hs00194498_m
Hs99999903_m1 Hs006063 Hs00173490_m1 Hs00217848_m Hs00156373_m
Hs00277509_m1 Hs002327 Hs00255287_s1 Hs00241459_m Hs00544355_m
Hs00158126_m1 Hs001740 Hs00196158_m1 Hs00300550_m Hs00158620_m
Hs00742896_s1 Hs008298 Hs00603586_g1 Hs00234119_m Hs00194498_m
Hs99999903_m1 Hs006063 Hs00173490_m1 Hs00217848_m Hs00156373_m
Hs00277509_m1 Hs002327 Hs00255287_s1 Hs00241459_m Hs00544355_m
Hs00158126_m1 Hs001740 Hs00196158_m1 Hs00300550_m Hs00158620_m
Hs00742896_s1 Hs008298 Hs00603586_g1 Hs00234119_m Hs00194498_m
Gene Symbols
ACTB ACTC AFP BRIX CD34
FN1 FOXA2 FOXD3 GABRB3 GAL
ISL1 KIT KRT1 LAMA1 LAMB1
POU5F1 PTEN PTF1A RAF1 REST
ACTB ACTC AFP BRIX CD34
FN1 FOXA2 FOXD3 GABRB3 GAL
ISL1 KIT KRT1 LAMA1 LAMB1
POU5F1 PTEN PTF1A RAF1 REST
ACTB ACTC AFP BRIX CD34
FN1 FOXA2 FOXD3 GABRB3 GAL
ISL1 KIT KRT1 LAMA1 LAMB1
POU5F1 PTEN PTF1A RAF1 REST
ACTB ACTC AFP BRIX CD34
FN1 FOXA2 FOXD3 GABRB3 GAL
ISL1 KIT KRT1 LAMA1 LAMB1
POU5F1 PTEN PTF1A RAF1 REST
Doc. PN 4385326A
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Appendix-1
Spreadsheet showing primer details of genes on TLDA card
Assay Map: Hs00233521_m1 Hs00174344_m1 Hs00230919_m1 Hs00361224_gH
Hs99999905_m1 Hs00171403_m1 Hs00232018_m1 Hs00230965_m1
Hs00267056_m1 Hs00764128_s1 Hs00158730_m1 Hs00702808_s1
Hs00231692_m1 Hs00173810_m1 Hs00165475_m1 Hs00293258_m1
Hs00233521_m1 Hs00174344_m1 Hs00230919_m1 Hs00361224_gH
Hs99999905_m1 Hs00171403_m1 Hs00232018_m1 Hs00230965_m1
Hs00267056_m1 Hs00764128_s1 Hs00158730_m1 Hs00702808_s1
Hs00231692_m1 Hs00173810_m1 Hs00165475_m1 Hs00293258_m1
Hs00233521_m1 Hs00174344_m1 Hs00230919_m1 Hs00361224_gH
Hs99999905_m1 Hs00171403_m1 Hs00232018_m1 Hs00230965_m1
Hs00267056_m1 Hs00764128_s1 Hs00158730_m1 Hs00702808_s1
Hs00231692_m1 Hs00173810_m1 Hs00165475_m1 Hs00293258_m1
Hs00233521_m1 Hs00174344_m1 Hs00230919_m1 Hs00361224_gH
Hs99999905_m1 Hs00171403_m1 Hs00232018_m1 Hs00230965_m1
Hs00267056_m1 Hs00764128_s1 Hs00158730_m1 Hs00702808_s1
Hs00231692_m1 Hs00173810_m1 Hs00165475_m1 Hs00293258_m1
Gene Symbols CD9 CDH5 CDX2 CGB
GAPD GATA4 GATA6 GBX2
LAMC1 LEFTB LIFR LIN28
RUNX2 SEMA3A SERPINA1 SFRP2
CD9 CDH5 CDX2 CGB
GAPD GATA4 GATA6 GBX2
LAMC1 LEFTB LIFR LIN28
RUNX2 SEMA3A SERPINA1 SFRP2
CD9 CDH5 CDX2 CGB
GAPD GATA4 GATA6 GBX2
LAMC1 LEFTB LIFR LIN28
RUNX2 SEMA3A SERPINA1 SFRP2
CD9 CDH5 CDX2 CGB
GAPD GATA4 GATA6 GBX2
LAMC1 LEFTB LIFR LIN28
RUNX2 SEMA3A SERPINA1 SFRP2
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Appendix-1
Spreadsheet showing primer details of genes on TLDA card
Assay Map: Hs00164004_m1 Hs99999901_s1 Hs00156568_m1 Hs00201350_m Hs00275636_m1
Hs00174967_m1 Hs00172692_m Hs00220998_m1 Hs00157674_m Hs00917999_g1
Hs00271574_m1 Hs00159528_m Hs02387400_g1 Hs00707120_s1 Hs00159598_m1
Hs00751752_s1 Hs00602736_s1 Hs00174949_m1 Hs00538143_m Hs00300531_m1
Hs00164004_m1 Hs99999901_s1 Hs00156568_m1 Hs00201350_m Hs00275636_m1
Hs00174967_m1 Hs00172692_m Hs00220998_m1 Hs00157674_m Hs00917999_g1
Hs00271574_m1 Hs00159528_m Hs02387400_g1 Hs00707120_s1 Hs00159598_m1
Hs00751752_s1 Hs00602736_s1 Hs00174949_m1 Hs00538143_m Hs00300531_m1
Hs00164004_m1 Hs99999901_s1 Hs00156568_m1 Hs00201350_m Hs00275636_m1
Hs00174967_m1 Hs00172692_m Hs00220998_m1 Hs00157674_m Hs00917999_g1
Hs00271574_m1 Hs00159528_m Hs02387400_g1 Hs00707120_s1 Hs00159598_m1
Hs00751752_s1 Hs00602736_s1 Hs00174949_m1 Hs00538143_m Hs00300531_m1
Hs00164004_m1 Hs99999901_s1 Hs00156568_m1 Hs00201350_m Hs00275636_m1
Hs00174967_m1 Hs00172692_m Hs00220998_m1 Hs00157674_m Hs00917999_g1
Hs00271574_m1 Hs00159528_m Hs02387400_g1 Hs00707120_s1 Hs00159598_m1
Hs00751752_s1 Hs00602736_s1 Hs00174949_m1 Hs00538143_m Hs00300531_m1
Gene Symbols COL1A1 18S COL2A1 COMMD3 CRABP2
GCG GCM1 GDF3 GFAP GRB7
MYF5 MYOD1 Nanog* NES NEUROD1
SOX17 SOX2 SST SYCP3 SYP
COL1A1 18S COL2A1 COMMD3 CRABP2
GCG GCM1 GDF3 GFAP GRB7
MYF5 MYOD1 Nanog* NES NEUROD1
SOX17 SOX2 SST SYCP3 SYP
COL1A1 18S COL2A1 COMMD3 CRABP2
GCG GCM1 GDF3 GFAP GRB7
MYF5 MYOD1 Nanog* NES NEUROD1
SOX17 SOX2 SST SYCP3 SYP
COL1A1 18S COL2A1 COMMD3 CRABP2
GCG GCM1 GDF3 GFAP GRB7
MYF5 MYOD1 Nanog* NES NEUROD1
SOX17 SOX2 SST SYCP3 SYP
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Appendix-1
Spreadsheet showing primer details of genes on TLDA card
Assay Map: Hs00170025_m Hs00251859_m Hs00157258_m Hs00171876_m1 Hs00745761_s1
Hs00747223_g Hs00744391_s Hs00232128_m Hs00169095_m1 Hs00705137_s1
Hs00415443_m Hs00271352_s Hs00383230_g1 Hs00187067_m1 Hs00265966_m1
Hs00610080_m Hs00356930_m Hs02339499_g1 Hs00162669_m1 Hs00232708_m1
Hs00170025_m Hs00251859_m Hs00157258_m Hs00171876_m1 Hs00745761_s1
Hs00747223_g Hs00744391_s Hs00232128_m Hs00169095_m1 Hs00705137_s1
Hs00415443_m Hs00271352_s Hs00383230_g1 Hs00187067_m1 Hs00265966_m1
Hs00610080_m Hs00356930_m Hs02339499_g1 Hs00162669_m1 Hs00232708_m1
Hs00170025_m Hs00251859_m Hs00157258_m Hs00171876_m1 Hs00745761_s1
Hs00747223_g Hs00744391_s Hs00232128_m Hs00169095_m1 Hs00705137_s1
Hs00415443_m Hs00271352_s Hs00383230_g1 Hs00187067_m1 Hs00265966_m1
Hs00610080_m Hs00356930_m Hs02339499_g1 Hs00162669_m1 Hs00232708_m1
Hs00170025_m Hs00251859_m Hs00157258_m Hs00171876_m1 Hs00745761_s1
Hs00747223_g Hs00744391_s Hs00232128_m Hs00169095_m1 Hs00705137_s1
Hs00415443_m Hs00271352_s Hs00383230_g1 Hs00187067_m1 Hs00265966_m1
Hs00610080_m Hs00356930_m Hs02339499_g1 Hs00162669_m1 Hs00232708_m1
Gene Symbols CTNNB1 DDX4 DES DNMT3B EBAF
HBB HBZ HLXB9 IAPP IFITM1
NODAL NOG NPPA NR5A2 NR6A1
T TAT TDGF1 TERT TFCP2L1
CTNNB1 DDX4 DES DNMT3B EBAF
HBB HBZ HLXB9 IAPP IFITM1
NODAL NOG NPPA NR5A2 NR6A1
T TAT TDGF1 TERT TFCP2L1
CTNNB1 DDX4 DES DNMT3B EBAF
HBB HBZ HLXB9 IAPP IFITM1
NODAL NOG NPPA NR5A2 NR6A1
T TAT TDGF1 TERT TFCP2L1
CTNNB1 DDX4 DES DNMT3B EBAF
HBB HBZ HLXB9 IAPP IFITM1
NODAL NOG NPPA NR5A2 NR6A1
T TAT TDGF1 TERT TFCP2L1
337 
 
 
 
 
  
Appendix-1
Spreadsheet showing primer details of genes on TLDA card
Assay Map: Hs00172872_m Hs00173564_m1 Hs00170454_m1 Hs001765
Hs00174360_m Hs00538956_m1 Hs00355773_m1 Hs002368
Hs00173014_m Hs00240871_m1 Hs00169777_m1 Hs001936
Hs00747497_g1 Hs00240913_m1 Hs01079824_m1 Hs003992
Hs00172872_m Hs00173564_m1 Hs00170454_m1 Hs001765
Hs00174360_m Hs00538956_m1 Hs00355773_m1 Hs002368
Hs00173014_m Hs00240871_m1 Hs00169777_m1 Hs001936
Hs00747497_g1 Hs00240913_m1 Hs01079824_m1 Hs003992
Hs00172872_m Hs00173564_m1 Hs00170454_m1 Hs001765
Hs00174360_m Hs00538956_m1 Hs00355773_m1 Hs002368
Hs00173014_m Hs00240871_m1 Hs00169777_m1 Hs001936
Hs00747497_g1 Hs00240913_m1 Hs01079824_m1 Hs003992
Hs00172872_m Hs00173564_m1 Hs00170454_m1 Hs001765
Hs00174360_m Hs00538956_m1 Hs00355773_m1 Hs002368
Hs00173014_m Hs00240871_m1 Hs00169777_m1 Hs001936
Hs00747497_g1 Hs00240913_m1 Hs01079824_m1 Hs003992
Gene Symbols EOMES FGF4 FGF5 FLT1
IL6ST IMP2 INS IPF1
PAX4 PAX6 PECAM1 PODXL
UTF1 WT1 Xist ZFP42
EOMES FGF4 FGF5 FLT1
IL6ST IMP2 INS IPF1
PAX4 PAX6 PECAM1 PODXL
UTF1 WT1 Xist ZFP42
EOMES FGF4 FGF5 FLT1
IL6ST IMP2 INS IPF1
PAX4 PAX6 PECAM1 PODXL
UTF1 WT1 Xist ZFP42
EOMES FGF4 FGF5 FLT1
IL6ST IMP2 INS IPF1
PAX4 PAX6 PECAM1 PODXL
UTF1 WT1 Xist ZFP42
338 
 
APPENDIX 2 
Table showing list of genes and corresponding Taqman probes 
used in chapter 7. 
 
 
 
 
 
 
 
Gapdh CONTROL Hs02758991_g1 
Beta Actin CONTROL Hs01060665_g1 
Pou5f STEM CELL Hs04260367_gH 
Nanog STEM CELL Hs04260366_g1 
Pax6 NEURAL Hs00240871_m1 
NESTIN NEURAL Hs04187831_g1 
Otx2 NEURAL Hs00222238_m1 
Beta3 Tubulin NEURAL Hs00801390_s1 
Neurod1  NEURAL Hs01922995_s1 
SOX1 NEURAL Hs01057642_s1 
FOXG1 NEURAL Hs01850784_s1 
DCN ENDO Hs00754870_s1 
PDGFRa MESO Hs00998018_m1 
Islet1 ENDO Hs00158126_m1 
PITX1 ENDO/MESO Hs00267528_m1 
Pecam1  MESO Hs00169777_m1 
Vimentin MESO Hs00185584_m1 
Hand1 MESO Hs02330376_s1 
Col1a1  
ENDO 
Hs00164004_m1 
Desmin MESO Hs00157258_m1 
N-cad MESO Hs00983056_m1 
SOX17 ENDO Hs00751752_s1 
Brachyury ENDO/MESO Hs00610080_m1 
FOXA2 ENDO Hs00232764_m1 
GSC ENDO Hs00418279_m1 
BMP4 MESO Hs00370078_m1 
CXCR4 ENDO Hs00607978_s1 
FGB MESO Hs00905942_m1 
